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Abstract
Introduction
Vision loss impacts >30 million people worldwide. Mutations in over 50 genes can
predispose to the retinal-degenerative disease retinitis pigmentosa (RP). Despite
this clear genetic component, disease progression in RP is potentially linked to en-
vironmental factors such as light, which can induce the formation of reactive oxygen
species leading to oxidative stress and oxidative DNA damage and inducing pho-
toreceptor cell death. Alkylating agents are used to produce animal models of RP
as DNA alkylating agents induce photoreceptor cell death. This cytotoxicity is me-
diated via the DNA repair protein alkyladenine DNA glycosylase (Aag). Hence, we
hypothesise that Aag-mediated processing of DNA base damage in photoreceptors
affects their function and the light responses in the animal.
Method
In-vivo, light/dark cycle entrained wild-type and Aag-/- mice were treated with
methyl methanesulfonate (MMS), under constant light or dark conditions, and har-
vested 6, 48, and 72-hours post-treatment for histopathological and gene expression
analysis. In-vitro, wild-type and Aag-/- primary embryonic fibroblast cells (pMEFs)
were treated with MMS at different circadian phases, and assessed for their circa-
dian phase-response to MMS.
Result
Marginal light exacerbation of Aag-mediated retinal-degeneration upon alkylation-
exposure is observed in wild-type retinas. Photoreceptor cell function is apparently
affected basally and upon alkylation-exposure in wild-type and Aag-/- mice. Mice
melanopsin expressing retinal ganglion cells are resistant to alkylation-damage with
no reduction in melanopsin expression. Early gene expression analysis of wild-type
and Aag-/- mice tissues in response to MMS-treatment showed a link between Aag
iii
iv
status and upregulation of key cellular stress response mechanisms. MMS seemed to
reset the circadian clock in pMEFs in a circadian-time dependent-manner without
involving Aag.
Conclusion
Aag-deficience can rescue alkylation sensitivity in specific cell types via reducing
BER-intermediates accumulation, but Aag is required to play a role in the tran-
scriptional activation of several key genes associated with cell survival, death and
function upon alkylation-exposure.
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Chapter 1
Introduction
1.1 The Eye and Photoreceptors Role in Light-Response
The eye is the sensory organ responsible for vision. Vision is described as the process
involved in the forming of mental image by the brain based on the translation
of light reflection from an object in the environment. From an anatomical and
histological point of view, the eye consists of three separate coats, or tunics namely
the sclera, the choroid, and the retina (Figure 1.1). The sclera is the outermost tunic
consisting of tough connective tissue, and modified interiorly to form the cornea
(white of the eye). The second coat of the eyeball is the choroid, which contains
a delicate network of connective tissues comprised of a lot of blood vessels, and
quite dark brown pigment. It is acting similar to the dull black lining of the camera
in order to protect the eyes inner surface from scattering and reflecting incoming
light rays. Finally, the innermost tunic is the retina, and it contains the eyes
actual photoreceptor layer. It is composed of light sensitive cells known as rods and
cones which generate the nerve impulses connected with vision as described below
(Silverthorn, 2016, Ganong, 2005). In addition, there are other types of features that
have an important function in vision and pathway of light rays and refraction such
as the aqueous-humor (watery fluid), the vitreous body (soft gelatinous matrix),
the optic disk, and other features (Silverthorn, 2016, Ganong, 2005).
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Figure 1.1: Cross section of mouse eye, explaining the anatomical & histological features
of the eye. GCL, ganglion cell layer; IPL, Inner plexiform layer; INL, inner nuclear layer;
OPL, outer plexiform layer; ONL, outer nuclear layer; IS, inner segment; OS outer segment;
RPE, retinal pigment epithelium. Magnification: 4X for whole cross section of the eye ball,
40X for the zoomed retinal layers; haematoxylin & eosin stained.
1.1.1 The Retina
The mammalian retina is remarkably refined and adapted tissue capable of light
detection. It plays important roles in formation of images and non-visual light per-
ception, such as manipulating the circadian rhythms, via the conversion of light
wavelengths into useful information for the brain. The retina is usually considered
to have two main components; the pigmented epithelium of retina (RPE), and the
neurosensory retina. Histological examination of the neural retina depicts its dis-
tinctive lamination where three principal layers of nuclei are ordered perpendicular
to the inner-outer axis (Figure 1.1). From internal to external, the first layer is the
ganglion cell layer, where cell bodies of the various classes of retinal ganglion cells
and displaced amacrine cell are located. The following layer is the inner nuclear
layer (INL) which is the location of the nuclei of bipolar, amacrine, horizontal, and
Muller cells. The third layer is the outer nuclear layer (ONL), where the nuclei of
rod and cone (classical) photoreceptor are located (Mullins and Skeie, 2010, Silver-
thorn, 2016).
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Additionally, within the retina, there are other sections not occupied by cell nu-
clei involving the two plexiform (synaptic) layers (Figure 1.1). The inner plexiform
layer is fitted between the ganglion cell and the inner nuclear layer, whereas the
outer one is located between the outer and inner nuclear layers. Both of the plex-
iform layers consist of complicated arrangement of axons and dendrites to support
early visual processing (Mullins and Skeie, 2010).
1.1.1.1 Classical Photoreceptors
The classical retinal photoreceptor cells are the exquisitely specialized neurons in
the outer nuclear layer of the retina. The light collecting component of photorecep-
tor cells is called the outer segment (Figure 1.1), and it is in contact with the retinal
pigment epithelium. It is comprised of stacks of highly organized membranous discs
enriched in an opsin protein, a heterotrimeric G protein (transduction) and other
biochemical machinery essential for phototransduction. The outer segment is con-
nected to the inner segment of photoreceptor cells, which comprises of a number
of organelles responsible for protein synthesis and oxidative respiration including
mitochondria and the nucleus (Mullins and Skeie, 2010, Luby-Phelps et al., 2008).
There are two types of photoreceptors in the outer nuclear layer namely, rods and
cones. Differences between these types of cells are summarized in table 1.1 (Silver-
thorn, 2016, Ganong, 2005, Jeon et al., 1998). In addition, the cell-type population
and distribution differs from one species to another. For example, the mouse retina
seems to be intensely rod-dominated as rods outnumber cones by approximately
35:1, and distributed all over the retina compared to the human retina, where rods
are present at 20:1 and are distributed toward the anterior part of the retina. Also,
cones are scattered between rods in mice, whereas they are concentrated at the
centre of the retina (fovea) in humans (Jeon et al., 1998).
The function of photoreceptor cells is the sensing and transformation of light intouseful i formation f r the brain, and this process is know as phototransduct on.
Phototransduction in rods and cones is initiated once the light hits the membranous
disk in the outer segments. This results in the binding of a photon to the photopig-
ment (chromophore) such as rhodopsin in rods. Each photopigment comprises of
two parts namely retinal and opsin, and the dissociation of the retinal part rapidly
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Table 1.1: Comparison of rods and cones photoreceptor in humans and mouse retinas
Species Human Mouse
Photoreceptor
Characteristic
Rods Cones Rods Cones
Shape Cylindrical Flask shaped Cylindrical Flask shaped
Cell-type  population 
Ratio
20 1 35 1
Distribution
Toward the anterior
of the retina
Concentrated at the centre
of the retina
Over the retina Scattered between rods
Stimulus Dim light Bright light Dim light Bright light
Visual acuity 
(sharpness)
Low High Low High
Pigments, &
Subset of Cones
Rhodopsin
Pigments sensitive to red 
(long-wavelength), green 
(medium-wavelength)  or 
blue (short-wavelength)  
presented in, L, M and S-
cones respectively
Rhodopsin
Pigments sensitive to 
green (medium-
wavelength)  or blue 
(short-wavelength)  
presented in, M and S-
cones respectively
Colour perception None; shades of grey Respond to colour None; shades of grey Respond to colour
from the opsin molecule is triggered by the photon binding to the chromophore upon
light exposure, leaving an active binding site on the opsin. The activated opsin (a
single opsin) in turn binds rapidly to many molecules of the G-coupled protein
transduction particularly the Gtβα subunit. This leads to the dissociation of the
active Gtα subunit via catalysing the exchange of guanosine diphosphate (GDP) to
guanosine triphosphate (GTP) (Luo et al., 2008, Lamb, 1996). Therefore, each two
of Gα-GTP in turn binds to and fully activates phosphodiesterase (PDE). Activated
PDE hydrolyses cyclic guanosine monophosphate (cGMP) to 5′-GMP (Lamb, 1996,
Lamb and Pugh, 1992). The reduction in cGMP level leads to the closure of cyclic
nucleotide-gated channels, and hence a decrease in the cation influx of sodium ion
(Na+) and calcium ions (Ca2+) with continuous potassium ion (K+) eﬄux. This in
turn creates a hyperpolarizing generator potential leading to reduce the release of
glutamate onto the bipolar neurons (Silverthorn, 2016, Luo et al., 2008, Breedlove
et al., 2007).
1.1.1.2 Intrinsically photosensitive Retinal Ganglion Cells
Besides the classical photoreceptors, a new class of photoreceptor cell has been lately
discovered and it is located within the retinal ganglion cell layer and called intrin-
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sically photosensitive retinal ganglion cells (ipRGCs). ipRGCs represent roughly
1-3% of all ganglion cells, and cannot be differentiated by conventional histology.
These cells are capable of sensing light because of expressing the melanopsin pig-
ment (chromophores). Yet, they sense light for non-image forming perception only
such as entrainment activity, melatonin release, and sleep regulation, and does not
participate in the formation of images like the classical photoreceptor cells (Han-
kins et al., 2008, Berson et al., 2002, Hattar et al., 2002, Provencio et al., 2000).
Although the melanopsin signalling pathway in ipRGCs is still not fully discovered,
it seems to differs from the phototransduction pathway in rods and cones photore-
ceptor. Studies performed in retinal explants, disassociated ipRGCs, and cellular
expression systems indicated that the melanopsin signalling pathway starts via the
activation of a Gq/11-type G-protein, which in turn activates phospholipase C. Ac-
tivation of phospholipase C leads to the opening of the transient receptor potential
(TRP)-type ion channels in the cell membrane. This opening of the TRP-type ion
channels increases the influx of Ca2+, which results in the generation of action po-
tentials (reviewed in Hughes et al. 2012).
ipRGCs have been shown to differ from classical photoreceptor cells in dif-
ferent aspects including function, phototransduction pathway as well as sensitiv-
ity/resistance to variable insult/disease. For example, aged rodless/coneless (rd/rd
cl) mice showed substantial transneuronal retinal degeneration in the classical pho-
toreceptor cells rods and cones. Yet, the expression level of melanopsin, the retinal
ganglion cells, and the circadian rhythm remained unaffected in these aged rd/rd
cl mice. This indicates the persistence of melanopsin expressing cells to the retinal
degeneration perceived in aged rd/rd cl mice as well as a positive correlation be-
tween the persistence of melanopsin expression and the maintenance of the circadian
rhythm in response to light (Semo et al., 2003). Recently, Jain et al. (2016) found
that N -methyl-N -nitrosourea (MNU)-induced retinal degeneration in the outer nu-
clear layer did not alter the mRNA and the protein expression level of melanopsin,
and the ipRGCs viability remained unaffected 14-days post MNU-insult in wild-
type mice in comparison with untreated wild-type mice.
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Controversially, melanopsin mRNA expression decreased rapidly in rats deficient
in the retinal dystrophy-gene aged 60-day, where majority of classical photorecep-
tor cells degenerated. These rats exhibited normal level of melanopsin expression
at the age of 21-day when classical photoreceptor cells were yet intact (Sakamoto
et al., 2004). Also, P23H-1 and P23H-3 rats, that carry one autosomal dominant
mutation in the rhodopsin gene perceived in the retinal degenerative disease retinitis
pigmentosa, aged 365-day and 540-day showed a significant decline in melanopsin
expression compared to the ones aged 30-day as well as age-match Sprague Dawley
rats (Garc´ıa-Ayuso et al., 2015). The reduction of melanopsin expression level in rat
was also observed in the event of acute degeneration in the classical photoreceptor
cells induced by the alkylating agents MNU (Wan et al., 2006). This was shown by a
significant reduction in the mRNA expression level of melanopsin 0.5, 1, 5, 7, 13 and
18 days after MNU-treatment associated with the progression of photoreceptor de-
generation in rat retina. However, the viability of ipRGCs was not affected by MNU
based on unaffected mRNA expression of the pituitary-adenylate-cyclase-activating
peptide (PACAP) (neurotransmitter specifically co-expressed with melanopsin in
ipRGCs) in the MNU-treated rats at all time points compared to the control, and
the effect was limited to the mRNA expression levels of melanopsin within these
cells (Wan et al., 2006). Thereby, the effects of retinal degeneration on the expres-
sion of melanopsin within the ipRGCs were controversial between species as studies
showed. However, there is no substantial evidence regarding the acute effect of
retinal- degeneration on the expression of melanopsin and ipRGCs viability in mice
retina.
Melanopsin-expressing and classical photoreceptor cells are exposed to light and
sense light for different purposes as a part of their physiological functions. This
exposure to light under some circumstances can trigger cell death process within
these cells especially the classical photoreceptor cells as reported by various studies
as described next.
1.1. THE EYE AND PHOTORECEPTORS ROLE IN LIGHT-RESPONSE 7
1.1.2 Retinal Degeneration
1.1.2.1 Light-induced Retinal-degeneration
Sensing and exposure to light is part of the photoreceptor cells function. How-
ever, light exposure can be associated with other factors including high oxygen-
consumption, high contents of polyunsaturated fatty acid and other intrinsic and
extrinsic factors that make these cells more susceptible to damage. The process by
which light exposure induces retinal degeneration is still not fully elucidated, and
it seems to involve different stages.
The initiation stage of photoreceptor cell damage induced by light is the exten-
sive bleaching of chromophores in photoreceptor cells by light. In mammals, light-
induced retinal-degeneration is dependent on a functional visual cycle. It requires
repetitive extensive bleaching of chromophores causing the continuous generation
of retinoid metabolites such as META I, and II as well as the other unknown toxic
by-products. These products may accumulate during extreme light exposure and
be deleterious for photoreceptor viability (Wenzel et al., 2005, Saari et al., 1998).
So, blocking the visual cycle via preventing or slowing rhodopsin regeneration has
been shown to protect photoreceptors cells from damage induced by light exposure
(Keller et al., 2001, Grimm et al., 2000, Redmond et al., 1998). This stage in the
process of light-induced photoreceptor cell damage seems to be followed by elevation
of intracellular calcium levels, and generation of reactive oxygen species (ROS) as
described below.
1.1.2.1.1 Intracellular Calcium Levels
Many different forms of neural cell degeneration involve elevation of intracellular
calcium levels. Elevated intracellular calcium associated with increased superoxide
anion was seen as an early event in light-induced retinal-degeneration in mice. This
was resulted from the activation of nitric oxide synthase, which leads to the gener-
ation of nitric oxide (NO). NO activates guanylate cyclase, which in turn increases
c-GMP production. This increase in c-GMP level allows the opening of c-GMP
gated cation channels in the photoreceptor outer segment, and hence increase the
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influx of Ca2+ (Donovan et al., 2001). In addition, the higher level of NO produc-
tion apparently linked to the increase in the generation of ROS. This was observed
as ROS generation was reduced when NO production reduced via inhibiting NO
synthase by Nω-nitro-L-arginine methyl ester (Donovan et al., 2001).
1.1.2.1.2 Oxidative Stress
Oxidative stress seems to have an important role in light-induced retinal dam-
age. It appears to be an early event, as within a minute of light onset an in-
crease in light-induced oxidation was detected in isolated rod cells (Demontis et al.,
2002). Furthermore, this production of oxidative product such as ROS probably
requires mitochondrial electron transport. In cultured salamander-photoreceptors,
high amount of ROS was generated in the photoreceptor ellipsoids, a part that
is enriched with mitochondria. This high of production of ROS in the mitochon-
dria was decreased through inhibiting the electron transport by respiration blocker
especially complex III such as antimycin (Yang et al., 2003). Additionally, two dif-
ferent models of inherited retinal degeneration namely P23H and S334ter transgenic
rats were protected against retinal degeneration via pre-treatment with the antioxi-
dant dimethylthiourea (a potent scavenger of hydroxyl radicals) (Organisciak et al.,
2003).
An additional oxidative stress related effect induced by light exposure is the
enhancement of the lipid peroxidation of polyunsaturated acids. Previous stud-
ies observed that exposure to visible-intensity light induced lipid peroxidation of
omega-6 and omega-3 unsaturated fatty acid to hydroxynonenal and hydroxyhexe-
nal respectively in rats (Wiegand et al., 1983, Richards et al., 2006).
1.1.2.1.3 Other Factors Influence Retinal-degeneration
There are number of factors that can somehow influence retinal degeneration. One of
these factors is the circadian timing of light exposure. A self-protection of photore-
ceptor cells can be accomplished with a number of endogenous factors expressed
in circadian fashion manner. Several studies suggested specific times of the day
when light-induced retinal-degeneration is enhanced, and other times when protec-
tion against light damage is extreme (Organisciak and Vaughan, 2010, Organisciak
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et al., 2000). For instance, rats exposed to intense visible light during the day-phase
of the diurnal cycle expressed less visual cell loss, less DNA fragmentation, and less
induction of heme oxygenase mRNA (HO-1) expression compared to extensive vi-
sual cell loss, extensive DNA fragmentation, and higher induction of HO-1 mRNA
expression in rats exposed during the night-phase (Organisciak et al., 2000). Other
factors play an important role in light-induced retinal degeneration including genes
mutation such as cases of retinitis pigmentosa disease (Hartong et al., 2006), as well
as exposure to hazardous chemicals in the environment such as the DNA damaging
agents like the alkylating agents as described next.
1.1.2.2 Retinitis Pigmentosa (RP)
Gene mutation has been shown to be a fundamental cause of retinal degeneration
diseases, and aspect of light-induced retinal-degeneration. One of the retinal de-
generation diseases associated with gene mutation is retinitis pigmentosa (RP). RP
is a hereditary disease, that involves over 50 genes so far implicated in its etiology
(Daiger, 2017, Daiger et al., 2013, Hartong et al., 2006). It starts with progres-
sive photoreceptor degeneration particularly rods toward the peripheral area of the
retina in the early stages of the disease. In the late stages of RP progression, the
degeneration is proceeded toward the central field of the retina, and ends with com-
plete depletion of the classical photoreceptor cells (Birch et al., 1999, Grover et al.,
1997). As a result of the peripheral degeneration in early stages, patients complain
about difficulties with dark adaption, night blindness and losing the peripheral field
of the vision (tunnel vision). Thereby, the patient will suffer from blindness (loss of
vision), majority at around 50 years of age. The progression and the development
of RP disease could potentially be affected by environmental factors such as light
exposure and exposure to other environmental toxicants, such as alkylating agents.
In fact, alkylating agents such as methyl methanesulfonate (MMS) and MNU have
been used to produce an animal model of retinal-degeneration to mimic the lesion
of RP disease, and this is due to their selective photoreceptor cell death induction
(Calvo et al., 2013, Meira et al., 2009, Yoshizawa et al., 2009, Taomoto et al., 1998,
Ogino et al., 1993). These alkylating agents are capable of inducing DNA base
damage, and hence potentially trigger cell-death as described next.
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1.2 DNA Damage and Repair
Living organisms are exposed to endogenous and exogenous DNA damaging agents.
These DNA damaging agents can give rise to several types of DNA damage, includ-
ing alkylated, oxidized or deaminated DNA bases. However, the living organism has
different types of repairing mechanism to deal with these type of damages. If the
damage is not repaired, it may cause carcinogenicity resulted from mispair during
replication, or cytotoxicity resulted from a block in DNA replication based on the
lesion generated by the damaging agents as described below.
1.2.1 Deamination Damage of DNA Bases
Deamination is defined as the loss of one of the exocyclic amino groups. Three of
the four DNA bases are vulnerable to natural deamination including adenine (A),
cytosine (C) and guanine (G), and deamination of these bases produce hypoxan-
thine, uracil (U), and xanthine respectively (Friedberg et al., 2006). DNA base
deamination damage is one of the major causes of mutations in the cell. For exam-
ple, the transition from AT (T,thymine base)−→GC appears when hypoxanthine
(deaminated adenine) pairs with cytosine during replication (Schouten and Weiss,
1999, Hill-Perkins et al., 1986), while the transition mutation CG−→TA occurs
when uracil (deaminated cytosine) pairs with adenine (Duncan and Miller, 1980,
Coulondre et al., 1978).
1.2.2 Oxidation Damage of DNA Bases
Oxidation of DNA bases can be caused mainly by ROS. Although ROS are beneficial
in some point and involved in some signalling pathway as well as the development of
the immune system, they can produce highly mutagenic and toxic products. ROS
can be formed endogenously from oxidative metabolism in the mitochondria and
some pathological conditions such as chronic inflammation (Bartsch et al., 2002,
Ohshima and Bartsch, 1994). There are also exogenous sources of ROS such as
gamma-rays and radiomimetic chemicals (reviewed in Meira et al. 2005). ROS
products such as hydroxyl radical (OH•), hydrogen peroxide (H2O2), and superoxide
radical (O2•-) can produce highly mutagenic oxidative products such as 8-Oxo-
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7,8-dihydroguanine and ring-opened forms of purines and thymine glycol (Rouet
and Essigmann, 1985, Marnett, 2000). In addition, DNA oxidative damage can
be resulted from a number of fatty acid aldehydes, and other compounds formed
during lipid peroxidation reactions as well, which leads to the formation of highly
cytotoxic and highly mutagenic etheno adducts of purines and pyrimidines such as
1,N6-ethenoadenine (εA) and 3,N4-ethenocytosine (εC) (Pandya and Moriya, 1996,
El Ghissassi et al., 1995, Basu et al., 1993).
1.2.3 Alkylation Damage of DNA Bases
Alkylation is defined as the addition of alkyl carbon groups to a large number
of nucleophilic sites within the DNA and other cellular macromolecules, includ-
ing proteins. Alkylating agents can be generated endogenously, presented in the
environment, or used as cytotoxic drugs in cancer therapy as shown below.
1.2.3.1 Environmental Alkylating Agents
Alkylating agents can be found in the environment as a product generated by
plants, fungi, and industrially. An example of environmental alkylating agents is
chloromethane, which occur in the atmosphere in small concentrations, (Hamilton
et al., 2003), and can alkylate DNA, producing mutagenic and potentially car-
cinogenic effects (Bolt and Gansewendt, 1993, Vaughan et al., 1993). Yet, the
evidence to conclude the carcinogenicity effect of chloromethane on humans and
animals is not substantial (Drabls et al., 2004). Another important environmental
source for alkylating agents is N -nitroso compound produced by tobacco smoke,
which represents the main environmental source of exposure to alkylating agents
for human. 4-(N -methyl-N -nitrosamino)-1-(3-pyridyl)-1-butanone (NNK), 4-(N -
methyl-N -nitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), and N -nitrosonornicotine
(NNN) are the most carcinogenic tobacco-specific nitrosamines in laboratory ani-
mals (Hecht, 1999). Also, these tobacco-specific nitrosamines particularly NNK and
its metabolite NNAL has been shown to increase the generation of O6-methylguanine
(O6-meG) and other methylated bases.
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1.2.3.2 Endogenous Alkylating Agents
Many potential sources of endogenous alkylating agents have been discovered, and
a number of compounds have been identified. For instance, S -Adenosylmethionine
(SAM) is a methyl-donor in numerous biochemical reactions, but it has been shown
to induce mutations in DNA, generating 7-methylguanine (7-MeG), 3-methyladenine
(3-MeA), and little O6-meG (Barrows and Magee, 1982, Rydberg and Lindahl,
1982). Also, several studies reported that alkylating agents can be produced en-
dogenously by using an exogenous source of nitrosated amines. For example, ni-
trosated amines and related compounds were shown to generate alkylating agents,
mostly in Escherichia coli deficient in the repair of O6-meG (Taverna and Sedgwick,
1996).
Another endogenous source of alkylating agents is chronic inflammation. It is an
inflammatory response to persistent injury and/or infection, and involves infiltration
of lymphocytes, plasma cells, macrophages, and neutrophils (reviewed Meira et al.
2008, and Fu et al. 2012). The reactive oxygen and nitrogen species produced by the
infiltrated neutrophils and macrophages can directly induce DNA base oxidation and
deamination, and indirectly induce alkylation base damage via lipid peroxidation
(Bartsch and Nair, 2002, Coussens and Werb, 2002, El Ghissassi et al., 1995). Rectal
biopsy samples from patients with active ulcerative colitis showed an increase in lipid
peroxidation reaction and its products under pro-longed inflammation. Therefore, a
reaction between the generated lipid peroxidation product such as trans-4-hydroxy-
2-nonenal and the DNA can be formed, and hence leads to generate and increase
the level of etheno-modified bases such as εA, 1,N2- ethenoguanine (εG), and εC
the DNA of affected tissues (Bartsch and Nair, 2002, Wiseman and Halliwell, 1996).
1.2.3.3 Alkylating Agents in Chemotherapy
Alkylating agents are the oldest anti-cancer drugs and still a key to the treatment
of different types of cancer. O6 and N7 positions of guanine are the main targets
for alkylating agents, but some other sites are also methylated depending on the
reaction mechanism of the alkylating agents (Fu et al., 2012, Meira et al., 2005,
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Drabls et al., 2004). SN1 alkylating agents such as MNU target both nitrogens
and oxygens, and generate the toxic and mutagenic O6-meG DNA lesion besides
3-MeA and 7-MeG. While SN2 alkylating agents, such as MMS, primarily attack
the nitrogen bases, generating mainly 3-MeA, 7-MeG, and very small amounts of
O6-meG DNA lesions (Fu et al., 2012, Sedgwick et al., 2007, Meira et al., 2005).
Despite the cytotoxic and mutagenic effect produced by the alkylating drugs, they
are powerfully counteracted by the DNA repair processes. Therefore, understanding
and controlling the repair processes may lead to the development of new therapies
by defending normal tissue from these agents or stimulating the effects in targeted
tissues/cells such as cancer cells (Trewick et al., 2002).
1.2.3.4 Consequences of Alkylation of DNA Bases
Consequences of exposure to alkylating agents vary from cytotoxicity to mutagenic-
ity. Some of the alkylating agents have a cytotoxic effect, resulting from a block
in DNA replication and other mechanism, whereas other alkylating agents have a
mutagenic effect caused by the methylation of DNA bases leading to mispair dur-
ing replication (Doublie et al., 1998, Beard et al., 1996, Rebeck and Samson, 1991,
Larson et al., 1985). Cytotoxicity can be resulted from N -methylated bases such
as 3-MeA and 7-MeG, which at high levels trigger the process of cell death such
retinal-degeneration induced by MNU and MMS (Meira et al., 2009, Taomoto et al.,
1998, Ogino et al., 1993). However, several studies show that the accumulation of
methylated base lesions may not cause toxicity, and toxicity may be resulted from
the accumulation of base excision repair (BER) toxic-intermediates instead when
imbalance in the BER pathway occur (Calvo et al., 2013, Meira et al., 2009, Trivedi
et al., 2005, Roth and Samson, 2002).
The other potential consequences of exposure to alkylating agent is mutagenic-
ity. According to Kyrtopoulos (1995) epidemiological studies represented a positive
association between the amount of O6-meG DNA lesion and the risk of developing
tumours. Also, O6-meG and O4-methylthymine DNA lesions can lead to GC−→AT
and AT−→GC transitions mutation respectively (Roth and Samson, 2002, Tao-
moto et al., 1998). Furthermore, methylation at the N3 position of both adenine
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and guanine could lead to AT−→TA and GC−→TA transversion mutations respec-
tively (Ogino et al., 1993).
1.2.4 Repair of Alkylated DNA Damage
Three main pathways for repairing alkylated DNA bases exist within the living or-
ganism; base excision repair (or BER), reversal of base damage by O6-methylguanine-
DNA methyltransferase (Mgmt), and oxidative demethylation by member of the
AlkB family of proteins. Mgmt protects against the genotoxic effects of the DNA
adduct O6-alkylguanine lesions such O6-meG and O6-carboxymethylguanine (O6-
CMG). It repairs the damaged DNA bases by a direct removal and transferring of
the alkyl groups from the O6-position to its active-site cysteine residue (Senthong
et al., 2013).
However, most alkylated DNA lesions cannot be repaired by Mgmt, so other
repair pathways come to action such as BER. The BER pathway is mainly respon-
sible for the repair of a large number of chemically altered DNA bases including
methylated, oxidized, and deaminated bases, apurinic/apyrimidinic (AP)-site, and
single strand breaks (SSBs) that occur via endogenous, environmentally, and ther-
apeutically stimulated mechanism. The BER pathway involves a number of steps
for repairing DNA damaged bases as represented in figure 1.2. It is initiated by
specific DNA glycosylases based on the type of DNA lesion, which recognize and
excise specific lesion by cleaving the N-glycosyl bound leading to formation of AP
site (Slupphaug et al., 1996, Dosanjh et al., 1994, O’Connor and Laval, 1990). The
formed AP site is subsequently cleaved by AP-endonuclease (APE1) leading to the
production of a 3′ hydroxyl (3′OH) and 5′ deoxyribose phosphate (5′-dRP) termi-
nus. Those termini are required for facilitating the completion of DNA repair by
polymerase-β (pol-β) and DNA ligase IIIα (Pascucci et al., 2002, Klungland et al.,
1999). Pol-β mediated DNA synthesis excises the cytotoxic 5′dRP group via its
5′dRP lyase activity, and replaces the damaged nucleotide cleaved by APE1 (Sobol
and Wilson, 2001, Sobol et al., 2000, 1996). Finally, the repair is completed by
formation and sealing of the ligatable nick via recruitment of DNA ligase I or the
DNA ligase IIIα/XRCC1 complex (Sleeth et al., 2004, Kubota et al., 1996).
1.2. DNA DAMAGE AND REPAIR 15
SSB
AP
XRCC1
Pol-β
APE1
LIG3
5`RDP
CH3
CH3
5`RDP
3`O
H
3`O
H
Alkylating 
agents
Aag
DNA 
replication 
block
Survival
Mutation
TLS
PARP1 
Hyperactivation
PARP1 
Activation
DNA 
Repair
Survival
NAD+/ATP 
Depletion
Cell Death
DNAA
B
C
Repaired
DNA
Single Strand Breaks Formation
B
E
R
 t
o
x
ic
-i
n
te
rm
ed
ia
te
s
Figure 1.2: Processing and base excision repair of alkylated DNA bases, and toxic-
intermediates formation. (A) Alkylated DNA base lesions induced by SN1 or SN2 alkylating
agent are deceted and removed by the DNA glycosylase Aag, and subsequently generating
an AP site. The AP-site is cleaved by APE1 producing 3′OH and 5′dRP termini. Pol-β
excises the 5′dRP species, and replaces the missing DNA bases; and the repair pathway is
then completed by sealing the nicked DNA by by DNA ligaseα (LIG3). (B) Tolerance and
by-pass of base lesions and AP sites can be assisted by Error-prone translesion (TLS) poly-
merases resulting in survival and/or mutation. (C) BER-toxic intermediates generating
SSBs that is processed through Parp1. Under-moderate DNA damage and SSBs forma-
tion, Parp1 activation facilitates BER resuling in repairing the breaks and survival of cells,
whereas hyperactivation of Parp1 is presumed upon high levels of DNA damage leading to
NAD+/ATP depletion, and subsequently triggering cell death.
1.2.4.1 Alkyladenine DNA Glycosylases
The BER in the event of alkylated DNA bases is initiated by alkyladenine DNA
glycosylase (Aag) , also knows as methyladenine DNA glycosylase (MPG). Aag is
the only mammalian glycosylase that has been identified for repairing simple alky-
lation DNA damaged bases in both mice and humans (reviewed in Fu et al. 2012
and Meira et al. 2005). It excises the methylated bases by a nucleotide flipping
mechanism, as the nucleotide bearing the damaged base (such as alkylated base) is
flipped into an active site pocket to be excised (Slupphaug et al., 1996).
Aag removes a large number of DNA lesions such as 3-MeA, 7-MeG, 3-methylguanine,
εA, and εG. For instance, the incision of 3-MeA, hypoxanthine, εA, and oxanine
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DNA lesions seemed to be reduced in cells originated from Aag null tissues (Hitch-
cock et al., 2004, Engelward et al., 1997). Also, the generation of εA, εC, and
8-oxoguanine DNA lesions induced by inflammation was increased rapidly in Aag-
deficient animals (Meira et al., 2008). Furthermore, treatment with urethane or
vinyl carbamate (carcinogens) increased the generation and persistence of εA le-
sions in both liver and lung DNA of Aag-deficient animals indicating that the main
repair mechanism for εA adducts in vivo is via Aag (Ham et al., 2004, Barbin et al.,
2003). Although BER initiated by Aag seems to be the main repair mechanism for
εA adducts in vivo, carcinogenicity incident in Aag null animals were comparable
to wild-type littermates exposed to vinyl carbamate for long-term (Barbin et al.,
2003). Moreover, the absence of Aag may increase the risk of developing cancer
in some cells under specific condition such as chronic inflammation. Meira et al.
2008 stated that under chronic inflammatory conditions, the DNA repair process
plays a significant role in the suppression of cancer development. For example, ac-
cumulation of alkylated DNA base damage in Aag-/- mice treated with a chronic
inflammation inducer dextran sulfate sodium presented a causal link between repair
deficiency and carcinogenesis (Meira et al., 2008).
Depending on the cell type or genetic context, glycosylase deficiency may have
positive effect in the presence of alkylated DNA bases. Roth and Samson 2002
observed that bone marrow cells derived from wild-type mice were more sensitive
than cells derived from Aag-/- mice to the cytotoxic effects of several alkylating
agents. Furthermore, in wild-type animals, deletion of the Aag gene prevents retinal
degeneration induced by both MMS and MNU. In addition to that, reintroducing
mice Aag cDNA into an Aag-/- mice followed by MMS-administration established
that alkylation-induced retinal-degeneration is Aag-dependent (Meira et al., 2009).
Another example, the deficiency of Aag in pol-β null mouse embryonic cells rescued
these cells from MMS-induced lethality (Sobol et al., 2003). In addition, deficiency
of Aag protected certain tissues including liver, kidney, and brain, against cell death
and tissue injury induced by alkylating, and reactive oxygen and nitrogen species
produced by ischemia-reperfusion condition. This was observed as liver, kidney
and brain from Aag-/- mice exhibited a reduction in hepatocyte death, renal injury,
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and cerebral infarction respectively relative to wild-type mouse following ischemia-
reperfusion (Ebrahimkhani et al., 2014).
1.2.4.2 Base Excision Repair Toxic-Intermediates
The resistance of Aag-/- animals to MMS-induced retinal degeneration is probably
due to preventing the initiation of the BER. Roth and Samson (2002) suggested
that the initiation of BER may result in cytotoxicity when high levels of BER
toxic-intermediates accumulate and cannot be repaired. Therefore, when BER is
initiated by Aag, BER toxic-intermediates such as AP-sites, 5′-dRPs and SSBs may
accumulate (Figure 1.2). SSBs are detected by poly(ADP-ribose) polymerases 1
(Parp1), a molecular sensor that is able to detect SSBs and auto-modify itself, and
a number of nuclear proteins involving DNA polymerase and ligase (Schreiber et al.,
2006, Kraus and Lis, 2003). Then, the activated Parp1 recruits XRCC1 in order
to facilitate the formation of BER complex comprised of APE1, DNA pol-β, and
DNA ligase III to repair the SSBs (ElKhamisy et al., 2003, Vidal et al., 2001).
However, excessive DNA base damage probably results in extreme accumulation
of BER toxic-intermediates, mainly SSBs. This accumulation would lead to Parp1
hyperactivation (Calvo et al., 2013, Ebrahimkhani et al., 2014). This hyperacti-
vation of Parp1 causes vast increase in nicotinamide adenine dinucleotide (NAD+)
consumption as well as adenosine-5′-triphosphate (ATP) depletion, which in turn
leads to cell death (Ebrahimkhani et al., 2014, Andrabi et al., 2008). The role of
Parp1 in the cell death process upon alkylation exposure was observed by Calvo et
al. (2013), as the retinal photoreceptor cells of Parp1-deficient mice were protected
against Aag-mediated MMS-induced toxicity. Additionally, deeper examination into
the toxicity and resistance of animal to the alkylating agents along with the role of
Aag were previously performed as described next.
1.2.4.3 Transcriptomic Profile of Aag Deficient Animal
Previous investigations into the scenario behind the resistance to alkylation damage
found in Aag deficient cells or tissues were carried out by Meira and collaborators
(unpublished) via a global transcriptomics analysis of mouse liver response to a
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sub-lethal dose of MMS. The analysis indicated a relation between the DNA repair
process initiated by Aag, and a strong transcriptional response in mouse liver 6-hour
after MMS-insult. So, the transcriptional response induced by the administration
of MMS was intensely modified in Aag-/- mice liver, where persistence of alkylated
DNA base damage is predicted, as perceived by clustering and gene ontology en-
richment analysis. This observation is based on up-regulation of transcripts associ-
ated with endoplasmic reticulum (ER)-stress/unfolded protein response (UPR), the
acute phase response, the suppressor of cytokine signalling and the circadian clock
6-hour after MMS-treatment in the wild-type liver, but not in the mutant. There-
fore, Aag activity seems to be required to activate the transcription of some genes
associated with the ER-stress/UPR, the acute phase response, the suppressor of
cytokine signalling and the regulation of the circadian clock after alkylation-insult.
1.3 Endoplasmic Reticulum Stress and Unfolded Pro-
tein Response
Proteome damage induced by alkylation insult affects the endoplasmic reticulum
homeostasis and triggers ER-stress. So, in order to resolve and adapt to the ER-
stress upon alkylation exposure within the living organisms, the UPR is activated
as a protective response to restore the ER homeostasis. This has been observed
previously as the UPR was induced in wild-type Saccharomyces cerevisiae exposed
to alkylation (Jelinsky et al., 2000, Jelinsky and Samson, 1999).
The accumulation of unfolded/misfolded proteins, oxidative stress, viral infec-
tions and other stresses may lead to ER overload with proteins and exhaustion of the
ER machinery. In response to that, ER-resident transmembrane proteins including
inositol-requiring protein 1α (IRE1α), activating transcription factor 6 (ATF6) and
protein kinase RNA-like ER kinase (PERK) activate the UPR. In healthy cells,
chaperones such as immunoglobulin heavy-chain binding protein (BIP) negatively
regulate IRE1α, ATF6 and PERK (Wang and Kaufman, 2014, Hetz, 2012, Dorner
et al., 1987). However, ER dysregulation triggers the dissociation of these chap-
erones, which leads to release the inhibition of the ER-resident transmembrane
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Figure 1.3: Endoplasmic reticulum (ER)-stree and the unfolded protein response (UPR)
signalling pathways. ER-homeostasis in healthy (upper right corner) cells where chaperons
including BIP binds and negatively regulates the UPR signalling pathways. Under ER-stress
conditions (left upper corner), unfolded and misfolded proteins binds to BIP, leading to the
activation of the UPR signalling pathways. The UPR signalling pathways consists of three
parallel signalling branches: IRE1α-XBP1, ATF6, and PERK-eIF2α-ATF4. The outcome
of UPR activation increases protein folding, transport and ERERAD, while attenuating
protein synthesis. If the stress persist, cells may enter ER-mediated apoptosis via Chop
and Gadd34.
proteins, and hence eliciting the UPR as shown in figure 1.3 (Wang and Kaufman,
2014, Hetz, 2012).
1.3.1 Activation of PERK-eIF2α Signalling Pathway in ER-Stress
In the event of ER-stress, accumulated unfolded proteins and misfolded proteins
bind to chaperones such as BIP. This allows the release of PERK for oligomerization
and autophosphorylation. The activated PERK in turn phosphorylates eukaryotic
translation initiation factor 2α (eIF2α), which inhibits translation but at the same
time increases translation of the activating transcription factor 4 (ATF4) (Figure
1.3). In turn, ATF4 activates the transcription of ER stress response genes such as
the growth arrest and DNA damage-inducible protein 34 (Gadd34) to direct eIF2α
dephosphorylation and restore global mRNA translation (reviewed in Wang and
Kaufman 2014, and Hetz 2012). ATF4 also activates the transcription of C/EBP
homologous protein (Chop), which has been shown to induce ER stress-mediated
apoptosis in both in vitro and in vivo (Song et al., 2008, Marciniak et al., 2004).
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1.3.2 Activation of IRE1α-XBP1 Signalling Pathway in ER-Stress
Under non-stressed conditions in the ER, chaperons such as BIP binds to IRE1α to
stabilize it and prevent its activation. However, under conditions of ER-stress, BIP
binds to misfolded proteins and unfolded proteins, allowing the release of IRE1α
for homodimerization, autophosphorylation as well as activation of its kinase and
activities. Activated IRE1α cleaves X-box binding protein 1 unspliced (Xbp1u)
mRNA to produce transcriptionally active form of Xbp1s (spliced) (reviewed in
Wang and Kaufman 2014, and Hetz 2012), figure 1.3. Xbp1s (the active form) enters
the nucleus, and up-regulates target genes, that enhance protein folding, trafficking
and ER-associated degradation (ERAD), to resolve protein misfolding and restore
ER homeostasis (Schuck et al., 2009). Additionally, enforced Xbp1s expression has
been shown to inhibit Chop expression which is induced via the PERK-eIF2α-ATF4
signalling pathway of the UPR (reviewed in Wang and Kaufman 2014, and Hetz
2012).
1.3.3 ATF6 Activation in ER-Stress
The last ER-resident transmembrane protein involved in the UPR is ATF6. In the
event of ER-stress, chaperons including BIP binds to accumulated misfolded and
unfolded proteins, leading to the release and trafficking of ATF6 to the Golgi appa-
ratus. After being trafficked to the Golgi apparatus, ATF6 goes through regulated
intramembrane proteolysis process by the site-1 protease (S1P) and site-2 protease
(S2P) leading to the generation of an active transcription factor 6, figure 1.3. In the
mammalian genome, two homologues of ATF6 have been discovered namely ATF6α
and ATF6β. Activated ATF6α has been shown to mediate an adaptive response
to ER protein misfolding through inducing the transcription of genes involved in
increasing the ER capacity, and the expression of Xbp1. While the function of
cleaved ATF6β might be a repressor of ATF6α mediated transcription and function
(reviewed in Wang and Kaufman 2014, and Hetz 2012).
1.3. ENDOPLASMIC RETICULUM STRESS AND UNFOLDED PROTEIN
RESPONSE 21
1.3.4 Output of The UPR
1.3.4.1 Dnajc12
The consequences of UPR activation varies from increasing the ER-capacity and
ERAD, to apoptosis. Increasing the ER capacity including proteins folding and
trafficking may be result from inducing the transcription of chaperones, and co-
chaperones, such as DNA J-domain superfamily C member 12 (Dnajc12), that is a
member of heat shock proteins family-40 (Hsp40) (Choi et al., 2014, Schuck et al.,
2009). The co-chaperone Dnajc12 forms complexes with unfolded proteins to avoid
aggregation, and hence assess the protein folding process which in turn increases
the capacity of the ER (Choi et al., 2014, De Bessa et al., 2006, Fan et al., 2003).
The Hsp40 proteins have been shown to assist the protein folding process by regu-
lating complex formation between Hsp70 (chaperones) and polypeptides (unfolded
protein) via different mechanisms. For instance, Hsp40 proteins have progressed
to contain specific classes of polypeptide-binding domains, which bind to specific
clients, and deliver it to Hsp70. It also drives the conversion of Hsp70-ATP form to
the Hsp70-adenosine diphosphate form, which in turn stabilize Hsp70- polypeptide
complexes (reviewed in Fan et al. 2003).
1.3.4.2 Herpud1
Another potential output of the ER-stress/UPR is the activation of the ER-associated
degradation. ERAD regulates the retro-translocation of incurably misfolded pro-
teins within the ER into the cytoplasm for protein-degradation process mediated by
proteasomes (Schuck et al., 2009). One of the ERAD players is the homocysteine-
responsive endoplasmic reticulum-resident ubiquitin-like domain member 1 protein
(Herpud1) called Herp1 or MMS-inducible fragments (Mif1) (Wang and Kaufman,
2014, Hetz, 2012, van Laar et al., 2000). The up-regulation of Herpud1 gene ex-
pression was previously observed 4-hour after MMS-treatment as well as ultra-violet
(UV) A irradiation in human diploid skin fibroblasts and Hela cells (van Laar et al.,
2000). Additionally, Herpud1 expression seemed to be induced by ER-stress, and
not oxidative stress. When HEK293T (human embryonic kidney cells) and mouse
embryonic fibroblast cells (MEFs) treated with the ER-stress stimuli tunicamycin
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and thapsigargin, the mRNA, and the protein expression level of Herpud1 were
induced significantly compared to the vehicle control cells. However, those changes
were not perceived in cells treated with oxidative stress stimuli including mena-
dione, and glucose oxidase (Ho and Chan, 2015).
Furthermore, the induction of Herpud1 expression is driven by ER-stress via
the nuclear factor erythroid-derived 2-related factor 1 (Nrf1). This was observed
as the expression of Herpud1 was blunted in Nrf1 mutant MEFs and mice exposed
to tunicamycin compared to up-regulation of it in wild-type MEFs and mouse (Ho
and Chan, 2015). Eventually, in the event of prolonged ER-stress cells may undergo
apoptosis, which can be mediated by Chop and Gadd34 (Wang and Kaufman, 2014,
Hetz, 2012, Song et al., 2008, Marciniak et al., 2004).
1.4 Suppressor of Cytokine Signalling-3 (Socs3)
In addition to the up-regulation of transcripts related to the ER-stress/UPR upon
alkylation exposure, clustering and gene ontology enrichment analysis depicts up-
regulation of suppressor of cytokine signalling transcript (Socs) as well. The analysis
indicated up-regulation of suppressor of cytokine signalling particularly Socs3 tran-
script 6-hour after MMS-insult in the wild-type mice liver, but not in the Aag-/-
mice. Socs3 has been shown to be modulating the consequences of light-induced
retinal-degeneration, infections and autoimmune diseases. It is an inducible endoge-
nous negative regulator, that is capable of regulating cytokine or hormone signalling
pathways mainly the Janus kinase pathway (JAK) and the signal transducer and
activators of transcription 3 (STAT3) pathway. JAK/STAT3 signalling pathways
are essential for the signalling of cytokines and other stimuli regulating the inflam-
matory gene expression (Rottenberg and Carow, 2014, Chaves de Souza et al., 2013,
Liu et al., 2008)
Socs3 acts directly via obstructing JAK/STAT3 activation by binding to both
the JAK kinase and the cytokine receptor leading to inhibit STAT3 activation. It
also acts indirectly through mediating the ubiquitination and subsequent protea-
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some degradation of the cytokine receptor (Rottenberg and Carow, 2014). In vivo,
rats injected with lipopolysaccharide from Escherichia coli showed an increase in
inflammation, gene expression of the pro-inflammatory cytokines Interleukin (IL-
1β, and IL-6), and tumor necrosis factor (TNF-α), phosphorylation of STAT3 and
p38 mitogen-activated protein kinases, as well as paralleled up-regulation of Socs3
(Chaves de Souza et al., 2013). In addition, Socs3 expression was stimulated by in-
flammation and infection in different myeloid and lymphoid cell populations as well
as in diverse non-hematopoietic cells including neural and retinal cells (Rottenberg
and Carow, 2014, Liu et al., 2008). Moreover, mice exposed to high-intensity light
capable of inducing apoptotic death of retina cells in vivo depicted a rapid STAT3
activation, and induction of vascular endothelial growth factor (VEGF) and Socs3
expression (Liu et al., 2008). Liu et al. (2008) noted that retinal cells have exhibited
a selective induction of Socs3 in response to either light damage, oxidative stress,
or diabetes-induced retinal damage, but not other Socs family members, thus Socs3
seems to play a significant role in preventing the neuro-retina from cellular stress.
This was evident as survival of retinal ganglion cells transfected with Socs3 cDNA
following treatment with staurosporin (apoptosis-inducer) was enhanced along with
a reduction in the number of cells undergoing apoptosis compared to cells trans-
fected with empty-vector (Liu et al., 2008).
Despite the protective role played by transient expression of Socs3 in case of
light-damage, hypoxia, and metabolic stress, persistent expression of Socs3 may
not be beneficial. Persistent expression of Socs3 resulted from chronic inflammation
and prolonged cellular stress may induce insulin resistance along with inhibition of
survival signals emerging from neurotrophic factors including ciliary neurotrophic-
factor, leukaemia inhibitory factor, and insulin, which are fundamental for retinal
cell survival (Liu et al., 2008, Amadi-Obi et al., 2007). Eventually, Socs3 might play
a role in alkylation response since its expression in some tissues including the retina
is dampened in Aag-/- mice upon alkylation exposure (Meira et al., unpublished);
however, no substantial evidence to support such a role has been obtained up to
date.
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1.5 The Circadian Rhythm
Genes closely associated with the circadian clock regulation were previously repre-
sented among genes that were significantly modulated in terms of their transcrip-
tional response in Aag-/- mouse liver upon alkylation exposure compared to the
wild-type animal. The result of this previous analysis was that up-regulation of
transcripts closely associated with the circadian clock including the nuclear recep-
tor subfamily 1 group D members 1 and 2 (Nr1d1, and Nr1d2 ), and D-element
binding protein (Dbp) 6-hour after MMS treatment was seen in the wild-type liver,
but not in the mutant liver (Meira et al., unpublished). To understand the potential
effect of alkylation, and Aag on the circadian clock itself or its output, we need to
know what is the circadian clock and how it is being regulated as described below.
1.5.1 The Internal Clocks
Variable biological processes in mammals are regulated by the circadian clock. Ex-
amples of these biological processes include the daily sleep and wake cycle, body
temperature, feeding behaviour, hormone secretion, drug and xenobiotic metabolism,
glucose homeostasis, cell-cycle progression and some other physiological processes
that show rhythmicity. Putting it simply, the circadian clock enables most living or-
ganisms to adapt their physiology to the time of the day in an anticipatory fashion.
This is accomplished via synchronising biochemical, physiological and behavioural
process to maintain synchrony with the environmental cycles of light, temperature
and nutrients (Bailey et al., 2014, Pittendrigh, 1993, Daan and Aschoff, 1982). Fur-
thermore, sustaining the living system for approximately 24-hour rhythms in the
absence of environmental signals indicates that most daily oscillations are generated
by an internal clock, and not responses to the diurnal cycle (Takahashi, 2016, Taka-
hashi et al., 2008). In mammals, the internal clock comprises a master pacemaker
in the supra-chiasmatic nuclei (SCN) of the hypothalamus composed of bilateral
nuclei containing approximately 10,000 neurons each, as well as peripheral oscilla-
tors situated throughout the organism.
The circadian rhythm in mammals is mainly manipulated by the daily light-dark
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cycle. This manipulation is carried out by the novel class of ipRGCs (melanopsin
expression cells), which integrates photic information for entrainment within the
retina and projects to the main region of the SCN via the retinohypothalamic tract
using glutamate and PACAP as neurotransmitter (Takahashi, 2016, Le´vi et al.,
2010, Hankins et al., 2008, Takahashi et al., 2008, Berson et al., 2002). There-
fore, the SCN generates both neuronal and humoral signals, which regulate output
pathways and generated circadian physiology. The generated circadian physiology
along with other signals directly or indirectly originating from the SCN coordinate
the peripheral oscillators within each cell. In turn, the peripheral clock rhythmi-
cally regulates many cellular functions such as drug metabolism and detoxification,
cellular proliferation, DNA damage sensing and repair, and apoptosis (Takahashi,
2016, Le´vi et al., 2010, Takahashi et al., 2008). In addition, both the master and
the peripheral internal clock possess paralleled molecular base, justifying the many
properties they are sharing including the regulation of the clock by its own genes.
1.5.2 Molecular Mechanisms of The Circadian Clock
The mechanism of regulating and generating the circadian rhythm involves a cell
autonomous transcription-translation feedback loops (Fiure 1.4), that are consisted
of a core set of genes highly preserved among animals. It is comprised of a dom-
inant negative-feedback loop, which contains the genes Circadian Locomoter Out-
put Cycles Kaput (Clock), brain and muscle aryl hydrocarbon receptor nuclear
translocator(ARNT)-like protein 1 (Bmal1 ), period homologue 1 and 2 (Per1 and
Per2 ), cryptochrome 1 and 2 (Cry1 and Cry2 ) (Takahashi, 2016, Le´vi et al., 2010,
Takahashi et al., 2008, Albrecht, 2002).
During the day-phase, the transcriptional factor CLOCK heterodimerises with
BMAL1. Then, the heterodimerised CLOCK-BMAL1 bind to E-boxes in the pro-
moter region of multiple target genes, involving core components of the circadian
clock mechanism namely Per and Cry genes, figure 1.4. This in turn leads to
high levels of PER and CRY transcripts. Thus, the generated PER and CRY pro-
teins heterodimerise, and then translocate to the nucleus. Once PER-CRY complex
translocated, they interact with the CLOCK-BMAL1 complex, and so inhibit their
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Figure 1.4: Diagrams of the molecular circa-
dian oscillator. Positive elements of the cir-
cadian clock transcriptional-translational neg-
ative feedback loop are depicted in blue,
while negative elements are showed in green.
The circadian transactivation complex con-
taining transcription factors BMAL1 and
CLOCK regulate the transcription of genes
with the circadian E-box elements in the pro-
moter, including transcription factors that
represent the elements of the transcriptional-
translational feedback loop namely PER and
CRY. PER and CRY in turn heterodimer-
ize and form complexes that inhibit the ac-
tivity of BMAL1-CLOCK complex and sub-
sequently their own expression. Rev-erb and
ROR (Components stabilizing the loop shown
in red) represent an additional loop; REV-
ERBα(Nr1d1) and β (Nr1d2) negatively reg-
ulates the expression of Bmal1, whereas ROR
positively regulate the expression of Bmal1.
The BMAL1-CLOCK complex also regulates
the expression of clock-control genes (CCGs),
and hence providing a circadian output in
physiology.
own transcription. Whereas during the night-phase, the PER-CRY repressor com-
plex is targeted for ubiquitylation and subsequent degradation by the proteasome.
Thus, the CLOCK-BMAL1 complex can activate a new cycle of transcription, which
roughly takes 24 hours to complete (Takahashi, 2016, Le´vi et al., 2010, Takahashi
et al., 2008, Albrecht, 2002).
In addition, there is a secondary negative-feedback loop targeting CLOCK-
BMAL1 complex via regulating Bmal1 transcription. It includes Nr1d1, and Nr1d2
known as Rev-erb α and β respectively, that strongly down-regulate Bmal1 tran-
scription in a cyclic manner, and the retinoic-related orphan receptor (ROR) such
as (ROR-α and γ), which are activating Bmal1 transcription constantly (Taka-
hashi, 2016, Takahashi et al., 2008, Guillaumond et al., 2005). This combination
of the constant activation by ROR and the cyclic repression by Nr1d1 and Nr1d2
of Bmal1 transcription results in generating a rhythm in Bmal1 expression, which
in turn regulate the heterodimerisation of the CLOCK-BMAL1 complex. This is
seen as a robust and rhythmic Bmal1 transcription at the night-phase is induced
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by ROR-α, whereas the inhibition of Bmal1 transcription during the day-phase is
driven by Nr1d1 and Nr1d2 (Guillaumond et al., 2005).
Furthermore, major components reported to regulate clock function is D-element
binding protein. Dbp is a member of proline-acidic amino acidrich basic leucine
zipper (PAR bZip) transcription factors, and expressed within a circadian period,
and its genes expression is regulated rhythmically by the clock (CLOCK-BMAL1
complex) (Albrecht, 2002). It is responsible for regulating pathways involved in
handling xenobiotic-metabolism and detoxification in several tissues including liver,
intestine, and kidney via the rhythmic control of receptors and enzyme activities
such as C-androstane receptor and P450 oxydo-reductases activity. Controversially,
Dbp can in turn influence the circadian clock. This is achieved via cooperation with
CLOCK-BMAL1 along with binding to the promoter of the Per-1 gene, and so pos-
itively influence Per-1 transcription (Le´vi et al., 2010, Albrecht, 2002, Yamaguchi
et al., 2000).
1.5.3 The Classical Behavioural Circadian Rhythms
Period length of the molecular oscillation of the circadian core genes varies be-
tween species. For example, it takes approximately 22.5 hours in Syrian hamster,
(Ralph and Menaker, 1988), 23.5 hours in laboratory mouse strains (von Gall et al.,
1998, Schwartz and Zimmerman, 1990), and 25 hours in humans (Aschoff, 1965).
This molecular oscillation of the core genes is synchronised with the daily light
(the positive elements BMAL1-Clock active during the night, the negative elements
PER-CRY active during the day). This in turn defines activity and rest phases for
the cells and the organism through generating precise rhythms in the behaviour,
physiology, and metabolism based on the daily light exposure (reviewed in Rip-
perger and Albrecht (2012). Therefore, nocturnal animals entrained to normal light
dark cycle exhibited locomotor activity during the night (active phase) and rest in
the activity during the day (rest phase) (Schwartz and Zimmerman, 1990, Paladino
et al., 2013). Although the molecular oscillation of core genes remains the same, the
pattern of locomotor activity (active/rest phase) is different in the diurnal animals
as they tend to be active during the day time, and rest during the night (Slotten
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et al., 2005).
The active and rest phases of the animal or organism are entrained by the daily
light via the circadian clock. Therefore, modification in the light/dark cycle such
as exposure to light pulses during the night could shift the clock, and subsequently
shift the active/rest phases of the animal (phase-shift) (Hughes and Piggins, 2011,
Hastings et al., 2004). For example, if light is encountered by the nocturnal ani-
mal during the early or late hours of the night phase of these animal’s endogenous
rhythm (mice were to become active before dusk or remain active after the dawn
respectively), it will delay or advance the phase of clock respectively (shift the
clock). This was observed as the phase of locomotor rhythm of Nude, BALB/c and
C57BL/6 mice strains was shifted by light exposure. Light pulses around the onset
of locomotor activity (early subjective night) delayed the succeeding activity rhythm
in light/dark cycle entrained mice, while light pulses near activity offset (late sub-
jective night) leads to a phase advance in the activity offset (Paladino et al., 2013,
Schwartz and Zimmerman, 1990). However, light pulses presented during inactivity
(subjective day) to light/dark cycle entrained mice had little or no effect (Paladino
et al., 2013, Schwartz and Zimmerman, 1990)
Phase shift in the clock upon exposure to light pulses during the night phase in
light/dark cycle entrained animals is due to the photic induction of Per expression.
This photic induction of Per is crucial for the daily adjustment of the rhythmic os-
cillation of the clock core genes. Therefore, light exposure during early part of the
night delays the rhythm (delay the onset of locomoter activity in nocturnal animal)
through activating Per expression in its decreasing phase, while light exposure dur-
ing the late part of the night will advance the increase in Per expression (advance
the offset of the locomotor activity in nocturnal animal) (Hastings et al., 2004).
1.5.4 Output of The Circadian Clock
The circadian clock has been proven to control various biological processes in mam-
mals involving body temperature, drug and xenobiotic-metabolism and detoxifica-
tion, cell-cycle progression and some other physiological processes. This control of
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various physiological processes is accomplished via regulating the transcription of
a number of genes encoding for proteins affecting transcription, translation, cell-
signalling, cell cycle/survival, and metabolism (Bailey et al., 2014). For example,
the extent of toxicity of some anticancer drugs including cytostatic, cytokines, and
targeted biological agents in mice or rats are shown to be modulated by the time
of administration (circadian timing), regardless of delivery route or the number of
daily or weekly administrations (Le´vi et al., 2010).
In fact, the circadian timing remarkably modifies the pharmacologic effects of
some anti-cancer drugs. This modification involves their tolerability and efficacy in
both experimental models via the circadian control of phase I and II metabolism.
For instance, the peak toxicity of 5-fluorouracil (5-FU) (antimetabolite anti-cancer
drug) to a healthy tissue is during the dark-phase (activity-span) of rats and mice.
This is due to a peak in all enzymatic activities such as dihydropyrimidine dehy-
drogenase involved in the generation of the cytotoxic forms of 5-FU (Le´vi et al.,
2010, Porsin et al., 2003). This effect of circadian timing on anticancer drug tol-
erability and efficiency is also seen among other anti-cancer drugs including DNA
damaging agent such as the alkylating agents cyclophosphamide. Clock and/or
Bmal1 mutant mice were highly sensitive to cyclophosphamide-treatment if com-
pared to a circadian rhythmatic sensitivity of wild-type mice depending on the time
of drug administration. This rhythmatic sensitivity was shown to be dependent
on a functional circadian CLOCK-BMAL1 transactivation complex as Cry1 and
Cry2 mutant mice depicted more resistance to cyclophosphamide when compared
with the wild-type mice and in contract to the highly sensitivity perceived in Clock
and/or Bmal1 mutant mice (Gorbacheva et al., 2005). As reviewed by Le´vi et al.
2010, the effect of circadian timing (time of drug administration) on anticancer
drug tolerability and efficiency is also reported for other alkylating agents such as
cisplatin, and carboplatin, the mitotic inhibitor such as vinblastine and vinorelbine,
and others.
Additionally, the mechanism by which circadian timing modulates tolerability
and efficacy of anti-cancer drugs extends to involve the circadian control of cell cycle
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checkpoints, and cell survival and apoptosis. This control is accomplished via rhyth-
mic expression of antiapoptotic and proapoptotic proteins, and rhythmic expression
or activity of the DNA damage sensing and DNA repair proteins (reviewed in Le´vi
et al. 2010). For example, the repair protein Mgmt, which repair O6-CMG and O6-
meG DNA lesions, activity and expression displayed a circadian rhythm in human
circulating mononuclear cells and mouse liver, coincident with that of chloroethyl-
nitrosoureas and MNU tolerability respectively (Marchenay et al., 2001). Another
example is the nucleotide excision repair pathway (NER), whose activity displayed
rhythmicity as well. The NER efficiency in human quiescent fibroblast cells was
shown to peak along with BMAL1 peaks, while the cellular sensitivity to UV light
damage controversially peaks at BMAL1 trough where a lower activity level of the
NER was presumed. Thus, cellular sensitivity to DNA damage induced by UV light
and efficiency of DNA repair particularly the NER pathway are regulated rhythmi-
cally by the circadian clock (Bee et al., 2015).
In addition to the NER pathway, the BER pathway initiated by Aag is also
modulated by the circadian clock. Kim et al. (2009) established the mRNA ex-
pression of several key DNA repair proteins including Aag, Mgmt and other repair
proteins in Clock mutant mice liver. The analysis demonstrated that a significant
lower gene expression of Aag, exclusively among other repair genes analysed, was
found in Clock mutant mice liver compared to those of wild-type mice liver. Also,
analysis of the Aag gene expression over 24-hours showed a significant lower expres-
sion of Aag in Clock mutant mice liver throughout the entire day compared to those
of wild-type mice liver, but no rhythmicity in Aag expression. Thus, the expression
of Aag seems to be positively regulated by the circadian genes via the CLOCK, and
not in a circadian rhythm fashion (Kim et al., 2009).
Furthermore, mutation in the Clock gene appeared to affect the mRNA expres-
sion as well as the activity of Aag as observed in Clock mutant mouse liver. For
instance, higher sensitivity to genotoxic stress such as MMS were observed in Clock
mutant primary cultured hepatocytes compared to the wild-type primary cultured
hepatocytes. This higher sensitivity in Clock mutant is attributed to the decrease of
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Aag level caused by the deficiency of CLOCK (Kim et al., 2009). In contrast to the
regulation of the DNA damage/repair-pathways by the circadian genes, exposure to
DNA damaging agents can phase-shift/reset the circadian clock as described next.
1.5.5 Circadian Induction by DNA Damaging Agent
A number of studies have reported the capability of DNA damage to act as a re-
setting signal for the circadian rhythm. Both chemical and physical genotoxicants
could have the ability reset the circadian clock (Le´vi et al., 2010, Oklejewicz et al.,
2008, Pregueiro et al., 2006). An example of physical genotoxicants able to phase-
shift the clock is ionizing-radiation. Exposure to ionizing-radiation has been proven
to reset the circadian rhythms in vitro and in vivo as well in a dose and time
dependent-manner. In vitro, the circadian rhythm of rat-1 fibroblasts expressing
an mPer2 promoter-driven luciferase was phase-shifted in advance upon exposure
to ionizing-radiation (Oklejewicz et al., 2008). The phase-shifting in the clock upon
ionizing-radiation exposure is mediated via ataxia-telangiectasia mutated (ATM),
which is a double strand break sensor capable of phosphorylating proteins, and
hence initiate activation of the DNA damage checkpoint. This in turn leads to
cell cycle arrest and DNA repair, or induce-apoptosis. ATM was shown to play an
important role in the modulation of the circadian clock upon ionizing-radiation ex-
posure, as the effect of ionizing-radiation was reduced in fibroblasts extracted from
cancer-patient predisposed mutation in ATM. In vivo, behavioural rhythm (indirect
output of the circadian clock) of mice were phase-shifted upon ionizing-radiation
exposure (Oklejewicz et al., 2008). The ability of physical genotoxicants such as
ionizing-radiation to arise a cue to reset the circadian clock is also observed in some
chemical genotoxicants as well as some anti-cancer drugs.
The effect of the chemical anti-cancer drugs on the circadian clock has been
observed both in vitro and in vivo. For example, exposure to the antimetabolite
anticancer-drug 5-FU disrupted the rhythm of Per1 and Per2 expression in mouse
liver and SCN in vivo, as well as in mouse NIH3T3 fibroblasts in vitro, and this
disruption was independent of circadian-timing (Terazono et al., 2008). Another
example is the cell cycle inhibitor seliciclib, which also interrupts the rhythmic ex-
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pression of Nr1d1, Per-2, Bmal1 in mouse liver but in a circadian timing dependent-
manner (reviewed in Le´vi et al. 2010). Furthermore, DNA damaging agent such as
the alkylating agent can also function as a signal to reset the circadian clock. For
instance, mice exposed to the alkylating agents oxaliplatin displayed interruption
in the rhythmicity of body-temperature and rest-activity in a day-time dependent-
manner, whereas the alkylating agent carboplatin was shown to disturbed the white
blood cell rhythms in mice in a circadian time dependent-manner as well(Le´vi et al.,
2010, Ron et al., 1998).
Additionally, DNA base damage induced by the alkylating agents MMS (not
used in the clinic) can play a role as a resetting signal for the circadian rhythm.
This was observed in Neurospora crassa exposed to MMS in culture, as the circadian
rhythm of the Neurospora conidiation was phase-advanced upon the exposure. The
mechanism of resetting the clock involves checkpoint kinase 2 mediated phosphory-
lation of the Neurospora clock protein frequency (Pregueiro et al., 2006). Moreover,
as previously mentioned, Meira and collaborators (unpublished) showed that the
alkylating agent MMS modulates genes that closely associated with the circadian
regulation in mouse liver, and this modulation is in an Aag-dependent manner. This
observation is based on a significant modification in the transcriptional response of
Aag-/- mouse liver upon exposure to a sub-lethal dose of MMS compared to the wild-
type mouse liver, which indicates a link between the DNA repair process initiated
by Aag, and this transcriptional response. This modification involves modulation
of several transcriptassociated with the circadian clock namely Nr1d1, Nr1d2, and
Dbp 6-hour post MMS-insult in the wild-type animals liver, but not in the mutant.
Thus, a potential effect of Aag on the expression of clock genes might exist, and
Aag may somehow modify the clock homeostasis particularly upon MMS-exposure.
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1.6 Hypothesis, Aims and Objectives
Previous studies appeared to focus on the effect of alkylation on the retina rather
than considering the potential interaction effect of alkylation and light exposure
on photoreceptor cell survival. As light exposure plays a role in photoreceptor cell
susceptibility to oxidative stress, it can potentially enhance photoreceptor sensitiv-
ity to alkylation exposure. Thereby, avoiding light exposure may protect against
Aag-mediated photoreceptor degeneration upon alkylation exposure. Hence, we
hypothesize that:
Aag-mediated processing of DNA base damage affects photoreceptor
function and cellular responses to light and stress, in vivo.
To test our hypothesis, several aims with underlying objectives to achieves these
aims were set:
1. Determining the interaction of light and alkylation in the phenotype of alkyla-
tion induced retinal degeneration in the outer nuclear layer in wild-type, and
Aag-/- mice.
• Objective 1: Quantify photoreceptor cell loss upon alkylation treatment
in the presence or absence of light exposure.
• Objective 2: Identify if Aag-mediated cell death occurs in both type of
photoreceptors (rods and cones) upon alkylation-exposure or if toxicity
is specific to a particular photoreceptor type.
• Objective 3: Inspect the effect of alkylation-induced retinal-degeneration
on the intrinsically photosensitive retinal ganglion cells viability and
functionality.
• Objective 4: Evaluate the functionality of photoreceptor cells post alky-
lation exposure indirectly via evaluation of the animal behavioural ac-
tivity under different light conditions.
2. Establishing the expression profile of genes associated with the endoplasmic
reticulum (ER) stress and the suppressor of cytokine signalling (SOCS) upon
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alkylation treatment during day or night-time within mouse liver and eye
tissues in the absence and presence of Aag.
• Objective 5: Establishing and evaluating the early expression profile
of genes associated with ER-stress, and SOCS in wild-type and Aag-/-
mice liver and eye tissues basally and (6-hour) after alkylation exposure
during day or night-time.
3. Examining the role played by Aag in the clock homeostasis upon alkylation-
insult in mice liver and eye tissues as well as primary mouse embryonic fibrob-
last cells.
• Objective 6: Establishing and evaluating the early expression profile of
genes associated with the circadian clock in wild-type and Aag-/- mice
liver and eye tissues basally and (6-hour) after alkylation exposure during
day or night-time.
• Objective 7: Establishing the circadian phase-response curves in wild-
type and Aag-/- primary mouse embryonic fibroblast in response to alkylation-
treatment in vitro.
Chapter 2
Materials and Method
2.1 Materials
2.1.1 Animal
Aag-/- mice were generated previously as described by Meira et al. (2009). Aag-/-
mice were a kind gift from Prof. Leona D. Samson from Massachusetts Institute
of Technology (Cambridge, USA). C57BL/6J wild-type mice were purchased from
Charles River (Saffron Walden, England).
2.1.2 Reagents and Labware
2.1.2.1 Cell Culture
Dulbeccos modified Eagle medium (DMEM) 4.5 g/L glucose, with and without phe-
nol red and without glutamine, 10,000 units/mL penicillin and 10 mg/mL strep-
tomycin solution, 200 mM L-glutamine solution, 0.4% trypan blue solution, 10x
trypsin-EDTA solution, protamine sulphate, and gelatine powder from porcine skin,
were supplied by Sigma-Aldrich (St. Louis, MO, USA). Small, medium cell culture
flasks (culture area 25 and 75 cm2 respectively), and cover glasses (40 mm diame-
ter) were obtained from VWR International (Radnor, PA, USA). Fetal bovine serum
(FBS) was obtained from PAA (Pasching, Austria). Corning® 35 mm TC-Treated
culture dishes were purchased from Corning (NY, USA). Mr. Frosty freezing con-
tainer, and 1.8 mL CryoTube™vials were purchased from Thermo Scientific (Lough-
borough, UK). Grease was supplemented by ACC silicones (Wallingford UK).
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2.1.2.2 Chemicals
Methyl methanesulfonate (MMS) (CH3SO3CH3) (purity >98%), Triton X-100, 30%
hydrogen peroxide (H2O2), ethylenediaminetetraacetic acid disodium salt dehy-
drate (EDTA disodium salt), isopropanol solution, dimethyl sulfoxide (DMSO),
and Hartman’s fixative were supplied by Sigma-Aldrich (Dorset, England). Also,
RNaseZAP™, chloroform, hydrochloric acid (HCL), and sodium dodecyl sulfate
(SDS) were obtained from Sigma-Aldrich. VECTOR® antigen unmasking solu-
tion was supplied by VECTOR LABORATORIES LTD. (Peterborough, UK).
Absolute ethanol, absolute methanol, industrial methylated spirit, agarose pow-
der, Tris Base, sodium hydroxide, acetic acid glacial, toluene and paraformaldehyde
powder, sodium chloride powder (NaCl), and sodium hydroxide (NaOH) powder
were obtained from Fisher Scientific (Loughborough, UK). Luciferin-EF™Endotoxin-
Free Luciferin Na (catalogue number E6551) was supplied by Promega (Madison,
WI, USA). Phosphate-buffered saline (PBS) tablets was obtained from Oxoid (Cam-
bridge, UK). Paraffin wax, and di-N-butyl-phthalate in xylene (DPX) mountant
were supplied by VWR International Ltd. (Pool, UK). Normal goat serum (cata-
logue number 5425S) was obtained from Cell Signaling Technology, Inc. (Danvers,
MA, USA).
2.1.2.3 General Labware
50 and 15 mL centrifuge tubes, and serological pipettes (50 mL, 25 mL, 10 mL and
5 mL) were obtained from Sarstedt, Germany. Universal polystyrene 30 mL tubes
were purchased from Sterilin (UK). 1000 µL, 200 µL, 20 µL and 10 µL Pipette
sterile filter tips (ZAP™Premier) and sterile non filter tips (Fastrak) were obtained
from Alpha Laboratories (Eastleigh, UK).
Superfrost™, and Superfrost™ultra plus microscope slides, disposable base molds
(15x15 mm) were purchased from Fisher Scientific (Loughborough, UK). 2, 1.5, 0.6,
and 0.2 mL microcentrifuge tubes were purchased from Axygen BioScience, Inc.
(Union City, CA, USA). BD 1 mL Insulin Syringe and Needle (912.7mm x 29g x
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200) were supplied by BD (Oxford, UK). Tissue-Tek® base molds (15x15x5 mm),
and embedding cassettes were obtained from VWR International Ltd. (Pool, UK).
MicroAmp® fast Optical 96-Well reaction plate, 0.1 mL, and MicroAmp® Optical
adhesive film were supplied by Applied Biosystems® by Life Technologies (Austin,
TX, USA).
2.1.2.4 Molecular Biology
Proteinase K solution (20 mg/mL) (AM2546) was obtained from Ambion (Life
Technologies, Austin, TX, USA). 100bp DNA Ladder was supplied by Promega
(Madison, WI, USA). Protamine sulphate, and RNAlater® were obtained from
Sigma-Aldrich (St. Louis, MO, USA). TRIzol Reagent was purchased from Invit-
rogen (Frederick, MD, USA).
2.1.2.5 Primers
2.1.2.5.1 Genotyping Primers
AAG P1, AAG P2 and AAG P4 primers for genotyping Aag-/- animal and cells by
polymerase chain reaction (PCR) (sequences shown in table 2.1) were supplied by
Integrated DNA Technologies (Coralville, IA, USA).
Table 2.1: Sequence of Primers Used to Genotype Aag-/- Mice, and Cells
Primers Name Primers Sequence
Aag P1 5- ACC CCG CTT TAC AGA GAA -3
Aag P2 5- GCC AAG ACA GAG ATG AGA CC -3
Aag P4 5-TGG GGG TGG GAT TAG ATA -3
2.1.2.5.2 RT-qPCR Primers
Set of forward and reverse primers target a number of mouse gene including Aag,
Actin, Atf-4, Atf-6, Chop, and Socs3 were purchase from Integrated DNA Technolo-
gies (Coralville, IA, USA). While Sigma-Aldrich (Dorset, England) supplied primers
for the following mouse genes Actin, Dnajc12, Herpud1, Nr1d1, Nr1d2, Dbp, Rho,
Opn1sw, Opn4, Pde6b, Pde6h, and Adcyap1. The primers sequences of these genes
(shown in table 2.2) were obtained from Origene website (www.origene.com) (Ori-
Gene Technologies, Inc., Rockville, MD, USA).
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Table 2.2: Forward and Reverse Primers Sequences for Mouse Gene for RT-qPCR.
Gene
Name
Forward Sequence Reverse Sequence
Actin CATTGCTGACAGGATGCAGAAGG TGCTGGAAGGTGGACAGTGAGG
Aag ACACCGAGCAGCCTCCATTTCT CTGAATCTGCCAGTCGCTGCTT
Chop GGAGGTCCTGTCCTCAGATGAA GCTCCTCTGTCAGCCAAGCTAG
Atf6 GTCCAAAGCGAAGAGCTGTCTG AGAGATGCCTCCTCTGATTGGC
Atf4 AACCTCATGGGTTCTCCAGCGA CTCCAACATCCAATCTGTCCCG
Dnajc12 CCGACAAGCATCCTGAGAACTC CGAACGGCATTGACATCTGGCT
Herpud1 CCTCCAAAATGCCAGAAACCAGC GCCGTAAACCATCACTTGAGGAG
Socs3 GGACCAAGAACCTACGCATCCA CACCAGCTTGAGTACACAGTCG
Nr1d1 CAGGCTTCCGTGACCTTTCTCA TAGGTTGTGCGGCTCAGGAACA
Nr1d2 CAGTGAGAAGCTGAATGCCCTC TGCACGGATGAGTGTTTCCTGC
Dbp ACACCGCTTCTCAGAGGAGGAA TCTCGACCTCTTGGCTGCTTCA
Rho GAGGGCTTCTTTGCCACACTTG AGCGGAAGTTGCTCATCGGCTT
Opn1sw GTCGCCATGTTTGTGCTCTGGA GCTTGGAGTTGAAGCGGATGCT
Opn4 CTACTCCACTGTGGCTCTGGTG TTGTGGATGGCAGAAGCCTTGG
Pde6b TGGAGAACCGTAAGGACATCGC TCCTCACAGTCAGCAGGCTCTT
Pde6h CTCGACAGTTCAAGAGCAAGCC AGCTCCAGATGGCTGAACGCTT
Adcyap1 AGTGTCTCCTGTTCACCTGCCG AGTAAAGGGCGTAAGCGTCACG
2.1.2.6 Antibodies
Primary rabbit polyclonal anti-melanopsin antibody (catalogue number ABN38)
was obtained from Advanced Targeting System (San Diego, CA, USA). Primary
mouse monoclonal anti-rhodopsin antibody [RET-P1] (catalogue number ab3267)
was supplied by Abcam (Cambridge, UK). DyLight 488 secondary goat anti-Rabbit
IgG antibody (catalogue number DI-1488), and DyLight 594 secondary goat anti-
mouse IgG antibody (catalogue number DI-2594) were supplied by VECTOR LAB-
ORATORIES Ltd. (Peterborough, UK).
2.1.2.7 Staining
Haematoxylin solution was obtained from Sigma-Aldrich (St. Louis, MO, USA).
SafeView Nucleic Acid Stain (catalogue number NBS-SV1) was purchased from
NBS Biologicals (Huntingdon, Cambridgeshire, UK). Eosin solution was supplied by
VWR International Ltd (Poole, UK). VECTASHIELD HardSet Antifade Mounting
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Medium with DAPI (catalogue number H-1500) was supplied by VECTOR LAB-
ORATORIES LTD. (Peterborough, UK).
2.1.2.8 Kits
Maxima™First Strand cDNA Synthesis Kit for RT-qPCR with dsDNase, and Lumi-
naris HiGreen Low ROX qPCR Master Mix kit were supplied by Thermo Scientific
(Loughborough, UK). Whereas, GoTaq® G2 Hot Start Green Master Mix was sup-
plied by Promega (Madison, WI, USA).
2.1.3 Reagents and Buffer Preparation
2.1.3.1 1X Phosphate-Buffered Saline (1X-PBS)
1 tablet of phosphate-buffered saline was dissolved in 100 mL distilled water, and
autoclaved for sterilisation.
2.1.3.2 Methyl Methanesulfonate (MMS)
2.1.3.2.1 Dosage Preparation for In-Vivo Study
The sub lethal dose of MMS for mice is 75 mg/kg body weight, and an injection
volume of 5 µL/g body weight (bw) was used. The calculation below was followed
to prepare MMS working solution.
To inject mice with 75µg/g MMS for injection volume of 5 µL/g bw:
MMS concentration (C2) in 1 µL of the injection volume should be:
C2 = 75/5 = 15µg/µl = 15mg/mL
MMS purchased as a liquid with density of 1300 mg/mL (C1), the following formula
used to calculate the appropriate dilution:
C1V 1 = C2V 2⇒ 1300∗V 1 = 15mg∗1mL⇒ X = (15∗1)/1300 = 0.0115mL = 11.5µl
So, 11.5 µL of MMS stock solution was added to 988.5 µL PBS to make 1 mL of 15
µg/mL MMS.
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2.1.3.2.2 MMS Preparation for In-Vitro Study
Previous work by Meira lab group has shown that 2.5 mM MMS is the IC50 for
this compound. Therefore, freshly prepared MMS concentration of 2.5 mM was
considered to be used for cell treatment in vitro.
2.1.3.3 Cell Culture Solution and Reagents
2.1.3.3.1 0.1% Coating Gelatine
0.1% Gelatine was used to coat cell culture flasks and dishes to enhance of cell
attachment. 100 mg of gelatine powder from porcine skin was added to 100 mL of
water, mixed until dissolved, sterilised by autoclavation, and stored at room tem-
perature to be used within a month. Cell culture dishes and flasks were precoated
with gelatine for 30 minutes at least before seeding any cells.
2.1.3.3.2 1X Trypsin EDTA
10X trypsin-EDTA was diluted ten times with 1X-PBS to make 1X trypsin-EDTA.
The solution was aliquoted, and stored at -20°C.
2.1.3.3.3 Protamine Sulfate (10mg/mL)
Stock solution of protamine sulfate was made at concentration 10 mg/mL of water.
So, 300 mg of protamine sulphate was dissolved in 30 mL of ds sterilised water,
mixed well and stored at 4°C.
2.1.3.3.4 0.1M Luciferin
To make 0.1M Luciferin (stock solution), 25 mg of Luciferin powder was dissolved
with 826 µL of sterilised water. The stock solution was aliquoted and stored in
-80°C, and thawed as needed.
2.1.3.3.5 Normal (Complete) Cell Culture Medium
DMEM with phenol red was supplemented with 1% of penicillin and streptomycin,
1% of L-glutamate, 15% FBS. The medium was stored at 4°C, and pre-heated at
37°C in water-bath before use.
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2.1.3.3.6 Shocking Cell Culture Medium
DMEM was supplemented with 50% FBS, 1% of penicillin and streptomycin, 1% of
L-glutamate. The medium was stored at 4°C, and pre heated at 37°C in water-bath
before use.
2.1.3.3.7 Bioluminescence Cell Culture Medium
DMEM (without phenol red) was supplemented with 1% of penicillin and strepto-
mycin, 1% of L-glutamate, and 15% FBS. In addition, 1 µL of 0.1 M Luciferin per
a mL of media was added (0.1 mM final concentration of Luciferin). The medium
was prepared fresh prior to use, pre heated at 37°C in water-bath, and protected
from light exposure.
2.1.3.3.8 Freezing Cell Culture Medium
3 mL of normal cell culture medium was mixed firstly with 1 mL of DMSO. Then
1 mL of FBS was added and mixed well. Freezing medium was made fresh and
preheated at 37°C prior to use.
2.1.3.4 Histology and Immunofluorescence
2.1.3.4.1 Paraformaldehyde Fixative 4% (PFA)
Paraformaldehyde (PFA) fixative 4% (PFA) was prepared by placing 450 mL of
distilled water in a glass beaker, heated up to 60°C by a hot plate, and continually
stirred. Then, 20 g of PFA powder was added to the heated water, and maintained
at 60°C. Afterward, 5 drops of 2M NaOH were added to clear up the solution. Once
it cleared, it was removed from heating, placed on ice, and 50 mL of 10X PBS
was added to the solution and mixed well. Then, the pH was adjusted to 7.2 by
adding HCl and measured by pH meter. Final solution was filtered, and used either
immediately or frozen at -20°C and thawed as needed. The procedure took place
under the microbial safety cabinet.
2.1.3.4.2 1X Phosphate Buffered Saline with 0.2% Triton (PBS-T)
200 µL of Triton X-100 was added to 100 mL autoclaved 1x PBS and mixed vigor-
ously.
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2.1.3.4.3 10% and 0.1% Goat Serum
100 µL of stock solution containing goat serum was added to 900 µL PBS to make
10% goat serum solution. A further dilution to 0.1% was carried out by mixing 10
µL of 10% normal goat serum with 990 µL PBS. These dilution were made fresh,
used within a week, and stored at 4°C.
2.1.3.4.4 3% Hydrogen peroxide (H2O2)
In order to prepare hydrogen peroxide at 3% concentration, 10 times dilution of
the 30% hydrogen peroxide was prepared by mixing 1 mL of H2O2 with 9 mL of
distilled water.
2.1.3.5 Molecular Biology
2.1.3.5.1 0.5M Ethylenediaminetetraacetic Acid Disodium Salt Dehy-
drate (EDTA)
The molecular weight of ethylenediaminetetraacetic acid disodium salt dehydrate
(EDTA) is 372.2 g/mol. To make 200 mL of 0.5M EDTA, 37.22 g of EDTA was dis-
solved in mq water by stirring and adjusting pH to 8.0 (required to dissolve EDTA)
using NaOH. Finally, the solution was autoclaved for sterilisation, and stored at
room temperature.
2.1.3.5.2 5M Sodium Chloride (NaCl)
To make 250 of 5M NaCl, 73.05 g of NaCl was dissolved in 225 mL of mq water
and mixed by stirring. After that, the mix was filled up with MilliQ water to 250
ml. The solution was then sterilised and stored at room temperature.
2.1.3.5.3 1M Tris (pH 8.0)
Tris (hydroxyl methyl) molecular weight is 121.4 g/mol. So, 12.14 g of Tris was
dissolved in 80 mL of MilliQ water by stirring to prepare 100 mL of 1M Tris. Then,
the pH was adjusted to 8 using concentrated HCl, and mq water was added to the
final volume 100 ml. Sterilisation of the solution was carried out, and storage was
done at room temperature.
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2.1.3.5.4 10% Sodium Dodecyl Sulfate (SDS)
Sodium dodecyl sulfate (SDS) is a detergent used to denature proteins.10g of SDS
was dissolved in 100 mL of mq water to make 10% SDS. The solution was stored at
room temperature and not autoclaved.
2.1.3.5.5 Tissue Lysis Buffer (TLB)
250 mL stock of tissue lysis buffer (TLB) was prepared using the components de-
scribed in the table below. The buffer was autoclaved for sterilisation prior to the
addition of SDS. After adding the SDS, the buffer was stored at room temperature.
Table 2.3: Tissue lysis buffer preparation
Component Final concentration Volume per 250 mL
(ml)
1M Tris pH 8.0 10mM 2.5
5M NaCl 100mM 5
0.5M EDTA pH 8.0 10mM 5
RO water 225
10% SDS* 0.5% 12.5*
*To be added post-autoclaving
2.1.3.5.6 Tris-EDTA (TE) Buffer
Stock of 100 mL of Tris-EDTA buffer was prepared and stored at room temperature
after sterilisation. To make 100 mL of the TE-buffer, 1 mL of 1M Tris, and 200
µL of 0.5M EDTA with pH 8 were mixed well with 98.8 mL of distilled water, and
autoclaved.
2.1.3.5.7 Primers Dilutions
Primers were centrifuged upon arrival. Then, each primer was resuspended with TE
buffer to final concentration 100 µM, mixed well and kept overnight at room tem-
perature. Thus, primers were spun down, stored at -20°C, and diluted as required
to the working concentration 10 µM by further dilution but in nuclease free.
2.1.3.5.8 Tris Acetate-EDTA (TAE) Buffer
5 L of 10X Tris Acetate-EDTA (TAE) buffer stock solution was prepared using
the substrates explained in the table below and stored at room temperature. The
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Table 2.4: 10X Tris acetate-EDTA (TAE) buffer preparation
Component Amount
Tris Base 242.5 g
Glacial acetic acid 57 mL
0.5M EDTA pH 8.0 100 mL
RO water 4 L
preparation is started by dissolving Tris base in water by stirring. Then, glacial
acetic acid and EDTA were added, and the final volume was adjusted to 5 L with
water. 10X- TAE buffer was diluted 10 times to 1X TAE buffer to be used for
agarose gel preparation, and running gel electrophoresis as described next.
2.1.3.5.9 2% Agarose Gel
2% agarose gel is used to run gel electrophoresis for genotyping assessment. 200 mg
of agarose was mixed with 100 mL of 1X TAE buffer. The mix was then heated up
by microwave till boiling. Next, the molten gel was left aside to cool down to 70°C
followed by adding 10 µL of SafeView nucleic acid stain, and mixing very gently.
The gel was poured immediately in gel mold, where gel tray and comb have been
already placed, until half of the comb covered. Once the agarose gel has solidified,
comb was removed with caution, and the gel was ready for use.
2.2 Software
List of specific software used in this project are shown in the table below:
Table 2.5: List of specific software used to achieve the project objectives
Software Developer
QuantStudio™Real-Time
PCR Software
Applied Biosystemsby® by Life Technologies
(Austin, TX, USA)
SAS 9.2 SAS, Cary, NC, USA (http://www.sas.com)
GraphPad Prism 6 GraphPad Software, Inc., La Jolla, CA USA
(http://www.graphpad.com/)
NIS elements acquisition soft-
ware
Nikon UK Limited (Kingston, UK),
https://www.nikoninstruments.com
ClockLab Data Collection Actimetrics (Wilmette, IL, USA)
ClockLab Chamber Control Actimetrics (Wilmette, IL, USA)
LumiCycle Data Collection Actimetrics (Wilmette, IL, USA)
Image Lab Bio-Rad Laboratories Ltd. (Hemel Hempstead,
UK)
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2.3 Equipments
List of equipments used in the project are shown in the table below.
Table 2.6: List of specific equipments used in the project
Equipment Manufacturer or Supplier
HERACELL 150i CO2 incubator. Thermo Scientific (Loughborough, UK)
Heraeus Biofuge Fresco refrigerated
microcentrifuge.
Thermo Scientific (Loughborough, UK)
NanoDrop 2000 spectrophotometer Thermo Scientific (Loughborough, UK)
TMS Inverted Microscope. Embi Tec. (San Diego, CA, USA)
Eclipse TS100 Epi-fluorescence In-
verted Microscope
Embi Tec. (San Diego, CA, USA)
Pellet pestles Cordless motor Sigma-Aldrich (Dorset, England)
Gene Genius Bio Imaging System Syngene (Cambridge, UK)
Tetrad PTC-225 Peltier Thermal
Cycler.
MJ Research (Waltham, Massachusetts,
USA)
Automatic Tissue Processor Shandon Citadel, Thermo Electron Cor-
poration (Runcorn, UK)
BUC2-500C USB2.0 colourful digi-
tal camera
Bestscope International Ltd. (BEIJING,
CHINA).
Vickers M15C Microscope Vickers Instruments Ltd. (York, UK)
Raymond Lamb Blockmaster II em-
bedding station
Thermo Scientific, Southend, UK.
Reichert-Jung 2040 microtom Leica (Milton Keynes, UK
Gel Doc™EZ system Bio-Rad Laboratories Ltd. (Hemel Hemp-
stead, UK)
LumiCycle 32 Actimetrics (Wilmette, IL, USA)
Labcaire PCR Workstation Labcaire
QuantStudio™7 Flex System Applied Biosystemsby® by Life Technolo-
gies (Austin, TX, USA)
RunOne Electrophoresis Embi Tec (San Diego, CA,USA)
Nikon A1M Confocal Microscope
and DS-Qi1 Widefield Camera on an
Eclipse Ti-E Microscope
Nikon UK Limited (Kingston, UK)
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2.4 Study Design
For the study detailed below, wild-type and Aag-/- mice were maintained and bred
to produce male mice used for breeding and running few experiments, and females
used for breeding and primary mouse fibroblast cells (pMEFs) isolation to be used
for in vitro study. Figure 2.1 represents the whole project experimental design.
Male mice were treated with 75 mg/kg MMS under different light conditions,
and compared to mock-treated (PBS (vehicle)-treated). The treatment compound
was administrated once by intraperitoneal (i.p) injection at specific time based on
the purpose of the experiment. Mice were culled at different time points after alky-
lation treatment depending on the purpose of the experiments as well; 6-hour for
the genes expression analysis, and 48-72 hours for inspecting alkylation and light in-
teraction. Study design of in-vivo experiments using male mice for the interaction
of light and alkylation, and genes expression evaluation are represented in figure
2.2 and figure 2.3 respectively. In addition, pregnant females were culled on post-
coitum day E12.5-E13.5 to isolate pMEFs for in-vitro purposes. Cells were then
transfected with Bmal1 -dLuc LV, and subsequently synchronised by serum-shock
for two hours, followed by monitoring Bmal1-bioluminescence by the LumiCycle
to determine the peak of Bmal1 expression. Cells were then mock-treated (serum
free media treated), 2.5mM MMS-treated for one hour after Bmal1-peak or left un-
treated (control). Thus, Bmal1-bioluminescence monitored and recorded again after
applying the treatment to observe any changes in the rhythm of Bmal1 expression.
Figure 2.4 depicts the study design of the in-vitro study that were followed in this
project.
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Figure Error! No text of specified style in document.-2: Study design of determining the 
interaction of light and alkylation. The study was aimed to find out light exposure can induce
photoreceptor degeneration upon alkylation exposure, and thereby impact the function of the 
cells. This study involved treatment of animal with 75mg/kg MMS, and expose them to either 
constant light or constant dark for 72 hours unless indicated. Harvested tissues were either 
frozen for RNA extraction and RT-qPCR for gene expression of specific cells marking such 
as Rho gene for rhodopsin in rods photoreceptors, or fixed for histopathology or 
immunofluorescence staining procedure.
Immunofluorescence 
* Light cohort exposed to normal light/dark cycle (12:12) for the 48 hour-post treatment.
RNA Extraction
RT-qPCR
Tissue Fixed
Tissue Process
Histopathology
Tissue Frozen
7 Mice
PBS i.p  inj.
7 Mice* 7 Mice
48 /72 Hours
7 Mice*
75 mg/kg MMS i.p inj.
WT/ Aag -/-  Mice
7-10 days
Culled
Figure 2.2: Study design for investigating the potential interaction effect of light and alky-
lation on photoreceptor cell survival and function in wild-type and Aag-/- mice. The study
was aimed to find out whether light exposure to induce photoreceptor degeneration upon
alkylation exposure, and subsequently impact photoreceptor cell function, as well as to in-
spect the alkylation-insult impact on melanopsin expressing RGCs viability and function.
Mock-treatment (PBS) and MMS-treatment were administrated by a single i.p. injection.
Figure Error! No text of specified style in document.-3: Study desiging of 6-hour gene 
expression upon alkyltion Treatment during the day, and night period. Wild type and 
ZT02:00 ZT14:00 
RNA Extraction
cDNA Synthesis
RT-qPCR
ZT08:00 ZT20:00Culled Culled
 20 Male WT/ Aag -/-  Mice
Night-Time Treatment
PBS 75 mg/kg MMS
5 5
PBS 75 mg/kg MMS
7-10 days
Day-Time Treatment
5 5
Tissues Frozen
6-hour 6-hour
* PBS and MMS
Treatment carried out
by i.p. inj
Figure 2.3: Study design for analysis of the transcriptional response of wild-type and Aag-/-
mice tissues 6-hour post alkylation treatment during either day or night-period using RT-
qPCR approach. Mock-treatment (PBS) and MMS-treatment were administrated by a
single i.p. injection.ZT, Zeitgeber time
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2.5 Method
2.5.1 Animal Breeding and Housing
C57BL/6J wild-type and Aag-/- mice have been bred and maintained at the animal
unit at the University of Surrey. The temperature was maintained at 19-22°C and
humidity at 55% ±10%. Ad libitum food (B & K Universal Ltd, Hull, UK) and
water were provided for the animal. Breeding of C57BL/6J Aag-/- mice (genetically
modified animal) and in vivo experiments of Aag-/- and wild-type mice had previ-
ously received a favourable opinion from the University of Surrey Animal Welfare
and Ethical Review Body (AWERB) and were carried out under a UK Home Office
Project License.
Breeding scheme of heterozygous Aag mutant (-/+) with heterozygous Aag mu-
tant (-/+) was applied to maintain the colony of the Aag transgenic mice, as well
as producing homozygous Aag mutant(-/-) mice for experimental purposes. Along
with applying this breeding scheme, the colony was backcrossed to the appropriate
parental inbred strain every 10 generations to prevent genetic drift. In order to
maintain the colony and breed Aag mutant mice genotyping of new born mice was
carried out as described in below.
2.5.2 Genotyping of Aag-/- Mice and Cells
Aag-/- mice were genotyped and maintained in order to produce the required num-
ber of mice for further breeding or studies purposes. In addition, pMEF cells were
genotyped as well. To identify the status of Aag gene within mice and cells, geno-
typing procedure using polymerase chain reaction (PCR) approach was carried out.
Therefore, the following genotyping procedure involving DNA isolation, PCR reac-
tion, and gel-electrophoresis was carried out as described next.
2.5.2.1 DNA Extraction
Ear tissue was collected by ear notching from each mouse age 4 week and over
during identification to be used for genotyping as well, while cell pellet or embryo
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tissue was used to genotype cells. Then, ear notch, or cell pellet were transferred
into 1.5 mL tube containing 500 µL of TLS buffer and 2.5 µL Proteinase K. Samples
were mixed well by vortexing, and incubated in a water bath at 55°C for 2 hours
at least with vortexing twice at defined intervals. This is followed by centrifugation
at 12000x g for 5 minutes to remove cellular debris from nucleic acid containing
solution.
Afterwards, the supernatant was transferred into another tube containing 500 µL
of 100% isopropanol, and mixed by inversion for 30-60 seconds. Next, centrifugation
was carried out at 12000 xg for 10 minutes to precipitate the DNA. The supernatant
was then removed, and the pellet (extracted DNA) left to dry for 10 minutes, re-
suspended with 200 µL TE buffer, and left on the bench overnight. On the following
day, DNA templates were incubated for 5 minutes at 95°C, followed by immediate
cooling on ice and stored at -20°C to be used for PCR reaction.
2.5.2.2 Polymerase Chain Reaction (PCR)
25 µL PCR reaction was carried out using Hot Start Green Master Mix kit for
genotyping purposes. The reaction components described in the table below were
made for each sample. Three different positive controls including Aag-/-, Aag+/-,
Table 2.7: PCR reaction preparation for Aag-/- mice/cells genotyping.
Component Volume per sample (µL)
Hot Start Green Master Mix 12.5
Aag P1 Primers* 1
Aag P2 Primers* 1
Aag P3 Primers* 1
Nuclease free water 8.5
DNA template** 1
* Primers sequence described in table 2.1, page 37.
** Nuclease free water added to negative control sample.
and wild-type, and negative control sample were prepared along with the test sam-
ples for each run. Samples were mixed, spun down prior to start the reaction.
Using Tetrad PTC-225 Peltier Thermal Cycler, the PCR reaction was run using
the following conditions with heated lid at 105°C.
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Table 2.8: Thermocycling conditions for Aag genotyping by PCR
Step Temperature(°C) Time (minute) Number of cycle
1 Initial Denaturation 95 5 1
2
Denaturation 95 1
35Annealing 60 1
Extension 72 1
3 Final Extension 72 10 1
4 Hold 4 Hold
2.5.2.3 Gel-electrophoresis
PCR reaction was analysed by agarose gel electrophoresis. 12.5 µL of each sample
was loaded onto 2% agarose gel as well as a 100 base pair (bp) DNA ladder. Gel
was run at 50 Volts for at least 40 minutes, and followed by imaging the blot using
the Gel Doc™EZ system by ultraviolet light. Representative gel image is shown
below. Band size of 500 bp, and 350 bp correspond to Aag null and wild-type
Positive Controls
1500
1000
800900700
600500
400
300
200
100
100bp  TEST1    TEST2     TEST3    TEST4     TEST5    TEST6     TEST7   TEST8    TEST9   TEST10    TEST11 TEST12    Aag-/- Aag-/+         WT  NTC
DNA ladder
2% Agarose Gel
Figure 2.5: Gel image of 2% agarose gel for Aag-/- mice and cell genotyping by PCR. The
band size of Aag-/- allele is 500 bp, whereas the 350 bp is the band size of the wild-type
allele. Having band size of 500 bp only corresponds to Aag-/- mouse or cells (Test3), while
having both bands the 500, and 350 bp indicates heterozygote mouse or cells (Aag+/-)
carrying both wild-type and Aag knockout alleles (Test1). DNA band size of 350 bp only
indicated wild-type mice (Test4), while NTC indicates negative test control sample.
alleles, respectively. Thereby, the presence of 500 bp band only indicates the mouse
or cells are Aag-/- such as Test3, while the appearance of both bands the 500, and
350 bp together indicate heterozygote mouse or cells (Aag+/-) carrying both wild-
type and Aag null alleles such as sample Test1. Eventually, wild-type mouse and
cells depicts band size of 350 only such as Test4 and 10 as shown in figure 2.5.
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2.5.3 In Vivo Studies
2.5.3.1 Interaction of Light and Alkylation
Photoreceptor cells of Aag-/- mice have shown a complete resistance to alkylation
exposure, whereas a severe degeneration has been observed in wild-type photore-
ceptor cells (Calvo et al., 2013, Meira et al., 2009). The degeneration has been
shown to be specific to the retinal outer nuclear layer (ONL). Photoreceptors cells
are vulnerable to damage due to light.
One of the aime of this thesis is to study the interaction between light and
alkylation in the phenotype of alkylation-induced retinal degeneration using mice
expressing different levels of the glycosylase Aag; namely wild-type, and Aag-/- mice.
The following objectives were set to answer this question:
• Quantify photoreceptor cell loss upon alkylation treatment in the presence
or absence of light exposure, by using morphometric measurement on stained
eye sections, as well as analysis of rod and cone-specific gene expression by
RT-qPCR.
• Inspect the effect of alkylation-induced retinal-degeneration on the intrinsi-
cally photosensitive retinal ganglion cells viability and functionality via im-
munofluorescence staining and ipRGC-specific gene expression by RT-qPCR.
• Evaluate the functionality of photoreceptor cells post alkylation exposure via
measuring animal activity in animals treated with MMS under different light
conditions.
Hence, the following in vivo experiments were carried out using wild-type and Aag-/-
mice treated with alkylating agent and housed in different light status as described
below.
2.5.3.1.1 48-hour Animal Post-Treatment
28 C57BL/6J wild-type male mice aged 6-7 weeks were divided into 4 of groups,
seven animal each, according to treatment and light conditions. Mice were then
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housed in group of 3-4 mice per cage in a sound-attenuated, climate-controlled (19-
22°C; 50% ±10% relative humidity) cabinet, and all mice were initially entrained
to a standard light/dark (LD) cycle (12-h light, Zeitgeber-time (ZT) 00:00-11:59;
12-h dark, ZT 12:00-23:59) with light intensity of 250-350 lux. Ad libitum food and
water were provided for the animal during the whole experimental period. During
entrainment period, mice can be fully adapted to the isolation cabinets, and to the
cage as well.
After 7 days of entrainment to LD cycle, mice were mock-treated (PBS) or (75
mg/kg) MMS-treated by i.p. injection just prior to light onset (approximately ZT
23:45). After that, they were placed into different light conditions either constant
darkness (DD), or LD cycle treatment conditions for 48 hours. Mice were then
sacrificed by carbon dioxide (CO2) inhalation, and death was confirmed by cervical
dislocation. Eyes were removed immediately from the socket using a curved forceps,
and fixed in 4% PFA for 24 hours. Normal Histology Procedure was carried out as
described later. Furthermore, the femur bone of each mouse was collected, punc-
tured, and fixed in 4% PFA for 48-72 hours, followed by soaking in ”Poly-NoCal &
Fixativer” solution (Polysciences, Inc., Warrington), formic acid and formaldehyde
based solution to decalcify the bones, for 12-18 hours prior to processing the tissue.
2.5.3.1.2 72-hour Animal Post-Treatment
By reviewing eye sections of wild-type mice after 48 hours of alkylation treatment,
the length of post-treatment time was increased, so the photoreceptors undergoing
cell death process can be completed probably producing more robust histological
result. Also, light cohort mice were exposed to constant light instead of light/dark
cycle to assess the impact of light clearly as well as the behavioural activity of mice
under constant light.
C57BL/6J wild-type, or Aag-/- male mice aged 6-7 weeks were singly housed and
divided into 4 groups according to MMS-treatment and light-exposure conditions.
Mice were entrained as described above to a standard LD cycle (light ZT 00:00 to
11:59, and dark ZT 12:00 to 23:59) for 7 days at least prior to MMS treatment. As
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mice were singly housed, their behavioral activities were recorded for the whole ex-
periment period using ClockLab data collection software and IR activity detectors
attached on the top of each cage. Ad libitum food and water were provided for the
mice during the whole experimental period. After 7-10 days of entrainment to LD
condition, mice were injected by i.p. with either PBS (mock-treatment) or MMS
(75 mg/kg) just prior to light onset (ZT 23:45). Then, they were housed according
to their group light condition into either a constant darkness (DD), or a constant
light (LL; 250-350 lux) for 72 hours.
72 hours post-treatment, mice were culled by CO2 inhalation, and death was
confirmed by cervical dislocation. Then, eyes were removed immediately from the
socket using a curved forceps, and one of the eye was moved into Hartmans Fix-
ative for histology and immunofluorescence (see sections 2.5.3.3 on page 57, and
2.5.3.4 on page 59), while the other eye was frozen immediately in liquid nitrogen
to evaluate gene expressions specific cell markers including Rho and Pde6b for rods,
Opn1sw and Pde6h for cones, Opn4, and Adcyap1 for ipRGCs along with the mouse
housekeeping gene Actin (as a reference gene) by RT-qPCR (see section 2.5.3.5).
In addition, behavioural activity data collected during conducting the experi-
ments was analyzed as described later in section 0. Additionally, the femur bone
of each mouse was collected, puncture, and fixed in 4% PFA for 48-72 hours, fol-
lowed by soaking in the decalcification solution foe 12-18 hours before processing
the tissue.
2.5.3.2 Evaluation of Gene Expression Levels Upon Alkylation Treat-
ment in Wild-type and Aag-/- Mice
Previous work by Meira and collaborators (unpublished) have aimed at transcrip-
tomics analysis to evaluate modifications in gene expression response 6-hour after
alkylation-insult in both wild-type and Aag-/- mice liver. Transcriptomics data
analysis has shown differential up-regulation and down-regulation of several genes
that are related to endoplasmic reticulum stress, and the suppressor of cytokine sig-
nalling, as well as genes closely associated with the circadian clock particularly after
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6-hours of alkylation exposure. Therefore, further investigation in gene expression
level after 6-hours of alkylation treatment was aimed using RT-qPCR method. In
order to reach this aim, the following objectives were set:
• Reproduce parallel experimental conditions to confirm the transcriptomic
analysis previously observed by Meira et al. (unpublished).
• Identify baseline different in the expression of key genes between Aag-/- and
wild-type mice during night-time (dark phase) as well as day-time (light phase)
in both liver and eye tissue.
• Evaluate changes in key genes expression response within wild-type and Aag-/-
mice liver and eye tissue 6-hours after alkylation treatment compared to time-
matched mock-treated cohort.
• Analysing the potential effect of the circadian clock (time of administration)
on the transcriptional response to the alkylation exposure in eye and liver
tissue from wild-type and Aag-/- mice.
Hence, in vivo study was carried out to investigate changes at the level of mRNA
gene expression 6-hour after MMS treatment (Figure 2.3 page 48). 40 57BL/6J
wild-type, and Aag-/- male mice aged 6-7 weeks were housed in group of 2-3 mouse
per cage, and entrained to a standard LD cycle (12-h of 250-350 lux light, ZT
00:00-11:59; 12-h dark, ZT 12:00-23:59) in a sound-attenuated, climate-controlled
(19-22°C; 50% ±10% relative humidity) cabinet for 10 days at least prior treatment.
Then, mice (n=5/treatment conditions) were either mock-treated (PBS) or
(75mg/kg bw) MMS-treated by a single i.p. injection during either day-time (ZT
02:00) or night-time (ZT 14:00). 6-hours later, mice were harvested specifically
at ZT 08:00 for the day-time cohort, and ZT 20:00 for the night-time cohort by
CO2 inhalation chamber, and death confirmed by cervical dislocation. Eyes, liver
and other tissues were then collected immediately and frozen in liquid nitrogen.
Afterwards, investigation of mRNA gene expression level by RT-qPCR method as
described later (see section 2.5.3.5, page 61) was carried out for the following genes;
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Atf4, Chop, Dnajc12, Herpud1, Socs3, Nr1d1, Nr1d2, Dbp, and Atf6 along with
mouse Actin as a reference gene.
2.5.3.3 Histopathology
2.5.3.3.1 Tissue Processing
Fixed eyes and decalcified femur bone from each mouse were transferred into appro-
priate labelled cassettes for tissue processing procedure by the automatic tissue pro-
cessor. This process involves tissue dehydration by gradual increase concentration
of ethanol, clearing by toluene, and impregnation with wax. An overnight routine
processing programme (Table 2.9) as recommended by Shandon Citadel operator
guide was used. Next, tissue base molds were used to embed fixed and processed
eye and bones in paraffin wax, and placed on the cold plate to solidify. The wax
embedding was performed using Raymond Lamb Blockmaster II embedding station.
Table 2.9: Routine overnight tissue processing programme.
Processing Reagent Required Time (hour)
Dehydration
70% alcohol 1
90% alcohol 1
100% alcohol I 1
100% alcohol II 2
100% alcohol III 2
Clearing
Toluene I 1
Toluene II 1.5
Toluene III 1.5
Impregnation
Paraffin wax I 2
Paraffin wax II 3
2.5.3.3.2 Microtome Sectioning
Very briefly, the embedded samples were cut using Reichert-Jung 2040 microtome.
Sections were cut at 5 µm thick, and mounted onto SuperFrost®, and SuperFrost®
Ultra Plus slides.
2.5.3.3.3 Haematoxylin and Eosin Staining
Haematoxylin and eosin (H&E) staining is one of the most common stainings used
to study the morphology of different tissues including the eye, and bone marrow.
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SuperFrost® slides with mounted tissues were placed in a staining rack, and de-
waxed by twice immersing in xylene for 3 and 1 minute respectively. Then, sections
were rehydrated by placing slides through descending ethanol series for 1 minute
each as follow; 100% ethanol, 70% ethanol, and 50% ethanol. Next, slides were
placed in distilled water for 1 minute to wash out any residue, followed by immersion
in Harris haematoxylin solution for 15 minutes, and washed in running tap water
for a minute. Then, sections were differentiated in acid alcohol solution (1% HCl
in 70% ethanol) for 5-10 seconds, and rinsed in running tap water for 10 minutes.
Counter staining was carried out by placing slides in eosin solution for 2 minutes.
Finally, sections were dehydrated through a rising concentration gradient of alcohol
to 100%, and cleared by immersion twice in xylene for 30 seconds in each. Slides
were then covered by a drop of DPX mountant, and a 24 x 60 mm coverslip. The
slides were left to dry under the fume hood for 1 hour before examination.
2.5.3.3.4 Microscopic Examination
Previous studies by Calvo et al. (2013), and Meira et al. (2009) observed that only
the outer nuclear layer of the retina (ONL) was affected upon treatment with MMS
resulted in shrinking of the layer width. Yet, the inner nuclear layer (INL) of the
retina width remains the same in both treated and untreated animals as no changes
has been observed upon alkylation exposure. Based on that the ONL is almost twice
wider than the INL, the lower ratio of ONL to INL correlates with more cell death
in the ONL. So, the ratio of ONL to INL was used as a morphometric approach
to determine the impact of alkylation, and light exposure, as well as interaction
between both of them.
Blind scoring examination was carried out under the microscope using 40x mag-
nification. Triplicate measurement of both the ONL and the INL width were carried
out on each section. The ratio was calculated and plotted as mean ± SEM using
GraphPad Prism.Also, bone marrow sections were examined to confirm the MMS
dose being used was not a toxic dose.
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2.5.3.4 Immunofluorescence (IF)
ipRGCs, the last discovered type of photoreceptor cells within the RGCs, represent
only 1-3% of the ganglion cells in rodent, and they have similar morphological
pattern to normal RGCs except expressing melanopsin. Thus, normal histology
cannot distinguish them, and so defining the impact of alkylating agent on mice
ipRGCs needs different approach. This was achieved by using immunofluorescence
(IF) or immunohistochemistry approaches to detect melanopsin within ipRGCs.
For IF, eye sections, mounted on SuperFrost® Ultra Plus slides, were dewaxed and
rehydrated as previously described (Table 2.9). Rehydrating procedure was followed
by immersing sections in PBS for 10 minutes. Afterwards, the following procedures
were carried out.
2.5.3.4.1 Antigen Retrieval
10 mM of Vector antigen unmasking solution (9.37 µL/mL of ds water) was pre-
pared in a beaker glass and heated up via microwave till it boiled. Sections were
then immersed immediately in the boiled Vector antigen unmasking solution and
maintained at sub-boiling temperature in a water-bath for 10 minutes. The un-
masking solution was left to cool down on the bench for 30 minutes. Afterwards,
using PAP pen (liquid blocker pen), a hydrophobic cycle around each eye section
was drawn. The size of the hydrophobic cycle indicates the volume of any solution
to be added to the section which was in our case approximately 50 µL. Blocking of
both endogenous peroxidase, and preventing non-specific binding was carried out
then, as explained below.
2.5.3.4.2 Blocking and Prevention of Non-Specific Binding
Sections were washed 3 times for 5 minutes each with 50 µL PBS-T per section.
Then, they were incubated with 3% H2O2 in for 5 minutes to block endogenous
peroxidase activity. Washing with PBS-T was carried out twice for 2 minutes each,
and then sections were incubated with 10% goat serum to avoid unspecific binding
of the secondary antibodies. Finally, sections washed twice for 2 minutes each with
PBS-T, and stained as described next.
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2.5.3.4.3 Staining
Indirect IF is based on incubation with primary antibodies that bind specifically to
the targeted antigen or protein (either melanopsin or rhodopsin), and followed by
incubation with secondary antibodies (carrying fluorochromes exhibit intense and
photostable flourescence) that targeting particularly the primary antibodies.
First Staining
The first protein to detect within each section was melanopsin using rabbit poly-
clonal anti-mouse-melanopsin antibody. Sections were incubated overnight with
(1:2500) primary polyclonal anti-melanopsin antibodies diluted in 0.1% goat serum.
Sections were then kept in humidified-chamber in a cold room during this incuba-
tion. On the following day, sections were washed three times with PBS-T for 2
minutes each. Hence, sections were kept in dark and light exposure was minimised
as possible. Goat anti-rabbit IgG secondary antibodies Dylight 488 (green fluores-
cent dye, detailed previously in section 2.1.2.6) were diluted 1:2000 in 0.1% goat
serum. Then, 50 µL of the diluted Dylight 488 was added to each section, and incu-
bated in humidified-chamber for 2 hours at room temperature. Then, washing with
PBS-T was carried three times for two minutes each, and followed by additional
staining detailed below.
Second Staining
As the protocol aiming to detect two different antigens within each sections, second
staining aiming for rhodopsin was carried out using primary mouse monoclonal anti-
rhodopsin antibodies. Sections were incubated overnight with (1:500) primary anti-
rhodopsin antibodies diluted in 0.1% goat serum at 4°C in humidified-chamber. On
the following day, three times washing with PBS-T for 2 minutes each was carried
out, and followed by incubation with goat anti-mouse IgG secondary antibodies
Dylight 594 (red fluorescent dye, refer to section 2.1.2.6) for two hours. After that,
another triple washing with PBS-T was carried, and sections were counter stained
as explained next.
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Counter Staining and Mounting
In order to distinguish different nuclear layers of the retina, and locate cells, counter
staining by nuclear dye was carried out using Vectashield mounting medium con-
taining DAPI. One drop of it was used to counter stain and mount the eye section.
Then, each slide was covered by coverslip and sealed using nail polish. Finally,
slides stored in slide box at 4°C for examination via confocal microscopy within two
weeks of staining.
2.5.3.4.4 Examination
Nikon A1M confocal microscope and DS-Qi1 wide-field camera on an Eclipse Ti-E
microscope along with NIS elements acquisition software were used to examine and
image IF stained eye sections. Using 40x magnification, three different channels
were used to detect fluorescent and capturing images including DAPI, FITC, and
mCherry. DAPI with emission wavelength 450 to was used to detect stained nuclei
(blue) and distinguish the retinal cell layers, whereas Dylight 488 green flourescence
showing melanopsin expression cells in the RGCs (ipRGCs) was detected by FITC
with emission wavelength 525 to detect. The last channel was mCherry with emis-
sion wavelength 595 detect Dylight 595 red flourescence staining rhodopsin, which
mainly depicts in the outer and inner segment of the retina.
2.5.3.5 mRNA Gene Expression By RT-qPCR
A number of factors can modify gene expression including light or chemical exposure,
time (circadian rhythm), addition or deletion of some genes, cells death and others.
These changes in gene expression can be an indication of cell death such as low
expression of Rho in the presence of rod cells death, or a sign of specific response such
as ATF4 and Chop as endoplasmic reticulum stress response marker. Hence, RT-
qPCR approach was used to evaluate mRNA gene expression as described below. To
quantify mRNA expression, tissues such as eyes and liver were frozen immediately
in liquid nitrogen after harvesting the animal to avoid RNA degradation. Following
that, RNA extraction procedure, cDNA synthesis, and RT-qPCR reaction were
carried out as explained next.
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2.5.3.5.1 RNA Extraction by TRIzol® Reagent
Homogenization and Phase Separation
Frozen whole eye ball or 200 mg liver were added to 500 µL, and 2 mL of TRIzol
respectively. Samples were then homogenised using the appropriate power homog-
enizer, and incubated at room temperature for 5 minutes. Then, 0.2 mL of chloro-
form per 1 mL of TRIzol used in homogenization were added to each sample, shaken
vigorously by hand for 15 seconds, and incubated at room temperature again for 3
minutes. After that, centrifugation at 12000x g for 15 minutes at 4°C was carried out
resulted in separating the mixture into three layers; a lower red phenol-chloroform
phase, an interphase, and a colourless upper aqueous phase (roughly 50% of the
total volume) which contains RNA. The aqueous phase was transferred into a new
tube for RNA precipitation and resuspension as described next.
RNA Precipitation and Resuspension
Per a mL of TRIzol used for homogenization, 0.5 mL of absolute isopropanol was
added to the aqueous phase, mixed well, and incubated at room temperature for 10
minutes. Samples were then centrifuged at 12000x g for 10 minutes at 4°C. This was
followed by cautious removal of the supernatant leaving the RNA pellet only in the
tube. The pellet was washed with 75% ethanol in free nuclease water (at ratio 1 mL
of 75% ethanol per 1 mL of used TRIzol), and shaken or vortexed briefly according
to the pellet size. Following that, centrifugation at 7500x g for 5 minutes at 4°C
was carried out, and the RNA pellet was dried for 5-10 minutes. RNA extracted
from eye and liver were resuspended with 20 µL, and 120 µL of nuclease free water
respectively. Then the total RNA was measured by NanoDrop-2000. Finally, RNA
templates were stored at -80°C, and used for cDNA synthesis as explained below.
2.5.3.5.2 cDNA Synthesis
cDNA (complementary DNA) can be synthesised from a single strand RNA template
via a reaction catalysed by the enzyme reverse transcriptase. Maxima™First Strand
cDNA Synthesis Kit for RT-qPCR with dsDNase was used to synthesize cDNA,
as described in the procedure below. When the procedure is being carried out,
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negative control, and minus RT (RNA template added without RT) samples were
run along with other samples.
dsDNA Decontamination
This step was carried out to decontaminate the RNA template from any DNA
residual from the extraction process that can alter the RT-qPCR result. In sterilised
0.6 mL tube, 1 µL of each 10X dsDNase buffer, and dsDNase were added to 1 µg of
total RNA. The mix was then filled up with free nuclease water to a final volume
of 10 µL, mixed well, spun down, and incubated for maximum 5 minutes at 37°C
in thermo-cycler. Samples were spun down, and placed on ice for the next step.
Reverse Transcription
Revers transcription involves the addition of RT enzyme (Maxima enzyme mix)
to the sample to catalyse the cDNA synthesis from the RNA templates. To each
sample, 4 µL of each nuclease free water and 5X reaction mix were added in addition
to 2 µL of RT. However, water was added instead of RT in minus RT to confirms
that the dsDNA decontaminated RNA template is DNA free and does not have any
residual DNA. Samples were then spun down, and incubated for 10 minutes at 25°C
followed by 15 minutes at 50°C. Finally, samples were spun down, and stored either
in -80°C for longer storage or -20°C for usage within a week for RT-qPCR.
2.5.3.5.3 Quantitative Reverse Transcription Polymerase Chain Reac-
tion (RT-qPCR)
The principle of RT-qPCR is the usage of the cDNA templates, synthesised from
RNA by RT, as the templates for the qPCR. This will quantify the real expression
of targeted gene in specific time relatively to endogenous genes such as Actin. The
RT-qPCR was carried out using Luminaris HiGreen Low ROX qPCR Master Mix,
and cDNA synthesised as previously described.
Luminaris HiGreen Low ROX qPCR Master Mix contains Luminaris Colour
HiGreen Low ROX qPCR master mix, 40X Yellow buffer, and nuclease free water.
The master mix includes Hot Start Taq DNA polymerase, uracil-DNA glycosylase,
dNTPs in an optimized PCR buffer containing double-stranded DNA (dsDNA)
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binding dye (SYBR® Green I) supplemented with ROX passive reference dye, and
inert blue dye. 40X Yellow sample buffer consists of a yellow dye, when it mixed
with the master mix in a qPCR reaction interact with inert blue dye and turning the
solution colour to green. That produces a visual aid when pipetting reducing pipet-
ting errors during reaction setup. Before setting up the reaction 5 µL of 40X yellow
buffer was added to each 20 µL volume of cDNA. So, the volume of cDNA tem-
plate for 20 µL qPCR reaction was 1.25 µL (1 µL cDNA, and 0.25 µL Yellow buffer).
In MicroAmp® fast optical 96-well reaction plate, 20 µL standard reaction was
set up using the formula described in the table below. Triplicate of each sample were
set up for the targeted gene as well as the endogenous gene (mouse Actin) (refer to
table 2.2 for primers sequences). Negative test control was included in each run for
each gene to exclude possibility of contaminating the reaction mix. Also, specific
calibrator sample per each study was included in each run within that study.
Table 2.10: The contents of 20 µL RT-qPCR reaction using Luminaris HiGreen Low ROX
kit
Component Volume (µL)
cDNA template with Yellow buffer 1.25
Free nuclease water 7.15
Luminaris HiGreen Low ROX qPCR Master
Mix
10
*Primer Forward of Target gene (10 µM) 0.8 (0.04 µM final concentration)
*Primer Reverse of Target gene (10 µM) 0.8 (0.04 µM final concentration)
*For Primers sequences see table 2.2
After setting up the reaction the plate was sealed by MicroAmp® optical ad-
hesive film, and centrifuged for 2 minutes at 500x g to spin down the reaction
contents and remove any residual bubbles that may interfere with the reading.
Then, QuantStudio™7 Flex System instrument was used to run the reaction, and
the QuantStudio™Real-Time PCR software 1.1 was used to set up the machine and
record the result. The thermocycling conditions described below were used to run
the RT-qPCR reaction
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Table 2.11: Thermocycling conditions of qPCR reaction using SYBR ® Green I run by
QuantStudio™7 Flex System
Stage Step Temperature C) Time (minutes) No. of Cycle
Hold
1 50 2
1
2 95 2
PCR
3 95 00:15
40
4 60 1
Melt curve
5 95 0.15
16 60 1
7 95 00:15
2.5.3.5.4 RT-qPCR Analysis
The results were analysed using QuantStudio™Real-Time PCR software 1.1. The
programme determined the threshold cycle (CT), and calculate CT mean, CT SD,
delta CT, delta CT SD, delta delta CT, and finally the ratio of the test sample
to wild-type untreated control sample (relative quantification (RQ)). The CT SD
of each technical triplicate was checked, to ensure that the SD is 0.25 in both the
targeted gene, as well as the endogenous gene, and exclude out layer amplification if
needed. After calculating the CT mean of both targeted (T) and endogenous gene
(E) for both calibrator and test sample, the delta CT are calculated by the software
as described below:
Calibrator Sample:
CT mean(Calibrator) (T) = 19.715 CT mean(Calibrator) (E) = 18.503
Delta CT mean(Calibrator)= CT mean (T) - CT mean (E)
Delta CT mean(Calibrator)= 19.715-v18.503= 1.212 (A)
Test sample:
CT mean(Test) (T)= 19.091 CT mean(Test) (E)= 17.508
Delta CT mean(Test)= CT mean (T) - CT mean (E)
Delta CT mean(Test)= 19.091 - 17.508 = 1.583 (B)
Then, the delta delta CT of each sample is calculated by subtracting the delta CT
mean of each sample from the delta CT mean of the calibrator as shown below:
Calibrator Sample:
Delta delta CT mean(Calibrator) =
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=Delta CT mean(Calibrator) - Delta CT mean(Calibrator)
Delta delta CT mean(Calibrator) = 1.212 (A) - 1.212 (A) = 0 (C)
Test sample:
Delta delta CT mean(Test) = Delta CT mean(Test) - Delta CT mean(Calibrator)
Delta delta CT mean(Test) = 1.583 (B) - 1.212 (A) = 0.371 (D)
Then, the RQ calculated using the following formula:
RQ = E−(deltadeltaCT ) = 2−(deltadeltaCT )
Where E is the amplification efficiency and it assumed to be 2.
RQ(Calibrator) = 2−(DeltadeltaCTmean(Calibrator) = 2−(0)(C) = 20 = 1
RQ(Test) = 2−(DeltadeltaCTmean(Test) = 2−(0.371)(D) = 2−0.371 = 0.773
After that, the mean ±SEM of the RQ of 5 animals per group was plotted by
Graph-Pad Prism.
2.5.3.6 Behavioural Activity
Behavioural activity data was recorded via ClockLab data collection software from
each mouse housed singly as described above (see section 2.5.3.1.2, page 54). The
data was recorded as the activity per minutes for the whole experimental period per
mouse by measuring the number of mouse interference with the IR detector located
on top of each cage.
Once the experiments finished, the recorded data were analysed using a number
of formulas via Excel software. At the beginning, the average and standard deviation
(SD) of baseline data (data of any two days prior to applying the MMS treatment)
was calculated for each animal. Then, using the baseline average and SD, Z-scored
activity per each minutes were calculated for both baseline, and post-treatment
recorded activity using the following formula:
Zscore =
x− µ
σ
Where x is the raw score, and µ is the mean of the baseline data, while σ is the
standard deviation of the baseline data.
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After calculating the Z-score, the average activity of each three hours was calcu-
lated. Then, activities recorded for 6-hours from the injection time were excluded
to avoid the impact of handling animals on their behaviour during the injection,
and the injection itself. Following that, the average activity of each three hours was
used for analysis and plotting the graph through Graph-Pad Prism.
2.5.4 In Vitro Study
Analysis of a previous obtained transcriptomic data by Meira and collaborators (un-
published) indicated a modulation in the transcripts of key genes including genes
that is closely associated with the circadian clock upon alkylation exposure in wild-
type mice liver, but not in Aag mutant. Therefore, investigating the potential
impact of alkylation treatment on the biological clock in both genotype wild-type
and Aag-/- mice was aimed by applying treatment at different time during 24 hours
period. However, as one of the 3Rs is reducing the usage of experimental animal
and for ethical reasons, in vitro approach was considered instead.
Thus, wild-type and Aag-/- primary mouse embryonic fibroblast cells (pMEFs)
with lower passage number (2-9) were used for this purposes. Bmal1 -dLuc (Bmal1,a
core gene and a distinct phase marker of the clock) wild-type and Aag-/- pMEFs
were generated through lentiviral (LV) infection of Bmal1 -dLuc luciferase reporter.
Hence, Bmal1-bioluminescence of these cells was monitored before and after alkylation-
exposure at different circadian phases to inspect the alkylation effect on the clock
homeostasis. Study design of the in vitro experiments was previously illustrated in
figure 2.4 (page 49).
2.5.4.1 Cell Line
Wild-type and Aag-/- pMEFs were isolated and generated from embryos of wild-
type and Aag-/- C57BL/6J mice. Complete cell culture growth medium (refer to
section 2.1.3.3, page 40) were used for both cell genotypes. Cells incubation was
carried out in a humidified incubator at 37°C under 5% CO2.
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2.5.4.2 Primary Mouse Embryonic Fibroblast Cells (pMEFs) Isolation
Timed-pregnant wild-type and Aag-/- female mice were culled by CO2 inhalation,
and death confirmed by cervical dislocation on postcoitum day E12.5-E13.5 consid-
ering that E0.5 is the day of finding a copulation plug. Both uterine horns were
dissected out of the pregnant mouse and placed in a 30 mL of 1X-PBS. Under the
laminar flow hood, each individual embryo was dissected from the uterus, followed
by separating the placenta and the yolk sacs as well. Then, using a 1 mL syringe
without needle each embryo was homogenised onto 60 mm dish pre-coated with
0.1% gelatine, and containing 5 mL of complete media. The homogenization is
carried out by drawing embryonic tissue up and down not harshly until the dis-
aggregated tissue moves freely in and out of the syringe. Overnight incubation at
37°C with 5% CO2 was carried out for desegregated tissue. Day later, the medium
is replaced with fresh complete medium, and the cells are incubated again until the
cells become 70-80% confluent. Then, the medium is replaced with fresh complete
medium 4 hours prior to passaging or freezing the cells.
2.5.4.3 Cell Passage and Seeding Procedure
pMEFs were grown in complete medium in either cell culture treated flasks or dishes
until reaching 70-80% confluency. The medium was aspirated, and cells were washed
with sterile 1X-PBS. Then, appropriate volume of 1x trypsin/EDTA solution was
added to cover the surface of the flask or the dish with gently rocking them to ensure
even coverage of the cells with the solution. Incubation at 37°C for approximately
2-5 minutes until the cells had detached as assessed by microscopy was carried out.
Following that, total inactivation of trypsin/EDTA was approached by the addition
of complete medium at the ratio of 2:1. For instance, 2 mL of complete media
was added per 1 mL of trypsin/EDTA solution used. Cell suspension was then
transferred into a universal tube (30 mL tube) and centrifuged for 5 minutes at
300x g. The supernatant was aspirated leaving only the pellet (cells). The cells
were re-suspended with complete medium and diluted 1:3 or 1:4 by dividing the
cell suspension between 3 or 4 new flasks or dishes (of equal culture area), unless
seeding cells was carried out for experimental purposes as described later. Then,
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complete medium was added to top up the flask or the dish with the appropriate
volume. For example, the total volume was 5 and 15 mL for culture area 25, and
80 cm2 flask respectively. Finally, the cells were incubated at 37°C with 5% CO2 in
humidified incubator.
If plating cells was aimed for experimental running, cells would be resuspended
with 5 mL of complete media. Thus, cell counting procedure by haemocytometer is
carried out, and 1∗105 cells were plated in 35mm dish containing 2 mL of complete
media. Dishes were finally incubated for 24 hours at 37°C and 5% CO2 to allow
them to attach to the surface and grow.
2.5.4.4 Frozen Stock Preparation
Preparation of frozen stock was carried out after pMEFs isolation at passage 1, or
after successful transfection of cells with Bmal1 -dLuc LV. When cells growing in
complete culture medium reached 80-90% confluency, they were fed with fresh media
and incubated at 37°C and 5% CO2 2 to 4 hours prior to freezing. Afterwards, cells
were trypsinised as previously described, and washed by centrifugation to remove
trypsin. Cells were then re-suspended in freezing cell culture medium previously de-
scribed (see section 2.1.3.3, page 40) at a concentration of 1∗106 cells/mL. Aliquots
of cell suspension in cryovials were placed in an isopropanol bath at -80°C for 24
hours to enable cooling at a rate of approximately 1-3°C/min before transferring
them to liquid nitrogen storage.
2.5.4.5 Plating of Frozen Stock
Frozen cells were thawed rapidly in a 37°C water bath, and cell suspension was
transferred immediately to 5 mL pre-heated complete medium at 37°C in univer-
sal tube and centrifuged for 5 minutes at 300x g. Supernatant was aspirated and
cell pellet re-suspended in 5 mL of growth medium. For non-transfected cells, the
new cell suspension was transferred into two-three small cell culture dishes 35 mm
pre-coated with 0.1% gelatine, and incubated at 37°C, 5% CO2. One day later, the
old complete medium was removed and replaced with fresh complete medium and
incubated until reaching 70-80% confluency; hence, the cells are ready for transfec-
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tion with Bmal1 -dLuc LV as described below.
However, previously transfected cells were transferred into T25 flask precoated
with 0.1 gelatine and incubated for a day at 37°C and 5% CO2. A day later, the
media was replaced with a fresh one, and cells incubated as usual until the passage
due. Finally, cell passage procedure was carried out as described previously once
the cells reached 70-80% confluency.
2.5.4.6 Cells Transcfection with Lentiviral Particles of Bmal1 -dLuc
Luciferase Reporter
Wild-type or Aag-/- pMEFs passage 1-2 were seeded in 35 mm dishes as described
above for Lentivirus (LV) transfection. Once the cells were 70-80% confluent, the
LV transfection procedure was carried out. The LV transfection procedure was car-
ried out in category 2 laboratory under sterilised laminar flow hood. Firstly, the
media was aspirated, and the cells were washed with 1X-PBS. Secondly, 2 mL of
fresh complete media supplemented with 10 mg/mL protamine sulfate (0.8 µL/mL
of media for 8 µg/mL final concentration) were added to the cells. Then, lentiviral
particles of Bmal1 -dLuc luciferase reporter (a kind gift from Professor S. A. Brown
from University of Zrich, Switzerland) were added at least 6 ∗ 1010 virus particles
per a mL of media for a successful transfection, and then swirled to mix the virus
particles with the medium. After that, cells were subjected for incubation at 37°C
with 5% CO2 for 24 hours.
On the following day, the media was replaced with fresh complete medium,
and replaced with fresh one again after 6-hour as well. A day later, cell passage
procedure was carried out by passaging each transfected 35mm dish into T25 flask
containing 5 mL of complete medium. Afterwards, another passage at the ratio
of 1:3 was carried out when the cells at the required confluency. When cells were
70-80% confluent, some cells were then frozen, passaged, or platted in 35 mm dish
for bioluminescence to test the transfection.
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2.5.4.7 Bioluminescence Recording of Bmal1 Gene Expression
Bmal1 -dLuc wild-type and Aag-/- pMEFs passages 6-9 were used for biolumines-
cence recording of Bmal1 expression. 1∗105 Bmal1 -dLuc pMEFs were platted in 35
mm dish containing 2 mL of complete medium and incubated at 37°C with 5%CO2
for 24 hours. When cells reached 70-80% confluency, they were synchronized by a
serum-shock to reset the clock within the majority of the cells. This was accom-
plished by aspirating the media, and cleaning the dish twice with 1X-PBS. Then,
cells were serum shocked with 2 ml/dish of shocking cell culture medium containing
50% FBS (refer to section 2.1.3.3, page 40), and incubated at 37°C with 5%CO2 for
2 hours.
After that, the media was removed and cells were rinsed twice with 1X-PBS, and
light exposure was minimised. 2.5 ml/dish of bioluminescence cell culture medium
containing 0.1 mM luciferin (see section 2.1.3.3, page 40) was added, and dishes
were sealed with 40mm diameter cover glasses by grease. The dishes were then
transferred into LumiCycle for bioluminescence monitoring and recording, and in-
cubated at 37°C until the appropriate time of treatment as described below.
LumiCycle luminometer with 32-Channel luminometer for bioluminescence mon-
itoring was used for circadian biology monitoring. It allows up to 4 plates to be
counted at the same time as it is equipped with 4 photon-counting multiplier tubes
selected for low dark counts with high sensitivity in the green portion of the spec-
trum. So, every 10 minutes 32 of 35mm-dishes bioluminescence can be counted at
one time, for one minute. Bmal1-bioluminescence recording was being monitored
during the experiment using Actimetrics LumiCycle Analysis software to determine
the peak of Bmal1-bioluminescence rhythm.
By defining the peak, MMS treatment was carried out at different phases of
Bmal1-rhythm by applying treatment 6, 12, 18 or 24 hours after Bmal1- biolumi-
nescence peak. Treatment was aimed at different phase of the circadian cycle to
determine the impact of alkylation on the clock through different circadian phases,
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and hence determine the possibility of a different response to alkylation-insult be-
tween both wild-type and Aag-/- pMEFs. Each treatment time point has 3 technical
replicate per each treatment conditions; control, mock-treated (serum free media-
treated; SFM), and 2.5 mM MMS-treated. Control (non-treated)condition is defined
as the condition where the treatment procedure was not applied to the dishes (cells),
and dishes remained within the lumicycle, while the other dishs of other treatment
conditions being temporarily removed. Mock-treated condition represents the im-
pact of the treatment condition but with the vehicle only for one hour which was
DMEM without a serum and MMS. 2.5 mM MMS-treated condition is where treat-
ment with 2.5 mM MMS was applied for one hour.
Once the treatment time point was due, dishes aimed for mock and MMS treat-
ment were removed from the lumicycle. Then, the media within each dish was trans-
ferred into labelled tubes and covered and kept in a water-bath at 37°C. Dishes were
rinsed twice with 1X-PBS. Then, cells were incubated with 1 ml/dish of either SFM
(mock-treatment) or 2.5 mM in MMS for 1 hour at 37°C. Afterward, both SFM and
SFM containing MMS were removed and replaced with the original media of the
dish which was transferred prior to treatment. Dishes were then covered with the
glass coverslip and sealed by the grease again. Finally, each dish was returned to
its previous location in the lumicycle to continue the bioluminescence monitoring
and recording, and incubated for 4 days at 37°C. The data were then analysed as
described below.
2.5.4.8 Bioluminescence Monitoring Analysis
To analyse bioluminescence recorded data, few equations were applied to the ob-
tained data. At the beginning, data recorded during treatment time, and affected
reading due to opening the lumicycle were discarded. Then, using Microsoft excel
software raw data were trended, and subsequently detrended as followed:
The average bioluminescence count of 24 hours (12-hour before and 12-after each
time point) was calculated (trend) based on that:
The data was recorded once each 10 minutes during 24 hours (1440 minutes).
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⇒The total time of recorded data within 24 hours per dish = 1440 / 10 = 144
So, the average recorded bioluminescence of in total 144 time-points before and
after each time point was calculated as the trend.
Then, the trend of each time point was subtracted from the actual recorded data
of that point, which is resulted in the detrended data.
After that, the detrended bioluminescence data was smoothed by calculating
the mean of in total 18-24 time-point of the detrended data before and after each
time point. This would reduce the background noise and smooth the data for graph
plotting. Thus, the mean(± of smoothed BMAl1-bioluminescence count per minutes
of the technical replicated (3) for each treatment conditions was calculated. Finally,
the fitting of the cosine curve was achieved by fitting data of 0.93 day (estimated
time for a complete cycle) by a least-squares procedure using the averaged smoothed
Bmal1-bioluminescence count. Prior to treatment and post treatment curves were
fitted individually. The following equation was used to fit the nonlinear regression
curve via Graph-Pad Prism software:
y =
(
Mesor+Amplitude∗cos
((
(2∗PI)∗(x−Acrophase))/0.93))∗exp(−x/Damping)
Where: X = Time. Mesor = the average value around which the variable oscillates.
Amplitude = the difference between the trough and the mean value of a wave.
Acrophase = the time at which the peak of a rhythm occurs.
Damping = decrease in amplitude of a rhythm over time (time distance between
two consecutive peaks).
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Figure 2.6: Description of fitting cosine
curve. Mesor is the average value around
which the variable oscillates, while ampli-
tude is the difference between the trough
and the average value of a wave, and
acrophase is the time where the peak of a
rhythm occurs.
After fitting the cosinor curve for each treatment time point, the shift in the clock
was calculated. This was accomplished by determine the post-treatment biolumi-
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nescence peak time of each treatment conditions (control, mock-treated, and MMS-
treated). Then, the time differences between bioluminescence peak of mock-treated
and the non-treated control treatment conditions as well as MMS-treated and mock-
treated were calculated, and correspond to the phase shift of mock-treatment and
MMS-treatment respectively. An example is shown in the figure below. This was
carried out for both wild-type and Aag-/- pMEFs, and for each treatment time-point
including 6, 12, 18 and 24 hours after Bmal1-peak. Finally, the circadian phase-
response curves of wild-type and Aag-/- pMEFs in response to mock-treatment,as
well as MMS-treatment were plotted.
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Figure 2.7: Diagram representing the calculation of the phase-shift in Bmal1 rhythm
in pMEFs in response to Mock or MMS-treatment. Fitted cosinor curve of Bmal1-
bioluminescence rhythm of pMEFs treated 6-hour after Bmal1-peak. The left panel (a)
shows the bioluminescence rhythm of mock-treated cells compared to the non-treated con-
trol cells, while the right one (b) compare the rhythm of 2.5mM MMS treated cells with the
mock-treated treated cells. Arrows indicated treatment period, whereas (A) correspond to
the time different of Bmal1-peak between mock-treated and control cells (mock-treatment
∆-phase), and (B) represent the time different of the Bmal1-peak between MMS-treated
and mock-treated cells (MMS ∆-phase).
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2.6 Statistical Analysis
All in vivo studies data are expressed as mean plus or minus standard error of the
mean (SEM). PROC MIXED model by SAS 9.2 was suggested to be the appropriate
mode of analysis using ANOVA along with Type III test of fixed effect to calculate
the sums of squares as the statistical analysis test. This was suggested because
either two, or three independent variables (light/time, alkylation, and genotype)
with multiple observations for each can influence one dependent variable includ-
ing the ratio of ONL/INL, behavioural activity, and gene expression. Thus, 2-way
ANOVA is used as the appropriate test to determine the main effect of 2 variables
such as MMS-treatment and light, MMS-treatment and time, or MMS-treatment
and genotype effects. Whereas three-way ANOVA is used to determine the main
effect of 3 variables such as MMS-treatment, genotype, and time in case of analysing
behavioural activity, or MMS-treatment, time of treatment, and genotype effect on
the early gene expression response upon alkylation exposure.
Analysis of variable effects by ANOVA is followed by post-hoc analysis. This was
achieved via performing pairwise comparison of the least squares means (LSmeans).
Statistical analysis tests were performed by using SAS 9.2 programme considering
that P value ≤ 0.05 is significant. In some cases (in-vitro study), statistical analysis
is not carried out due to lower number of biological replicates, but the obtained
data were based on several technical replicates.
Chapter 3
Interaction of Light and Alkylation
3.1 Introduction
Vision is one of our five main senses. Visual perception requires that light be sensed
in the eye by photoreceptor cells via a process called the phototransduction path-
way. Being unavoidably exposed to light along with other associated factors such
as high consumption of oxygen, possessing a considerable amount of polyunsatu-
rated acids and specific genes mutation make photoreceptor cells more susceptible
for damages (Hartong et al., 2006, Specht et al., 2000, 1999, Rapp et al., 1990).
In fact, exposure to light has been shown to influence the progression of several
retinal degenerations disease such as the hereditary disease retinitis pigmentosa, a
disease where only the photoreceptor cells in the retinal outer nuclear layer (ONL)
are degenerated (Hartong et al., 2006, Organisciak et al., 2003).
The mechanism by which light induce-retinal-degeneration require a functional
phototransduction pathway and seems to involve different stages. Initially, func-
tional phototransduction pathway is required because the damage initiated by repet-
itive and extensive bleaching of the photopigments (chromophores) in photoreceptor
cells by light. This results in continuous generation of retinoid metabolites and the
other unknown toxic by-products, that could accumulate during extreme light ex-
posure and be deleterious to photoreceptor viability (Wenzel et al., 2005, Saari
et al., 1998). For example, accumulated photo-intermediate such as Metarhodopsin
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I, II and III can interact with, and transfer an electron (hydrogen) to/from other
molecules including poly unsaturated fatty acids leading to the generation of free
radicals including reactive oxygen species (ROS) and other toxic-byproduct that po-
tentially leads to oxidative stress (reviewed in Organisciak and Vaughan 2010, and
Rozanowska et al. 2009). The initiation stage of light-induced retinal-degeneration
appears to be followed by elevation of intracellular calcium levels along increasing
the production of nitric oxide (NO), and generation of ROS (Organisciak et al., 2003,
Demontis et al., 2002, Donovan et al., 2001). Potentially, all the above-mentioned
scenarios particularly the generation ROS can lead to the formation of oxidative
deoxyribonucleic-acid (DNA) base damage. ROS products such as hydroxyl rad-
ical, hydrogen peroxide, and superoxide radical, are capable of generating highly
mutagenic and toxic oxidative products such as 8-Oxo-7,8-dihydroguanine and ring-
opened forms of purines and thymine glycol (Marnett, 2000, Rouet and Essigmann,
1985).
An additional oxidative stress related effect induced by light exposure is the
enhancement of the lipid peroxidation of polyunsaturated acids. Rat exposed to
intense-light or constantly illuminated by visible light for 2-3 day showed that the
level of lipid peroxidation of poly-unsaturated fatty acid such peroxidation of omega-
6 and omega-3 to hydroxynonenal and hydroxyhexenal respectively was twice the
normal steady-state levels found in control rats (Richards et al., 2006, Wiegand
et al., 1983). These fatty acid radicals, aldehydes, and other product formed during
lipid peroxidation reactions such as hydroxynonenal can originate oxidative damage
to DNA and lead to the formation of the etheno-modified bases (representing indi-
rect endogenous source of alkylation DNA base damage) such as 1,N6-ethenoadenine
(εA) and 3,N4-ethenocytosine (εC) 1,N2-ethenoguanine (εG) in the DNA of affected
tissues (Bartsch and Nair, 2002, Wiseman and Halliwell, 1996, El Ghissassi et al.,
1995). These etheno DNA adducts (alkylated DNA bases) have been shown to
be highly cytotoxic and mutagenic as well (Pandya and Moriya, 1996, Basu et al.,
1993), and this cytotoxic effect in the form alkylated DNA bases damage is well
established in photoreceptor cells.
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The capability of alkylating agents to induce retinal degeneration has been re-
ported in numerous studies. In fact, alkylating agents have been even used to
produce animal model of retinitis pigmentosa disease, and this due to the capability
of the agents to induce retinal degeneration in the ONL only and not the other
retinal layers (Calvo et al., 2013, Meira et al., 2009, Yoshizawa et al., 2009, Tao-
moto et al., 1998, Ogino et al., 1993). One of these agents being used in laboratory
animal to mimic the progression of retinitis pigmentosa disease agent is alkylat-
ing agents methyl methanesulfonate (MMS). It is a cytotoxic agent, and mainly
generates 7-methylguanine (7-MeG) and 3-methyladenine (3-MeA) DNA lesions,
and little amount of O6-methylguanine (O6-MeG) DNA lesion (mutagenic lesion)
(Sedgwick et al., 2007, Meira et al., 2005). 7-MeG and 3-MeA DNA lesions are not
toxic by them self, and the toxicity is resulted from the end product of the dam-
aged bases such as single strand breaks (SSBs) and abasic site. The cytotoxicity
and mutagenicity produced by the alkylating agents are powerfully adjusted by the
DNA repair processes. This repair process involves three different repair pathway
namely base excision repair (BER), reversal of base damage by O6-methylguanine-
DNA methyltransferase (Mgmt), and oxidative demethylation by AlkB, that are
activated based on the type of the methylated lesion. For instance, O6-position
methylated DNA bases are mainly repaired by Mgmt, whereas N7, and N3 -position
methylated bases are mainly repaired by the BER.
The BER pathway is mainly responsible for the repair of a large number of
chemically modified DNA bases such as methylated, oxidized, and deaminated
bases occurred through endogenous, environmentally, and therapeutically stimu-
lated mechanism. In case of alkylated DNA bases, the BER is initiated by specific
DNA glycosylases named alkyladenine DNA glycosylase (Aag). It is an enzyme that
recognizes and removes alkylated DNA bases such as 7-MeG, 3-MeA, εA, and εG
generating apurinic/apyrimidinic (AP)-site (toxic-intermediates) (Slupphaug et al.,
1996, Dosanjh et al., 1994, O’Connor and Laval, 1990). The AP-site is then cleaved
by AP-endonuclease producing a 3′ hydroxyl (3′OH) and 5′ deoxyribose phosphate
(5′-dRP; toxic-intermediates) terminus (Pascucci et al., 2002, Klungland et al.,
1999). Therefore, polymerase-β mediated DNA synthesis removes the cytotoxic
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5′dRP group via its 5′dRP lyase activity, and substitutes the damaged nucleotide
cleaved by AP-endonuclease (Sobol and Wilson, 2001, Sobol et al., 2000, 1996).
The repair is then completed by formation and sealing of the ligatable nick through
recruitment of DNA ligase I or the DNA ligase IIIα/XRCC1 complex (Sleeth et al.,
2004, Kubota et al., 1996).
Apparently, the role of Aag and the BER in repairing alkylated DNA bases is
not beneficial to some extent as expected when the alkylation base damage occurs
in the DNA of several specific tissues including the retina. This was observed by
Meira et al. (2009) as the photoreceptor degeneration was induced upon MMS-
insult in wild-type mice, and this degeneration was completely prevented in Aag-/-
mice whereas it was even exacerbated in Aag-/-Tg+ mice when Aag was restored.
Thus, preventing the initiation of BER (repair process for alkylated DNA bases)
by removing Aag protect against MMS-induced photoreceptor degeneration via re-
ducing the production and accumulation of the BER toxic-intermediates such as
AP-site and 5′-dRP termini, which potentially generate excessive amount of SSBs
(Schreiber et al., 2006, ElKhamisy et al., 2003, Kraus and Lis, 2003, Vidal et al.,
2001). Therefore, excessive SSBs in turn lead to poly(ADP-ribose) polymerases 1
(Parp1) hyperactivation resulting in higher consumption of nicotinamide adenine
dinucleotide (NAD+), which in turn leads to NAD+ and adenosine triphosphate
(ATP) depletion, and hence cell death (Calvo et al., 2013, Andrabi et al., 2008).
This was observed as MMS-induced photoreceptor cell degeneration in wild-type
and Aag-/-Tg+mice were abrogated in the absence of Parp1.
Alkylation treatment has been reported to induce retinal degeneration. Interest-
ingly, alkylation-induced retinal-degeneration cell loss exclusively in the outer nu-
clear layer (ONL) of the retina while all other retinal cell layers remain unaffected.
This cell-type specificity in alkylation sensitivity could indicate that photoreceptor
cells are exquisitely sensitive to alkylation-induced accumulation of toxic BER in-
termediates especially if the former is combined with exposure to light. Thus, due
to the capability of light to induce-retinal degeneration, preventing light exposure
at the time of administrating the alkylating agents can potentially reduce the extent
CHAPTER 3. INTERACTION OF LIGHT AND ALKYLATION 80
of the photoreceptor cell toxicity. If that is the case, then other cells exposing to
and capable of sensing light within the retina are liable to be toxified upon alkyla-
tion exposure as well. To be more precise, the late discovered photoreceptor cells
reside within the retinal ganglion cells namely intrinsically photosensitive retinal
ganglion cells (ipRGCs) (Provencio et al., 2000, 1998) are at risk of being toxified
upon alkylation-insult accompanied by light exposure (during the light-phase).
ipRGCs are able to sense light among other RGCs due to the expression of
specific photopigment namely melanopsin within these cells. They represent 2-3%
and 1% of the total RGCs in rat and mice respectively and sense light for non-
visual perception function such as entrainment activity (Berson et al., 2002, Hattar
et al., 2002, Provencio et al., 2000). In rats, the viability of ipRGCs remained
unaffected upon exposure to the alkylating agents N -methyl-N -nitrosourea (MNU)
(Wan et al., 2006). This was based on unaffected ganglion cell numbers, and mRNA
expression of the neurotransmitter pituitary adenylate cyclase-activating polypep-
tide (PACAP) (co-expressed with melanopsin in ipRGCs) at 0.5, 1, 5, 7, 13 and
28 days after MNU injections (rats harvested at ZT 14:00/dark-phase) compared
to control. However, a significant reduction in the melanopsin mRNA expression
was observed at 0.5, 1, 5, 7, 13 and 28 days after MNU injections compared to
control. This reduction in melanopsin mRNA expression after MNU-exposure as-
sociated with a nuclei contraction in the classical photoreceptor (early feature of
apoptosis), thinning of the ONL and detection of apoptotic bodies, and a remain-
ing of only two to three cell layers in the ONL at 0.5, 1, and 5 days after MNU
treatment respectively, whereas cells in the retinal inner nuclear layer and in the
retinal ganglion layer morphologically remained intact at all time (Wan et al., 2006).
Wan et al. (2006) believed that the melanopsin expression decreased upon MNU
exposure is not due to ipRGCs death, but due to the induced retinal-degeneration
in the ONL (classical photoreceptor cells death). Those observations were also seen
in rats with a defect in the retinal dystrophy gene (inherits a retinal degeneration
disease), as the melanopsin mRNA expression reduced upon progression in the reti-
nal degeneration in the ONL, whereas PACAP mRNA expression remained stable
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(Sakamoto et al., 2004). Therefore, in rats the classical photoreceptor cells regulate
the expression of melanopsin potentially via dopamine synthesis and release in the
retina, and a degeneration in them leads to decrease the melanopsin expression un-
der both hereditary diseases and alkylation exposure (Wan et al., 2006, Sakamoto
et al., 2005, 2004).
In contrast, the effect of the classical photoreceptor degeneration on melanopsin
expression within ipRGCs is not perceived in mice. Semo and collaberators (2003)
noted that the melanopsin mRNA expression in middle and old rodless/coneless
mice (∼1 and 2 years old respectively) with a progressed retinal degeneration was
not down regulated, and was paralleled to the expression in age-matched wild-type
mice. Also, the pupillary light-reflex in the aged rodless/coneless mice were indistin-
guishable from congenic wild-type mice. This seemed to correlate with the survival
of the RGCs particularly the ipRGCs, along with the preservation of melanopsin
mRNA expression when a progressed retinal degeneration in the ONL and INL were
observed in the aged rodless/coneless animal (Semo et al., 2003). Additionally, a
recent work by Jain et al. (2016) found that MNU-induced retinal degeneration did
not alter the mRNA and the protein expression level of melanopsin, and did not
affect the ipRGCs viability in wild-type mice 14-days after MNU-administration
compared to untreated wild-type mice. Thus, ipRGCs viability remains unaffected
upon alkylation-exposure in both rats and mice, but in contrast to rats, melanopsin
mRNA expression is not regulated by the classical photoreceptor cells viability and
function in mice (Jain et al., 2016, Semo et al., 2003).
Thereby, the interaction of light and alkylation will be investigated to determine
whether light exposure can contribute to alkylation-induced retinal degeneration or
not. To achieve that, the effect of alkylation-insult and light exposure on the classi-
cal photoreceptor cells viability in Aag-proficient and deficient animal was inspected
using routine histopathology method along with morphometric measurement. Ad-
ditionally, the analysis of photoreceptor cell-specific gene expression has aided in
identifying which type of photoreceptor cell is sensitive to alkylation and contributed
to photoreceptor cell death quantification. Likewise, immunofluorescence staining
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method and the analysis of ipRGCs-specific gene expression has assisted in inves-
tigating the effect of alkylation-induced retinal degeneration on the late discovered
photoreceptor cells (ipRGCs) viability and functionality in Aag proficient and de-
ficient mice. Moreover, the impact of alkylation treatment and light exposure on
photoreceptor cell functionality was also examined in animals expressing different
levels of Aag by recording and monitoring the activity levels of experimental ani-
mals.
3.2 Aim
To study the interaction of light and alkylation in the phenotype of alkylation-
induced retinal degeneration using mice expressing different levels of the glycosylase
Aag; namely wild-type, and Aag-/- mice.
3.3 Objectives
• Quantify photoreceptor cell loss upon alkylation treatment in the presence
or absence of light exposure, by using morphometric measurement on H&E
stained eye sections, as well as analysis of rod and cone-specific gene expression
by RT-qPCR.
• Inspect the effect of alkylation-induced retinal-degeneration on the ipRGCs vi-
ability and functionality via immunofluorescence staining and ipRGC-specific
gene expression by RT-qPCR.
• Evaluate the functionality of photoreceptor cells post alkylation exposure via
measuring animal activity in animals treated with MMS under different light
conditions.
3.4 Methods
The following experimental procedure detailed in chapter 2 were used to set up, and
run the required experiments to achieve our objectives:
• Animal Breeding and Housing (section 2.5.1, page 50).
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• Genotyping of Aag-/- Mice and Cells (section 2.5.2, page 50).
• In Vivo Studies:
– Interaction of Light and Alkylation (section 2.5.3.1, page 53).
• Histopathology (section 2.5.3.3, page 57).
• Immunofluorescence (IF) Staining (section 2.5.3.4, page 59).
• mRNA Gene Expression by RT-qPCR (section 2.5.3.5, page 61).
• Behavioural Activity (section 2.5.3.6, page 66).
• Statistical Analysis (section 2.6, page 75).
Briefly, light dark cycle (LD; 12:12) entrained wild-type (WT) and Aag-/- adult
male mice were mock-treated or MMS-treated (75 mg/kg) by intraperitoneal (i.p.)
injection (at ZT∼23:45), and subjected to either LD cycle, constant light (LL) or
constant dark (DD) for 48 or 72 hours. Mice were then harvested, eyes and the
femur were either frozen in liquid nitrogen or fixed. Fixed tissues were processed
and either stained with haematoxylin and eosin (H&E) for conventional microscopy
or stained following immunofluorescence method. RNA were extracted from frozen
eyes, and followed by cDNA synthesis and RT-qPCR run for classical photoreceptor
and ipRGCs specific gene expression. Additionally, as mice were singly housed,
behavioural activity of mice was recorded while running the experiment in order
to inspect the effect of Aag-mediated alkylation-induced retinal degeneration on
photoreceptor cell functionality.
3.5 Results
3.5.1 Interaction of Light and Alkylation
It has been shown that photoreceptor cells are sensitive to alkylating agents and
this sensitivity is Aag-dependent (Calvo et al., 2013, Meira et al., 2009). However,
as one of their functions is sensing light for vision and non-visual photopercep-
tion, photoreceptor cells have also been shown to be susceptible to light-induced
damage. Thus, exposure to light and the consequent repetitive activation of pho-
totransduction pathways can lead to accumulation retinoid metabolites and other
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toxic-intermediate. These photo-intermediates can interact with, and transfer an
electron to or from other molecules resulting in the generation of free radicals such
as ROS and other toxic-byproduct that potentially cause oxidative stress (reviewed
in Organisciak and Vaughan 2010, Rozanowska et al. 2009). Oxidative stress could
in turn interact with alkylation damage to induce photoreceptor cell degeneration.
Therefore, this unique photosensing capability may explain the specific vulnerabil-
ity of photoreceptor cells to alkylation damage. We hypothesise that light exposure
interacts with alkylation treatment and can exacerbate alkylation-induced photore-
ceptor cell degeneration.
3.5.1.1 Alkylation treatment induces retinal degeneration of the ONL
To test this hypothesis, at the beginning wild-type mice were subjected to either
light-dark cycle or constant-dark for 48-hours post mock or MMS-treatment, fol-
lowed by harvesting, and fixing eyes and the femur. Because bone marrow cells are
known to be sensitive to alkylating agents (Roth and Samson, 2002), we have exam-
ined bone marrow sections by H&E staining to ensure that a non-toxic alkylating
agent dose was being used (Figure A.1). As can be appreciated from figure A.1, no
alteration in bone marrow morphology in MMS-treated wild-type mice compared to
mock-treated ones regardless of the light condition as observed, therefore confirming
that the dose of alkylating agent we employ does not induce systemic toxicity in
the animals.
In order to analyse the extent of photoreceptor cell toxicity upon alkylation and
light exposure, eye sections were stained with H&E for conventional microscopy
examination. Confirming previous results found by (Meira et al., 2009), figure
3.1a shows that mice retina is exquisitely sensitive to alkylation treatment, and
severe retinal degeneration is observed in the ONL of MMS-treated wild-type mice
regardless of the light condition. Retinal degeneration is apparent in MMS-treated
mice retina where a reduction in the number of photoreceptor cells within the ONL
is seen, leading to a reduction in layer width if compared to the width of the ONL
in untreated retinas as can be observed in figure 3.1a.
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Figure 3.1: Virtual light exacerbation of MMS-induced retinal degeneration in wild-type
animals. (a) Photomicrographs depicts H&E stained retinas from mock-treated and MMS-
treated WT mice subjected to either light dark cycle (12:12); or constant dark (DD) for
48 hours after the treatment (Magnification: 40X). Scatter plots in panel (b) represent the
retinal ratio of ONL to INL width of mock-treated (n) and MMS-treated WT mice (l)
applied to either LD cycle (clear background) or DD (grey clear background) for 48-hour
after treatment. n=7 per treatment group; each plot representing the average ratio of each
mouse eyes calculated from the mean of triplicate measurement of the ratio within each
eye; the ratio was analysed by two-Way ANOVA and LSmeans pairwise comparison for
MMS-treatment and light effects; *, **, ***P value 6 0.05, 0.01, and 0.001, respectively.
To test our hypothesis that light could exacerbate alkylation-induced retinal
degeneration, we compared retinal morphology in animals treated with MMS un-
der LD cycle conditions versus animals treated under DD conditions. As it can
be appreciated from figure 3.1a, no gross morphological differences were detected
in retinas of MMS-treated wild-type mice within the LD cycle cohort compared to
retinas from DD cohort. Thus, we undertook a morphometric measurements ap-
proach that was based on the reduction of the ONL width resulting from the specific
sensitivity of the photoreceptors to the treatment, while other retinal layer such as
the inner nuclear layer should remain with a constant width if treated and untreated
cohorts are compared. The results of the morphometric analysis are shown in figure
3.1b.
As can be appreciated from figure 3.1b, the ratio between the width of the ONL
and INL width in untreated retina is ∼1.7. Alkylation treatment results in a sig-
nificant decrease in this ratio of the retinal ONL/INL width and this decrease is
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significant, and independent of the light regimen (p=0.0004),figure 3.1b. Also, a
significant effect of light exposure on overall width ratio of the retinal ONL/INL is
perceived (p=0.035) as the ratio tend to be higher in the DD cohort if compared to
the LD cohort. Even though there is no significant statistical interaction between
alkylation and light(p=0.36), virtually there seems to be a light exacerbation of
alkylation mediated photoreceptor cell degeneration. This is seen as the retinal
ONL/INL width ratio is slightly lower in MMS-treated mice within the LD cohort
than what is found for the DD cohort (Figure 3.1b). Overall, light virtually seems
to exacerbate photoreceptor cell degeneration upon alkylation-insult in wild-type
mice. In order to examine this relationship more closely, an experiment was set up
with few fundamental changes as explained below.
Additional in vivo experiments were carried out to explore whether light indeed
exacerbates photoreceptor cell degeneration upon alkylation. Thus, wild-type and
Aag-/- mice were subjected to either LL or DD for 72-hours post mock or MMS-
treatment, followed by harvesting, freezing an eye (for RT-qPCR analysis),and
fixing the other for histopathological examination as shown in figure 3.2. Pho-
tomicrographs in figure 3.2 represent a severe retinal-degeneration in the ONL of
MMS-treated wild-type retinas compared to retinas from untreated wild-type an-
imal within either LL or DD cohort. This induced photoreceptors-degeneration
upon alkylation-insult was completely abolished in the MMS-treated Aag-/- retina
as they display a normal healthy retina (unaffected ONL) when compared to eyes
from untreated wild-type and Aag-/- mice under either light condition. Confirm-
ing previously published results (Calvo et al., 2013, Meira et al., 2009), retinas
from MMS-treated wild-type mice show striking retinal-degeneration in compari-
son with retinas from untreated wild-type mice, whereas retinal-degeneration is not
observed in MMS-treated Aag-/- retinas (Figure 3.2). However, a vigorous morpho-
logical differences particularly between retinas from MMS-treated wild-type animal
within light cohort and retinas from the ones within dark cohort are not observed
(Figure 3.2). Therefore, morphometric approach by measurement of the ONL and
INL width were carried out on H&E stained eye sections to calculate the ratio of
ONL/INL width as previously described.
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Figure 3.2: Aag-/- animals protected from MMS-induced retinal degeneration under dif-
ferent light conditions. Photomicrographs show H&E-stained retinas from mock-treated or
MMS-treated WT and Aag-/- mice subjected to constant light or constant dark for 72 hours
after the treatment. Magnification: 40X; GL, ganglion cell layer; INL, retina inner nuclear
layer; ONL, retinal outer nuclear layer where photoreceptor cells reside.
Photoreceptor cell degeneration upon alkylation-insult is mediated via Aag as
shown in figure 3.3. Alkylation exposure leads to a significant decrease in the ra-
tio of the retinal ONL/INL width (∼1) in the wild-type animal when compared
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Figure 3.3: Light virtually exacerbate Aag-mediated photoreceptor cell degeneration upon
alkylation-insult. Plot of the ratio of the retinal ONL to INL width 72-hours after Mock-
treatment (square) or MMS treatment (circle) in WT (green) and Aag-/- (blue) mice sub-
jected to LL (clear background) or DD (grey background) conditions after treatment. Each
dot represents the mean retinal ONL/INL width ratio of triplicates measurements within
each eye section. WT, n=14/treatment grope; Aag-/-, n=7/ treatment group;the ratio was
analysed by three-Way ANOVA and LSmeans pairwise comparison for MMS-treatment,
light, and genotype effects; *, **, ***P value 6 0.05, 0.01, and 0.001, respectively.
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to the ratio of ONL/INL width (∼1,7) in retinas from untreated wild-type under
either light conditions (p<0.0001). This reduction in the ratio of ONL/INL width
upon alkylation exposure is not perceived in Aag-/- retinas when compared to the
ONL/INL width ratio in untreated Aag-/- mice retina (Figure 3.3). This indicates
that the effect of alkylation on the retinal ONL/INL width ratio is Aag-dependent
(p<0.0001) confirming the resistance of Aag-/- retinas to alkylating agents, as previ-
ously shown by gross histopathological examination (Figure 3.2), and in consistent
with Meira et al. (2009) and Calvo et al. (2013) observation.
Another conclusion observed from figure 3.3 is that Aag-mediated photoreceptor
cell death upon alkylation exposure seems to be virtually exacerbated by light. An
overall significant effect of light exposure on the retinal ratio of ONL/INL width
is observed (p=0.03) as the overall ratio is slightly higher in the DD cohort when
compared to the LL cohort. Although there is no significant statistical interaction
between alkylation and light(p=0.68), apparently a light exacerbation of alkyla-
tion induced photoreceptor cell degeneration seems to be perceived as a slightly
lower retinal ratio of the ONL/INL width is perceived in MMS-treated wild-type
mice within the LL cohort if compared to that one of the DD cohort (Figure 3.3).
Overall, there seems to be a trend toward light exacerbation of Aag-mediated pho-
toreceptor cell degeneration upon alkylation-insult.
Next, we sought to identify the photoreceptor cell type that was most susceptible
to alkylation-induced cell death, and this was achieved by mRNA gene expression
analysis of specific photoreceptor cell markers.
3.5.1.2 Rod and Cone Photoreceptors Specific-gene Expression
Quantification of mRNA gene expression of specific photoreceptor cell marker was
used to identify the photoreceptor cell type that is sensitive to alkylation and also
as an alternative way to quantify photoreceptor cell loss. Quantification of photore-
ceptor cell death via mRNA gene expression of specific markers was accomplished
using RT-qPCR method. The gene expression of following markers were assessed:
Rho and Pde6b for rods (encoding rhodopsin, and rods phosphodiesterase 6β re-
3.5. RESULTS 89
spectively), as well as Opn1sw and Pde6h for cones (encoding cone opsin shortwave,
and cones phosphodiesterase 6γ respectively) along with mouse Actin as reference
gene.
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Figure 3.4: Aag-initiated BER drives alkylation-induced cell death in both rods and cones.
Bar charts display (mean±SEM) of mRNA expression of rod-specific gene expression (top
panel) including Rho and Pde6b genes, and cone-specific gene expression (bottom panel)
including Opn1sw and Pde6h genes in eyes from WT (green) and Aag-/- (blue) mice sub-
jected to either constant light or dark for 72-hours after mock treatment (filled bars) or
MMS-treatment (hatched bars). mRNA expression of targeted genes were normalised to
specific WT untreated mouse within the dark cohort. Clear and grey backgrounds indicate
light and dark conditions respectively. n=5/treatment group; mouse Actin as reference
housekeeping gene; gene expressions were analysed by three-Way ANOVA and lSmeans
pairwise comparison for MMS-treatment, light, and genotype effects; *, **, ***P value 6
0.05, 0.01, and 0.001, respectively.
As can be appreciated from figure 3.4, the expression of the rod-specific mark-
ers Rho and Pde6b is reduced dramatically 72 h post MMS-treatment in wild-type
mice if compared to untreated wild-type mice, housed under similar light condi-
tions (p<0.0001). Likewise, the expression of the cone-specific markers Opn1sw
and Pde6h is significantly reduced (p<0.0001) in MMS-treated wild type retinas
as shown in figure 3.4. These results strongly suggest that both rods and cones
are sensitive to alkylation treatment. The data obtained with wild-type retinas
are even more convincing when considered in combination with data obtained from
MMS-treated Aag-/- retinas (p<0.01). In MMS-treated Aag-/- retinas, we observe
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a small reduction in the rod-specific gene expression of Rho (LL, p=0.0005; DD
p=0.022) and Pde6b (LL, p=0.002; DD p<0.0001) compared to untreated Aag-/-
mice under identical light conditions (Figure 3.4). Nonetheless, no significant re-
duction in cone-specific gene expression is observed in the MMS-treated Aag-/- eye
if compared to untreated ones apart from a significant reduction in Opn1sw expres-
sion in MMS-treated Aag-/- mice within the dark cohort (p=0.005) (Figure 3.4).
Taken together, these results indicate that Aag-initiated base excision repair drives
alkylation-induced retinal-degeneration in both rods and cones.
Overall, light apparently exacerbates Aag-mediated photoreceptor cell degener-
ation upon alkylation exposure. As our data shows a significant impact of genotype
(p<0.0001) light (p=0.03) and alkylation treatment (p<0.0005) on photoreceptor
cells viability (Figures 3.1 and 3.3). Although no significant interaction between
light and alkylation (0.05<p≤0.6) is observed at the level of morphometric results,
virtually there appears to be light exacerbation of Aag-mediated photoreceptor cell
degeneration upon alkylation-insult. This in consistent with what observed from the
quantification of photoreceptor cell death via the analysis of photoreceptor-specific
gene expression upon alkylation exposure under different light conditions. This is
seen as genotype, light, and alkylation treatment were found to interact in defining
rod-specific mRNA gene expression, indicating that alkylation affect rod-specific
mRNA gene expression in Aag and light dependent-manner (p≤0.008). Whereas
the effect of alkylation exposure on cone-specific mRNA gene expression was ob-
served to be dependent of Aag (p<0.0001), and not influenced by light exposure
(p>0.09) even though independent effect of light was perceived (p=0.017) (Figure
3.4; Table A.1). So, exposure to light seems to play a role in the classical photore-
ceptors sensitivity to alkylation damage especially in rods, which means other type
of cells capable of sensing light such as ipRGCs could be at risk as well. Therefore,
Aag-mediated ipRGCs survival and function upon alkylation exposure was assessed
as described next.
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3.5.2 Mouse ipRGCs Response to Alkylation-induced Retinal De-
generation
The most recent discovered type of photoreceptor cells is ipRGCs retinal ganglion
cells. These cells reside within the retinal ganglion cell layer, compose 1-3% of the
retinal ganglion cells, and are capable of sensing light due to melanopsin expression.
From a morphological perspective ipRGCs are indistinguishable from normal retina
ganglion cells, so routine histopathology cannot be used to examine or detect them.
Therefore, this can be achieved by other approaches such as immunohistochemistry,
immunofluorescence and ipRGCs specific-gene expression. Hence, investigation of
Aag-mediated ipRGCs sensitivity to alkylating gents, as well as the influence on
melanopsin expression due to rods and cones photoreceptor dysfunction or degen-
eration (possibly disrupting the dopamine system in the retina, which in turn affect
melanopsin expression) was set as one of this study objectives.
At the beginning, immunofluorescence approaches were used to image and de-
tect ipRGCs in eye sections by staining with anti-melanopsin antibody. As shown
in figure 3.5a, photomicrographs illustrate retinal ganglion cells with a green stained
membrane (dendrites) indicating detection of melanopsin within these cells (arrow).
Also, no major differences in melanopsin distribution and expression in retinas from
Aag proficient and deficient mice 72-h post MMS-administration are shown as ∼2-3
melanopsin expression cells per eye section were detected in each treatment condi-
tion (n=5). At the same time, disrupted distribution and expression of rhodopsin
(red stained) as well as thinning of the outer nuclear layer are observed in MMS-
treated wild-type retinas compared to eyes from untreated wild-type animals and
MMS-treated Aag-/- animals (Figure 3.5a). We therefore conclude that ipRGCs are
resistant to alkylation-induced cell death and that the Aag genotype does not alter
ipRGCs response to alkylation. Yet, another approach to confirm the resistance of
the mouse ipRGCs to alkylation-induced cell death, namely gene expression analy-
sis of ipRGCs-specific marker was achieved as described next.
The expression of Opn4 (encoding melanopsin), and Adcyap1 (encoding pitu-
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Figure 3.5: Resistant of mouse ipRGCs to Retinal degeneration induced by alkylation
exposure. Panel (a) shows fluorescent staining of retinas from 72-hours post-treatment of
WT(top), and Aag-/- (bottom) mice after mock-treatment (left column) or MMS-treatment
(right column) indicating resistant of ipRGCs (arrow) to alkylation-insult. Retinas were
stained with TOPRO-3 (DNA stain blue), anti-melanopsin antibody (stained green), and
mouse anti-rhodopsin antibody (stained red). Magnification 40x; RGCs: the retinal gan-
glion cells layer; INL: the inner nuclear layer;ONL: the outer nuclear layer; IS and OS:
the inner and outer segment; n=5/treatment condition. Bar charts in panel (b) repre-
sents (mean±SEM) mRNA expression of ipRGC-specific gene expression including Opn4
(left chart) and Adcyap1 (right chart) genes in WT (green) and Aag-/- (blue) mice eye
subjected to LL or DD for 72-hours after mock (filled bars) or MMS-treatment (hatched
bars). mRNA expression of targeted genes were normalised to specific WT untreated mouse
within the dark cohort. Clear and grey backgrounds indicate light or dark conditions being
applied respectively. n=5/treatment group; mouse Actin as reference housekeeping gene;
gene expressions were analysed by three-Way ANOVA and lSmeans pairwise comparison
for MMS-treatment, light, and genotype effects; *, **, ***P value 6 0.05, 0.01, and 0.001,
respectively.
itary adenylate cyclase-activating polypeptide; PACAP) was quantified relative to
the reference gene mouse Actin using RT-qPCR method (Figure 3.5b). As can be
appreciated from figure 3.5b, no reduction in Opn4 gene expression in MMS-treated
wild-type and Aag-/- retina compared to eyes from untreated wild-type and Aag-/-
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mice within the same light conditions. This result indicates that ipRGCs are not
alkylation sensitive irrespective of Aag status. However, there is a slight increase in
Opn4 expression within wild-type retinas upon alkylation exposure (LL, p=0.005;
DD, =0.02) within paralleled light conditions, but not in Aag-/- animals (p=0.002).
Thereby, no reduction in the mRNA expression of melanopsin is caused either di-
rectly by the alkylating agent (cells remained viable), or indirectly as a subsequent
from the retinal degeneration in the ONL.
In addition, Adcyap1 gene expression (co-expressed with melanopsin in ipRGCs)
was analysed as well (Figure 3.5b, right bar chart). Alkylation-induced retinal-
degeneration represses Adcyap1 expression levels in Aag and light dependent man-
ner (MMS-treatment*genotype*light, p=0.002). As can be appreciated from figure
3.5b, light induces the expression of Adcyap1 by 2-4 fold in light cohort retinas
compared to eyes from the dark cohort (p<0.0001). Within the light cohort, the
induction of Adcyap1 expression is decreased basally (p<0.0001) from 3.5-fold in
untreated wild-type retinas to 2.5-fold in eyes from untreated Aag-/- animals (Figure
3.5b). Also, Adcyap1 expression level was repressed by 1.5-fold upon alkylation-
insult in retinas from wild-type animals within the light cohort (p<0.0001), while
the repression is minimized to 0.5-fold upon alkylation-exposure in the Aag-/- co-
hort (p=0.034). This is understandable as MMS-treated wild-type mice must sense
less light than untreated mice due to the alkylation-induced retinal degeneration,
which in turn reduces the light stimulation of Adcyap1 expression.
Additionally, the viability of ipRGCs remains unaffected upon alkylation-insult
as can be appreciated form analyzing Adcyap1 expression level in retinas from mice
within dark cohort (Figure 3.5b). In the dark cohort, the level of Adcyap1 expres-
sion remains unaffected upon alkylation exposure as no induction or repression are
observed in MMS-treated wild-type and Aag-/- retinas compared to eyes from un-
treated wild-type and Aag-/- animals. Therefore, ipRGCs viability is not affected
upon alkylation-insult as no major reduction or induction is observed in ipRGCs-
specific markers including melanopsin and PACAP mRNA expressions (Opn4 and
Adcyap1 respectively) upon alkylation exposure under dark condition.
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Following the evaluation of different type photoreceptor cells survival upon alky-
lation and light exposure in Aag-proficient and deficient animals, the assessment of
photoreceptor cell function was set as an objective of the study as well. This was
accomplished analysing mice locomotor activity under the influence of different light
conditions and alkylation exposure.
3.5.3 Aag-Mediated Alkylation-induced Retinal-Degeneration Im-
pair Photoreceptor Cells Function
As previously published, alkylation-induced retinal-degeneration is Aag-dependent
(Calvo et al., 2013, Meira et al., 2009). Moreover, as shown above Adcyap1 gene
expression within the light cohort basally was lower in Aag-/- mice compared to
wild-type mice, which suggests a potential link between Aag expression and pho-
toreceptor cell function. Thus, an approach to assess photoreceptor cells function is
required. Hence, a novel approach to measure the alkylation effect on photoreceptor
cell function by recording and analyzing animal locomotor activity under controlled
light conditions and MMS-treatment was developed. This method is depending on
the fact that mice are nocturnal animal, which are active during the night, and
suppression of the activity should be observed during light exposure. Therefore,
evaluation of the function of photoreceptor cells via measuring the activity of mice
under different light regiments specifically LL, and DD upon alkylation exposure is
set as one of this study objectives. In order to accomplish the above objective, the
locomotor activity of wild-type and Aag-/- mice subjected to either LL or DD for
72 h after MMS-exposure were recorded. Figures 3.6 and 3.7 illustrate the mean
activity of wild-type and Aag-/- mice for every three hours from 2-days prior to
treatment in LD cycle to 3-days post-treatment in either DD or LL respectively.
As can be appreciated from figure 3.6, the behavioural activity of wild-type
and Aag-/- mice remains unaffected under constant dark upon alkylation exposure
(p=0.0597). As can be seen in figure 3.6a, the activity rhythm of MMS-treated wild-
type mice remains in agreement with the activity of untreated wild-type mice sub-
jected to DD, and this is perceived within Aag-/- cohort as well in figure 3.6b. This
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Figure 3.6: Basal locomotor activity differences exhibited by Aag null mice if compared
to wild type mice. Scatter plots represent the (mean±SEM) behavioural activity of mice
entrained to LD cycle (12:12), and subjected to constant dark for 72-hour after a single mock
or MMS-treatment (time zero hour=injection/apply of treatment). Sub-figures (a) and (b)
depict a comparison of the behavioural activity of MMS treated WT (l) and Aag-/- (l)
mice with untreated WT (n) and Aag-/- (n) mice respectively. Sub-figure (c) represents
a comparison of WT mice activity in (a) (green) and Aag-/- mice activity in (b) (blue)
basally and upon MMS-insult. Grey filled area indicate light-off period, whereas clear area
express light on period. Data shown as the average of 3-hours Z-scored activity ±SEM;
n=7/treatment-group; the average activity were analysed by two-way ANOVA or three-
Way ANOVA along with lSmeans pairwise comparison for MMS-treatment, time effects or
MMS-treatment, time, and genotype effects respectively; *, ** and ***P value≤0.05, 0.01,
and 0.005 respectively.
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Figure 3.7: Aag-mediated retinal degeneration upon alkylation-exposure influences mice
locomotor activity. Plots depict the (mean±SEM) behavioural activity of LD cycle en-
trained mice subjected to constant light for 72-hour after mock or MMS-treatment (time
zero hour=injection of the treatment compound). Panels (a) and (b) depict a comparison of
the behavioural activity of mock-treated WT (n) and Aag-/- (n) mice with untreated WT
(l) and Aag-/- (l) mice respectively. Panel (c) compares WT mice activity in (a) (green)
to the Aag-/- mice activity in (b) (blue) basally and upon MMS-administration. Grey filled
area indicate light-off period, whereas clear area express light on period. Data shown as
the average of 3-hours Z-scored activity ±SEM; n=7/treatment-group; the average activ-
ity were analysed by two-way ANOVA or three-Way ANOVA along with lSmeans pairwise
comparison for MMS-treatment, time effects or MMS-treatment, time, and genotype effects
respectively; *, ** and ***P value≤0.05, 0.01, and 0.005 respectively.
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observation is justified by the fact that mice are nocturnal animals and therefore
active during the night (absence of light exposure). Thus, both MMS-treated and
untreated wild-type mice are supposed to be active even though retinal-degeneration
appeared in MMS-treated ones as the function of the classical photoreceptor cells
is not much needed under DD condition because no light there is to be sensed.
Moreover, comparing the behavioural activity of the two genotypes wild-type
and Aag-/- animals indicates a baseline differences in the activity between both
genotypes over the time (p≤0.0003; Figure 3.6c). The baseline differences observed
in the activity between both genotype wild-type and Aag-/- over time were in-
dependent of MMS-treatment effect (p=0.26). Hence, the behavioural activity of
wild-type and Aag-/- mice remains unaffected upon alkylation-insult under DD con-
dition. This is understandable taking into account both the constant dark condition
(active-span for mice) being applied and the mice being nocturnal animal (active in
the dark). Therefore, light should have an impact on mice activity if photoreceptor
cell dysfunction or death occurred as described next.
As can be observed from figure 3.7, alkylation-induced retinal-degeneration re-
duces the suppression of mice behavioural activity under constant lights exposure
(p<0.0001). Figure 3.7a depicts a comparison of the activity of untreated with
MMS-treated wild-type mice within light cohort, and it indicates a reduction in the
suppression of MMS-treated mice activity compared to untreated ones upon light
exposure over the time (p=0.043). By being nocturnal animal, mouse activity is
suppressed during the day (presence of light), but not during the night (active-span;
dark-period). Thus, alkylation-induced retinal-degeneration leads to a reduction in
the amount of light sensed, leading to lower suppression of activity upon light ex-
posure compared to untreated cohort. This is clearly seen in the activity of Aag-/-
mice where the activity of MMS-treated Aag-/- mice is identical to untreated Aag-/-
mice within light cohort (genotype effect, p=0.002; Figure 3.7b). This is due to the
resistance of Aag-/- mice photoreceptor cells to alkylation damage, and hence the
amount of sensed light by MMS-treated Aag-/- mice is equivalent to the one sensed
by untreated Aag-/- mice leading to an equivalent level of activity suppression upon
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light exposure.
In addition, a comparison between wild-type and Aag-/- mice subjected to con-
stant light post alkylation-treatment depicts a baseline differences in activity be-
tween both genotypes over the time (p<0.0001; Figure 3.7c). Moreover, the pattern
of activity shows that untreated Aag-/- mice tend to be more active compared to
wild-type untreated mice under constant light exposure. This in consistent with the
basal lower induction of the neurotransmitter PACAP mRNA expression previously
found (Figure 3.5b) in Aag-/- untreated retinas compared to eyes from wild-type un-
treated animals under LL conditions.
Overall, the activity of Aag-/- cohort differs basally and upon alkylation exposure
from the wild-type cohort especially under LL condition. This suggests a role played
by Aag in maintaining photoreceptors survival and function. This role of Aag
particularly in photoreceptor cell survival is lethal in the incident of alkylation-
exposure, which is exacerbated when associated with light exposure as discussed
next.
3.6 Discussion
The typical retinal photoreceptor cells, including rods and cones, are susceptible to
alkylation-induced damage. This susceptibility could be due to their unique func-
tion involving sensing of light and transfer it into useful information for the brain.
This involvement of light exposure in their function besides other factors including
high oxygen consumption increase their vulnerability to oxidative stress, and hence
retinal-degeneration (Organisciak and Vaughan, 2010, Yang et al., 2003, Hao et al.,
2002, Organisciak et al., 1999)
The ability of alkylating agents to induce retinal-degeneration has been found
to be affected by imbalances in base excision repair. According to Meira et al.
(2009) the induction of photoreceptor cell degeneration by alkylating agents is Aag-
dependent (the initiator of base excision repair) as Aag-/- mice resisted to alkylation
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damage compared to wild-type mice at the level of photoreceptor cells and some
other tissues. Yet, these studies did not consider the influence of light on retinal-
degeneration upon alkylation exposure and the potential interaction between both.
Therefore, we aimed to define the interaction of light and alkylation in mice
with different levels of Aag expression; namely wild-type, and Aag-/- mice. This was
achieved by assessment and quantification of photoreceptor cell death and function
upon MMS treatment under different light regiments by histopathology, mRNA
gene expression quantification, and locomotor activity analysis methods. Our re-
sult apparently indicates a light exacerbation of Aag-mediated photoreceptor cell
degeneration upon alkylation exposure. As can be appreciated from figures 3.1, 3.3,
and 3.4, a trend towards protection against MMS-induced retinal-degeneration in
the ONL in wild-type mice kept in DD after MMS treatment if compared to the
cohort kept in LD cycle and particularly LL is seen.
To begin with, alkylation-induced retinal-degeneration in the ONL in wild-
type mice was observed (p<0.0005). This was perceived as severe degeneration
in the ONL accompanied by a significant lower ratio of the ONL/INL in MMS-
treated wild-type retinas compared to untreated wild-type mice retina within par-
allel light conditions (Figures 3.1, 3.2, and 3.3). This finding is in consistent with
the what published in literature (Calvo et al., 2013, Meira et al., 2009, Nagar et al.,
2009, Moriguchi et al., 2003, Doonan et al., 2003, Yoshizawa et al., 2000, Taomoto
et al., 1998, Nambu et al., 1997, Nakajima et al., 1996). Whereas, retinas from
MMS-treated Aag-/- cohort showed indistinguishable morphology and even ratio of
ONL/INL compared with retinas from untreated Aag-/- cohorts, even though dif-
ferent light regiments were applied (Figure 3.2 and 3.3). This is in line with what
have been pub;shed by Meira et al. (2009) and Calvo et al. (2013) where Aag-/-
mice exhibited a complete resistance to alkylation-induced retinal-degeneration.
Photoreceptor cells in wild-type animal appears to be slightly prevented from
the retinal-degeneration induced by alkylation-insult by avoiding light exposure.
MMS treated wild-type mice showed slight resistance to alkylation damage in con-
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stant dark compared to cohort kept in LD or LL after treatment. This is based
on slight increases in the retinal ONL/INL width ratio of MMS-treated wild-type
within DD due to the slightly higher width of the ONL indicating a trend toward
photoreceptor cell survival in cohort kept in dark compared the light ones (Fig-
ures 3.1 and 4.3). This marginally better survival in dark-treated photoreceptor
cells was reflected in the rods and cones photoreceptors specific-gene expression.
For instance, rod-specific gene expression including Rho (encoding the rod-specific
opsin rhodopsin) and Pde6b (encoding rods Pde6β subunit) (Larhammar et al.,
2009) was slightly higher in MMS-treated mice within dark cohort compared to
light cohort (p<0.0001; Table A.1), which could indicate a better survival of pho-
toreceptor cells within the dark cohort (Figure 3.4). Hence, this slight protection
against retinal-degeneration induced by alkylation exposure seems to be rational
considering that an induction of retinal-degeneration by visible light (Hao et al.,
2002, Specht et al., 2000, 1999, Rapp et al., 1990) might contribute to the induction
of retinal-degeneration in retinas from LD and LL cohorts compared to retinas from
DD cohorts especially within MMS-treated wild-type mice.
Photoreceptor-specific gene expression in MMS-treated wild-type mice was strik-
ingly reduced compared to all other treatment cohorts within wild-type and Aag-/-
mice. The expression of rod-specific gene and cone-specific gene (Larhammar et al.,
2009) was dramatically decreased in MMS-treated wild-type mice compared to un-
treated ones as well as other treatment groups within Aag-/- cohort subjected to
either LL or DD for 72 hours after treatment, figure 3.4. This decrease in rod-
specific gene expression was slight in MMS-treated Aag-/- mice when compared to
untreated Aag-/- mice but this effect was not of the same magnitude as the gene
expression reduction apparent in MMS-treated wild-type. Overall, within the reti-
nal outer nuclear layer alkylating agents induces cell degeneration in both types of
photoreceptor, rods and cones, and this degeneration is enhanced in the presence
of light. Following that, we assessed whether Aag influence ipRGCs survival and
function upon alkylation-insult or not.
ipRGCs are retinal ganglion cells capable of sensing light, for non-image form-
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ing function, due to the expression of the opsin melanopsin. Our study reports
that wild-type ipRGCs are resistant to degeneration induced by alkylating agents.
This was assessed via immunofluorescence staining of ipRGCs and assessment of
ipRGCs-specific gene expression. We find that there is an equivalent number
of melanopsin-expressing RGCs (∼2 cells per eye section) in retinas from MMS-
treated and untreated wild-type and Aag-/- mice 72-hour after treatment regardless
of light exposure conditions (Figure 3.5). In addition, further investigations into
the mRNA gene expression melanopsin (Opn4 ) as well as PACAP (co-expressed
with melanopsin; Adcyap1 ) (Hannibal et al., 2002) were accomplished. Opn4 was
similarly expressed among different treatment groups exposed to different light con-
ditions within wild-type and Aag-/- cohorts (Figure 3.5). This was also seen in
Adcyap1 expression levels between different treatment groups as well within dark
cohort. Based on melanopsin detection by immunofluorescence staining, and levels
of Opn4 expression in addition to Adcyap1 expression with DD environment, the
study hereby indicates resistance of ipRGCs to alkylation damage along with stable
expression of melanopsin gene.
Our results are consistent with the recent published report by Jain et al. (2016)
where ipRGCs viability and melanopsin mRNA expression remained unaffected in
wild-type mice 10-days after MNU-exposure. However, our results are partially in
contrast to what observed by Wan et al. (2006) as the melanopsin mRNA expression
in ipRGCs reduced along with classical photoreceptor degeneration in rats upon
MNU-insult, despite the survival of ipRGCs as perceived by unaffected PACAP
mRNA gene expression as well as total number of retinal ganglion cells at 0.5,1,5,
7,13 and 28-days after MNU-treatment (harvested at ZT 14:00). This reduction
observed in melanopsin mRNA expression in rats upon alkylation exposure seemed
to be due to that classical photoreceptor degeneration may disrupt the dopamine
synthesis and release in the retina, which in turn affect melanopsin expression
(Sakamoto et al., 2005, Wan et al., 2006). Hence, the impact of photoreceptor degen-
eration on melanopsin expression could be controversial and species-specific. For
example, substantial transneuronal retinal-degeneration in aged rodless/coneless
mice, and MNU-treated wild-type mice has not affected the expression of melanopsin
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mRNA gene compared to age-matched wild-type mice and untreated mice respec-
tively (Semo et al., 2003, Jain et al., 2016). Whereas substantial transneuronal
retinal-degeneration in rats with defect in retinal dystrophy gene at postnatal 60-
day or in MNU-treated wild-type rats has led to a massive decrease in melanopsin
mRNA expression (Wan et al., 2006, Sakamoto et al., 2004).
Within ipRGCs, PACAP is a neurotransmitter co-expressed with melanopsin
(Hannibal et al., 2002). It is stimulated by light exposure and plays a role in con-
stituting the retinohypothalamic tract (RHT), which in turn entrains the suprachi-
asmatic nucleus in the hypothalamus generating the mammalian circadian rhythm
(Hannibal et al., 2001, 1997). Within dark cohort, mRNA expression of PACAP
(Adcyap1 ) was similar among different treatment cohort within wild-type and Aag-/-
mice (Figure 3.5). This is consistent with expression of PACAP mRNA expression
previously found in rats harvested at the night phase (ZT 14:00) 0.5, 1, 5, 7, 15,
and 28 days after MNU administration. Nevertheless, different pattern of expres-
sion was shown within light cohorts (Figure 3.5) as expected from a light-inducible
neurotransmitter (Hannibal et al., 2002, 1997, Wan et al., 2006). For instance, Ad-
cyap1 gene expression was significantly repressed in wild-type MMS-treated retinas
compared to the eyes from untreated wild-type mice upon alkylation exposure un-
der LL condition, and this seems to be due to classical photoreceptor degeneration
(Sakamoto et al., 2005). This effect of alkylation on Adcyap1 gene expression in
the wild-type animal under LL condition was minimized in the Aag-/- cohort (Fig-
ure 3.5), and that is probably because of Aag-/- photoreceptor cell persistence to
alkylation damage (Calvo et al., 2013, Meira et al., 2009).
Additionally, a baseline differences in the expression of Adcyap1 under LL con-
dition were observed. Adcyap1 gene expression under LL condition was induced
more in the untreated wild-type mice (3.5-fold) compared to untreated Aag-/- mice
(2.5-fold) (Figure 3.5). PACAP-mediates the transmitting of photic cue to the
suprachiasmatic nucleus via the retinohypothalamic tract, and hence entertain the
suprachiasmatic nucleus (Hannibal et al., 2001, 1997). Thus, this basal lower in-
duction of PACAP mRNA expression in the Aag-/- animal indicates a potential
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reduction in the establishment of the retinohypothalamic tract, which in turn affect
various physiological process regulated by the suprachiasmatic nucleus such as in-
hibiting the physiological suppression of mice behavioural activity in the presence of
light. This was observed as the Aag-/- untreated mice with a basal lower induction
of Adcyap1 gene expression (Figure 3.5) tend to be more active over the time com-
pared to the untreated-wild-type mice where a higher induction level of Adcyap1
gene expression perceived under constant light exposure (Figure 3.7).
The link between Adcyap1 gene expression and the suppression of mice be-
havioural activity during light exposure was also clearly observed in wild-type mice
upon alkylation exposure. Alkylation induced photoreceptor cell degeneration in
the wild-type mice (Figures 3.2, 3.3 and 3.4) resulted in less light being sensed and
hence lower induction of Adcyap1 gene expression, figure 3.5. This resulted in less
photic cue being transmitted to the suprachiasmatic nucleus, and hence the sup-
pression of mice behavioural activity mediated by the light exposure is repressed as
perceived in the MMS-treated wild-type mice when compared to the untreated wild-
type mice under constant light exposure (Figure 3.7). This also indicates that the
photoreceptors function of the wild-type mice was affected upon alkylation expo-
sure. The suppression of behavioural activity in MMS-treated wild-type mice was
reduced significantly compared to untreated wild-type mice under LL conditions
due to photoreceptor cell death and hence less light being sensed. This reduction
in mice activity upon alkylation-exposure was not observed within the Aag-/-cohort
where persistence to alkylation damage is expected (Calvo et al., 2013, Meira et al.,
2009).
However, the case of mice behavioural activity and Adcyap1 gene expression
level under constant dark seems to be different. Even though, Adcyap1 gene ex-
pression in wild-type and Aag-/- mice eye remained unaffected basally and upon
alkylation-insult, a basal different in the behavioural activity was observed in the
untreated Aag-/- mice compared to the untreated wild-type animal as Aag-/- mice
tended to be more active over the time (Figure 3.6). The scene behind this basal
difference in the behavioural activity is unclear.
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Our results show that Aag-mediated alkylation-induced degeneration in the clas-
sical photoreceptor cells appears to be exacerbated by light exposure. This effect
was observed at the level of morphometric measurement, photoreceptor-specific
gene expression, and at the level of photoreceptor cell function. Also, we reported
that viability of ipRGCs and melanopsin mRNA expression remained unaffected
by alkylation-induced retinal degeneration mediated by Aag. However, a part of
ipRGCs function seems to be affected basally by Aag under constant light exposure
as observed in the gene expression of Adcyap1. Thus, the amount of sensed light
along with the required component for this function such as rhodopsin, and cones
opsins seems to play a role somehow in photoreceptor cells sensitivity to alkylating
agent and the cell function as well. Hence, different theory can be suggested to
explain the mechanism of the contribution of light to alkylation-induced retinal-
degeneration such as ROS production, and depletion of glutathione-S-transferase
(GSH), induction of cellular stress, and other.
One of the possible mechanisms for the contribution of light to alkylation damage-
induced retinal-degeneration seems to be via the generation of ROS (Demontis et al.,
2002, Donovan et al., 2001). As light can induce ROS production, then light may
increase DNA damage burden and hence potentially induce photoreceptor degen-
eration via inducing ROS formation. ROS are well known for their capability of
inducing oxidative damage to DNA bases and hence induce toxicity (Marnett, 2000,
Rouet and Essigmann, 1985). In addition to that, one of the repair mechanism of
oxidation of DNA bases is the base excision repair pathway (reviewed in David
et al. 2007, Dizdaroglu 2005); thus, this may increase the chances of BER toxic-
intermediate generation and accumulation even more if accompanied by alkylating
agent exposure (Calvo et al., 2013, Meira et al., 2009). This increase in BER toxic
intermediates can potentially led to Parp1 hyperactivation. Parp1 hyperactivation
might in turn lead to cell death because of ATP/NAD+ depletion (Calvo et al.,
2013). This consumption of ATP by Parp hyperactivation is escorted by high con-
sumption of energy by normal function of photoreceptor cells as well (Biernbaum
and Bownds, 1985), which could make photoreceptor cells highly susceptible to ATP
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depletion.
Another suggested mechanism for the interaction of light and alkylation is the
saturation of GSH, and the induction of intracellular stress response. Rods and
cones express low level of GSH (Organisciak et al., 1998, Atalla et al., 1988), which
is capable of direct detoxification of both ROS (Walker et al., 1995) and alkylating
agents such as MMS (Kroese et al., 1990). Therefore, ONL photoreceptor cells are
at higher risk of GSH depletion, and so being affected by toxic compound such as
MMS. According to Mizumoto et al. (1993) MMS treatment can lead to dramatic
decline in the GSH level. Then, depletion of the low contents of GSH by ROS
generated from light exposure may increase the chances of cells being toxified by
alkylating agents; likewise, GSH depletion upon alkylation exposure could increase
cells sensitivity to ROS.
In addition, previous study by Wilhelm et al. (1997) indicated that MMS is
capable of inducing cellular stress independent of its cytotoxicity property. This in-
duction of cellular stress can be prevented by enhancing GSH level (Wilhelm et al.,
1997), as it is already expressed at low levels within the ONL cells. Therefore, in
addition to its cytotoxicity (Alkylation of DNA bases) the effect MMS may inter-
act with the effect of ROS (generated from light exposure) via lowering GSH level,
and hence trigger the induction of oxidative stress. This trigger of oxidative stress
involves induction of c-Fos protein, which is involved in the mechanism of light-
induced photoreceptor cell death (Wenzel et al., 2000, Hafezi et al., 1997) as well
as MMS-induced cellular stress (Wilhelm et al., 1997).
In summary, light apparently exacerbates retinal degeneration upon alkylation
exposure. This is observed via the analysis of morphometric measurement as well
as photoreceptor-specific gene expression. Yet, other photosensitive cells within the
retina namely ipRGCs showed a resistance to alkylation-induced retinal damage,
and the melanopsin mRNA expression remains unaffected as well. Also, the func-
tion of photoreceptor cells in the wild-type animal is disturbed upon alkylation
exposure, but not in the Aag-/- animal corresponding to the photoreceptor resistant
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to alkylated DNA base damage. However, the function of photoreceptor cell in the
Aag-/- animals seems to be basally different from the wild-type mice as they tend
to be more active, and their retinas express lower level of Adcyap1 gene expression
under the influence of light compared to that of the wild-type animal.
Chapter 4
Characterization of the Aag-mediated
Induction of the Endoplasmic Reticulum
Stress Response Upon Alkylation Exposure
4.1 Introduction
Macromolecular damage is estimated to increase along with age, and accumulation
of damage to DNA, proteins, and other biological macromolecules play a prominent
etiological role in specific age-related diseases, such as Alzheimer and Parkinsons
diseases. Modification or damage to biological macromolecules can result from ex-
posure to abundant and highly reactive compounds present in the environment or
formed within living organism and causing cellular stress and dysfunction (Burch
et al., 2014, Richardson and Schadt, 2014, Hetz, 2012). An example of these damag-
ing reactive compounds are alkylating agents. These agents can arise within living
cells as a byproduct of reactive oxygen and nitrogen species generated via metabolic
processes or inflammation, and are also environmentally relevant and result from
exposure to nitrosamines, present in processed meat, N -nitroso compound produced
by tobacco smoke such as 4-(N -methyl-N -nitrosamino)-1-(3-pyridyl)-1-butanone ,
and other products (Liu et al., 2009, Andrzejewski et al., 2005, Hecht, 1999). Al-
though exposure to alkylating agents in the environment has been linked to several
pandemics such as neurodegenerative disease like Alzheimers disease, and other pan-
demics (de la Monte and Tong, 2009, Tong et al., 2009), alkylating agents are ones
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of the most frequent chemotherapeutic agents used in clinics for cancer treatment.
Alkylating agents are frequently used in clinic for cancer treatment due to their
genotoxic ability. They are capable of adding alkyl carbon groups to a number of
nucleophilic sites within the DNA and other cellular macromolecules, including pro-
teins (Friedberg et al., 2006), and thus modifying the structure of these biological
molecules as well as disrupting their function (Fu et al., 2012). However, alkylated
DNA bases generated by alkylating agents can be repaired via different repair mech-
anisms depending on the lesions produced by that alkylating agents. For example,
7-methylguanine (7-MeG) and 3-methyladenine (3-MeA) generated upon exposure
to methyl methanesulfonate (MMS) and other type of alkylating agents are mainly
repaired by base excision repair pathway (BER) initiated by 3-alkyladenine DNA
glycosylase (Aag) (reviewed in Fu et al. 2012, Sedgwick et al. 2007, and Meira et al.
2005). The initiation step of BER involves detection and removal of the alkylated
bases by Aag, and subsequently followed by enzymatic steps required to complete
the repair of the damaged DNA bases. Yet, these enzymatic steps give rise to BER
toxic-intermediates, such as abasic site (AP site) and single strand breaks (SSBs)
(Fu et al., 2012, Meira et al., 2009, 2005, Roth and Samson, 2002) that are detected
by the BER accessory factor Poly (ADP-ribose) polymerase 1 (Parp1) (Schreiber
et al., 2006, ElKhamisy et al., 2003, Kraus and Lis, 2003). Although Parp1 can
mediate DNA repair and survival, it can mediate cell death as well in response to
excessive SSBs and a variety of other insults (Yu et al., 2006, Eliasson et al., 1997).
BER is a crucial DNA repair pathway. One of the BER initiators namely Aag is
responsible for excising a variety of alkylated DNA bases as well as methylated bases
such as etheno adducts formed in chronic inflammation/oxidative stress conditions.
This was seen as sensitivity to DNA damage were induced by colonic chronic in-
flammation and infectious agents such as Helicobacter pylori in Aag deficient mice
(Calvo et al., 2012, Meira et al., 2008). In contrast, this deficiency of Aag pre-
vents certain tissues from cell death and tissue injury induced by alkylating, and
reactive oxygen and nitrogen species produced by ischemia-reperfusion condition
(Ebrahimkhani et al., 2014, Calvo et al., 2013, Meira et al., 2009). These find-
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ings indicate that Aag plays an important role in the biological responses to DNA
damage induced not only by alkylation stress but also by chronic inflammation and
ischemia reperfusion.
A deeper investigation of the mammalian response to alkylation, and the role
played by DNA damage and repair in the process were previously accomplished
via global transcriptomics analysis. According to Meira and collaborators (unpub-
lished), a remarkable modification in the transcriptional response in mouse liver were
observed upon exposure to a sub-lethal dose of MMS, indicating a link between the
DNA repair process initiated by Aag, and this transcriptional response. Clustering
and gene ontology enrichment analysis depicted that the number of unique tran-
scripts modulated in the wild-type mouse liver upon MMS-insult were significantly
higher compared to transcripts modulated in the Aag-/- mouse liver, representing
that the BER process initiated by Aag plays a role in the transcriptional response
to MMS (Meira et al., unpublished). The set of modulated genes upon alkylation
exposure (meaning changed upon treatment in the wild type but not in the Aag
knockout) included transcript associated with endoplasmic reticulum (ER) stress
and the unfolded protein response (UPR), the acute phase response, the suppressor
of cytokine signalling and the circadian clock. Thus, the transcriptomic analysis
suggested that Aag activity is required for UPR activation in response to ER-stress
upon alkylation exposure, and deficiency of Aag may somehow modify the response
particularly upon MMS-insult.
UPR is activated apparently to resolve the proteome damage induced by alky-
lation insult. This was observed preciously as the UPR transcription in wild-type
Saccharomyces cerevisiae was induced upon alkylation exposure (Jelinsky et al.,
2000, Jelinsky and Samson, 1999). UPR is activated as a protective response to
stress-triggered modification in ER homeostasis. In other simple word, accumula-
tion of unfolded/misfolded proteins, oxidative stress, viral infections and other in-
duce stress signals leading to ER overload with proteins and exhaustion of the ER
machinery. Thus, ER-resident transmembrane proteins including inositol-requiring
protein 1α (IRE1α), activating transcription factor 6 (ATF6) and protein kinase
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RNA-like ER kinase (PERK) activate the UPR. In healthy cells, the transmem-
brane proteins IRE1α, ATF6 and PERK are negatively regulated by chaperones
such as immunoglobulin heavy-chain binding protein (BIP) Wang and Kaufman
(2014), Hetz (2012), Dorner et al. (1987).
Under ER-stress conditions, the dissociation of chaperones such as BIP is trig-
gered by ER dysregulation leading to release the inhibition of the ER-resident trans-
membrane proteins, and hence eliciting the UPR (Wang and Kaufman, 2014, Hetz,
2012) as previously described in chapter ?? (Figure 1.3, page 19). For example, ini-
tiation of PERK signalling pathway involves eukaryotic translation initiation factor
2α (eIF2α) phosphorylation which inhibits translation but at the same time in-
creases translation of the activating transcription factor 4 (ATF4). In turn, ATF4
activates the transcription of ER stress response genes such as the growth arrest
and DNA damage-inducible protein 34 (Gadd34) to direct eIF2α dephosphoryla-
tion and restore global mRNA translation (Wang and Kaufman, 2014, Hetz, 2012).
ATF4 also activates the transcription factor C/EBP homologous protein (Chop),
and subsequently induce apoptosis (Palam et al., 2011). Chop is responsible for ER
stress-mediated apoptosis as previous studies reported a promotion of Chop mutant
primary mouse embryonic fibroblast cells survival and a protection against renal
injury upon exposure to the ER stress-inducing drug tunicamycin, resulted from
a reduction in ER protein load and modification in the redox conditions within
the organelle (Marciniak et al., 2004). This was also seen in both genetic and
diet-induced animal models of diabetes type 2, as the survival of the pancreatic
β cells was promoted in Chop-/- mice, associated with arising expression of UPR
and oxidative-stress response genes along with a decrease in the levels of oxidative
damage (Song et al., 2008).
The consequences of UPR activation varies from increasing the capacity of pro-
tein folding, to inducing programmed cell-death. The increase of protein folding
capacity upon ER-stress/UPR activation is achieved by inducing the transcription
of chaperones, and co-chaperones such as DNA J-domain superfamily C member
12 (Dnajc12 ) (Choi et al., 2014), and ER-associated protein degradation known as
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ERAD such as inducing the transcription of homocysteine-responsive ER-resident
ubiquitin-like domain member 1 protein (Herpud1 ), along with attenuating protein
synthesis (Wang and Kaufman, 2014, Hetz, 2012). However, if the stress is sus-
tained, cells may undergo apoptosis that can be mediated by Chop and Gadd34.
In addition to the ER-stress/UPR upregulation in mice upon alkylation exposure
observed previously by transcriptomic analysis, transcripts related to the suppressor
of cytokine signalling were up-regulated as well. This was observed as transcript
of these genes particularly the suppressor of cytokine signaling-3 gene (Socs3 ) were
modulated in the wild-type mice liver 6-hour after alkylation-exposure, but not in
the Aag mutant (Meira et al., unpublished). Socs3 is an inducible endogenous neg-
ative regulator of the Janus kinase pathway (JAK) and the signal transducer and
activators of transcription 3 (STAT3) pathway that are necessary for the signaling
of cytokines and other stimuli regulating inflammatory gene expression (Rottenberg
and Carow, 2014). Transient induction of Socs3 in the event light-damage, hypoxia,
inflammation and metabolic stress appeared to be a protective adaptive response to
cellular damage or stress (Liu et al., 2008). It was also shown to regulate photore-
ceptor cell function in the event of retinal inflammation as Socs3 down-regulated
STAT3-mediated ubiquitin-proteasome-dependent degradation of rhodopsin in the
inflamed retina (Ozawa et al., 2008). This was seen as up-regulation of rhodopsin
degradation in the inflamed retina was observed in Socs3 deficient animal and lasted
longer compared to retinas from wild-type animals (Ozawa et al., 2008). Therefore,
Socs3 could play a role in protecting photoreceptor cell viability and function against
retinal degeneration induced by alkylation exposure.
Overall, transcriptomic analysis by Meira et al. (unpublished) showed different
transcriptional response of key genes including ER-stress/UPR genes namely ATF4,
Chop, Herpud1, and Dnajc12, and the suppressor of cytokine signalling genes such
as Socs3, as well as genes closely associated with the circadian clock of Aag-/-
mouse liver upon alkylation-exposure compared to the liver of wild-type mouse.
Hence, re-analysis and validation of expression levels of these genes is suggested
using real time RT-qPCR approach. In addition, the expression and activity of
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Aag were linked to the circadian clock regulatory gene circadian locomoter output
cycles kaput gene (Clock). The expression of Aag was significantly reduced in
Clock mutant mice liver compared to wild-type control liver, and the reduction
was over 24-hours (no rhythmicity observed in Aag expression) (Kim et al., 2009).
Thus, time of treatment may modify the transcriptional response to alkylation-
insult through the base excision repair initiator Aag. Hence, administration of
the alkylating agent MMS is suggested to be at different circadian phase (time of
the day), to inspect modification in the transcriptional response upon alkylation
exposure within a specific circadian phase either during day-time (light-phase) or
night-time (dark-phase).
4.2 Aims
Establishing the expression profile of genes associated with the endoplasmic retic-
ulum(ER) stress and the suppressor of cytokine signalling (Socs) upon alkylation
treatment during day or night-time within mouse liver and eye tissues in the absence
and presence of Aag.
4.3 Objectives
• Reproduce parallel experimental conditions to confirm the transcriptomic
analysis previously observed by Meira et al. (unpublished) using RT-qPCR
method.
• Identify baseline different in genes expression between Aag-/- and wild-type
mice during night-time(dark-period) as well as day-time (light-period) in both
liver and eye tissue.
• Evaluate changes in genes expression response within wild-type and Aag-/-
mice liver and eye tissue 6-hours after alkylation treatment compared to time-
matched untreated cohort.
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4.4 Methods
The following procedures previously detailed in chapter 2 were carried out to ac-
complish our objectives:
• Animal Breeding and Housing (2.5.1, page 50).
• Genotyping of Aag-/- Mice and Cells (2.5.2, page 50).
• In Vivo Studies:
– Evaluation of Genes Expression Levels Upon Alkylation Treatment in
Wild-type and Aag-/- Mice (2.5.3.2, page 55).
• mRNA Gene Expression by RT-qPCR (2.5.3.5, page 61).
• Statistical Analysis (2.6, page 75).
Briefly, light/dark cycle (12:12) entrained wild-type and Aag-/- mice were mock
treated (vehicle, phosphate buffer saline) or (75 mg/kg) MMS treated at either
ZT02:00 (day-time) or ZT14:00 (night-time), and harvested 6-hour later (at ZT8:00,
and ZT20:00 respectively) followed by collection and freezing of liver and eye tissues
in liquid nitrogen (n=5/ treatment group). Then, total RNA was extracted from
eyes and liver tissues, followed by cDNA synthesis, and eventually running RT-
qPCR for several targeted genes including ATF4, Chop, Dnajc12, Herpud1, and
Socs3 along with mouse Actin as a reference housekeeping gene. RT-qPCR results
were then expressed as (mean±SEM) normalised mRNA expression of targeted
genes in eye or liver relative to the gene expression of one specific untreated wild-
type eye or liver respectively within the same treatment-time conditions.
4.5 Results
Previous transcriptomic analysis showed that Aag-/- mice liver displayed a different
profile of gene expression response 6-hours post-alkylation treatment if compared
to wild-type liver (Meira et al., unpublished). Differential responses were observed
in transcripts related to ER-stress response genes, the suppressor of cytokine sig-
nalling genes, and genes closely associated with the circadian clock. Thus, validating
and establishing the status of wild-type and Aag-/- mice tissues, including eyes and
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liver, in terms of their transcriptional response to alkylation treatment was under-
taken, along with assessing the impact of treatment-time as well namely day-time,
and night-time in this transcriptional response. Hence, using real time RT-qPCR
method, the expression profile of genes associated with ER-stress response including
ATF4, Chop, Dnajc12 and Herpud1, and suppressor of cytokine signalling partic-
ularly Socs3 6-hour after MMS-insult in wild-type and Aag-/- mice liver and eye
were established as shown in figures 4.1 and 4.2 below.
4.5.1 Aag-mediated Endoplasmic Reticulum Stress/Unfolded Pro-
tein Response to Alkylation-treatment
As a starting point, genes involved in the ER stress/UPR upon alkylation treatment
were investigated. As shown in figure 4.1, gene expression levels of ATF4, Chop,
Herpud1 and Dnajc12 were measured 6-hour post mock and MMS-treatment dur-
ing either day-time or night-time in wild-type and Aag-/- mice, using both liver and
eye tissue. Generally, the transcription of the UPR components including ATF4
and Chop in both wild-type and Aag-/- mice are induced by alkylation treatment
(p<0.05) within both tissues liver and eyes compared to time-matched untreated
cohort (Figure 4.1a). Yet, the magnitude of changes in ATF4 gene expression
level upon alkylation-insult is small as its expression in MMS-treated wild-type and
Aag-/- livers and eyes is higher by no more than ∼0.8-fold compared to untreated
wild-type and Aag-/- mice liver and eye respectively within paralleled light condi-
tion. Therefore, no substantial modifications are observed in the established profile
of ATF4 gene expression upon alkylation treatment applied at different time of the
day in wild-type and Aag-/- mice liver and eye even though a significant treatment
effect is statistically shown (p<0.05).
However, upregulation of the UPR upon alkylation exposure in wild-type and
Aag-/- mice is evident particularly in the liver by the transcriptional induction of
Chop regardless of the time of treatment, as shown in figure 4.1a. The Chop gene
expression is induced by ∼2 and ∼3-fold in wild-type and Aag-/- mice liver respec-
tively upon alkylation exposure within the day-time cohort (p=0.001). This induc-
tion is also seen within the night-time cohort as it induced by ∼5-and ∼3-fold in
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Figure 4.1: Gene expression profile of endoplasmic reticulum stress/unfolded protein re-
sponse genes in WT and Aag-/- mice eye and liver upon alkylation exposure during either
day or night-time. Bar charts represents (mean±SEM) mRNA expression of ATF4 and
Chop (panel a), as well as Dnajc12 and Herpud1 (panel b) 6-hour after mock treatment
(filled bars) or MMS-treatment (hatched bars) in WT (green) and, Aag-/- (blue) mice eye
(left sub column) and liver (right sub column). mRNA expression of targeted genes within
day-time or night-time treatment cohort were normalised to specific untreated WT mouse
within day-time or night-time cohort respectively. Clear and grey backgrounds indicate
treatment and harvesting being carried out within the day-time or the night-time respec-
tively. Horizontal bars indicate time of lights-on (open) and lights-off. n=5/treatment
group; Mouse Actin used as reference gene; normalised gene expressions were analysed by
two-way ANOVA and lSmeans pairwise comparison for MMS-treatment, and genotype ef-
fects; significant interaction/effect other than treatment indicated in the top left corner of
the chart; *, **, ***P value 6 0.05, 0.01, and 0.001, respectively.
both wild-type and Aag-/- mice liver respectively upon alkylation-insult (p=0.005)
(Figure 4.1a). The effect of alkylation on Chop gene expression is apparently tissue-
specific as the magnitude of changes in Chop expression are small upon alkylation
expression in both wild-type and Aag-/-mice eye within paralleled treatment-time
conditions (meaning the gene expression in not higher by 1-fold or more in the MMS-
treated eyes compared to untreated ones) even though a significant treatment effect
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is statistically observed (day-time, p=0.03; night-time, p<0.0001). Therefore, a
modification in the gene expression profile of Chop is caused by alkylation exposure
particularly in the liver regardless of the genotype and time of treatment.
In terms of Aag impact, the overall expression status of Chop is apparently af-
fected by Aag status as well as the treatment-time. As can be seen in figure 4.1a,
an overall significant effect mediated by Aag on Chop gene expression is perceived
during the day-time (p=0.03) as an overall higher expression of Chop in the Aag-/-
liver compared to the wild-type-liver is shown, while an overall trend toward higher
gene expression in the wild-type liver compared to the Aag-/- mice liver is perceived
during the night-time (p=0.49). These changes in the gene expression of Chop me-
diated by Aag are apparently evident more upon alkylation exposure; however, no
interaction effect between Aag genotype and MMS-treatment is statistically per-
ceived during either day (p=0.9) or night (p=0.2) time treatment conditions. The
induction level of Chop gene expression in the Aag-/- mice liver (null Aag expression
is presumed) upon alkylation exposure remains 3-fold if compared to time-matched
untreated Aag-/- liver, whereas it varies within the wild-type mice liver upon alky-
lation exposure (where proficient Aag expression perceived) from 5-fold to 2-fold
when compared to untreated wild-type mice liver during day-time or night-time
respectively (Figure 4.1a). Our result could indicate that the induction of the ER-
stress/UPR gene expression upon alkylation-exposure is partially mediated via Aag.
The activation of the UPR in response to ER-stress induced by alkylation expo-
sure may result in maintaining and restoring the ER homeostasis, activation of the
ER-associated degradation, and/or mediating apoptosis. Because alkylation expo-
sure upregulates the expression of ER-stress/UPR genes as perceived in the gene
expression profile of Chop especially in mice liver 6-hour after MMS-administration,
it may subsequently upregulate genes involved in the ER-associated degradation
such as Herpud1 and in the regulation of the ER stress, and capacity such as the
co-chaperons Dnajc12 as well. Therefore, the gene expression profile of Herpud1
and Dnajc12 upon alkylation-insult during either day-time or night-time in wild-
type and Aag-/- mice are established, including both liver and eye tissues as shown
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in figure 4.1b.
As can be appreciated from figure 4.1b, the expression status of Herpud1 and
Dnajc12 genes within the eye remains unaffected upon alkylation exposure regard-
less of Aag genotype within different treatment time conditions. This is observed
as no induction in the gene expression of Herpud1 and Dnajc12 are perceived in
MMS-treated wild-type and Aag-/- eyes when compared to time-matched untreated
wild-type and Aag-/- mice eye, even though a significant effect of genotype or treat-
ment is sometimes statistically observed as shown in figure 4.1b. Therefore, the
gene expression level of Herpud1 and Dnajc12 within mice eye is not upregulated
upon alkylation exposure.
In contrast to the eye, the gene expression profile of Herpud1 and Dnajc12
is significantly upregulated within the liver particularly when alkylation exposure
applied during the night-time (Figure 4.1b). In case of Dnajc12, a trend toward
inducing the expression level of Dnajc12 in mice liver upon alkylation exposure is
perceived within the day-time cohort (p=0.057). This is seen as Dnajc12 is in-
creased by ∼2.5 in wild-type liver upon alkylation exposure compared to untreated
livers within the day-time cohort as depicted in figure 4.1b. This magnitude of in-
duction in Dnajc12 upon alkylation exposure is not observed in Aag-/- livers within
the day-time cohort, which seems to be due to a non-significant trend toward basal
elevation of Dnajc12 in livers from the Aag-/- untreated mice if compared to wild-
type (by 1.5 fold) within the day-time cohort (genotype, p=0.6). Yet, this basal
induction of Dnajc12 expression in untreated Aag-/- mice liver compared to that
one of wild-type mice is also perceived within the night-time cohort but by 2.5 fold
(genotype, p=0.02; figure 4.1b).
In addition to the basal induction seen in Aag-/- liver, the gene expression of
Dnajc12 is also induced upon alkylation exposure in both genotypes within the nigh-
time treatment cohort (treatment, p=0.007). It is increased by the same magnitude
(∼3-fold) in MMS-treated wild-type and Aag-/- liver if compared to time-matched
untreated wild-type and Aag-/- mice liver respectively within the night-time co-
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hort as shown in figure 4.1b. Despite the modifications perceived in Dnajc12 gene
expression within the liver that are mediated by Aag basally and upon alkylation-
insult, the statistical analysis does not indicate any significant interaction of Aag
genotype and MMS-treatment effect on the gene expression within either day-time
cohort (p=0.10) or night-time cohort (p=0.96). Therefore, Dnajc12 gene expression
is apparently modulated basally and upon alkylation exposure, and this seems to
be a tissue-specific effect.
Herpud1 gene expression is potentially affected by alkylation exposure in Aag
and a circadian-time dependent-manner within the liver. As can be appreciated
from figure 4.1b, no major changes in Herpud1 expression are observed in the mice
liver 6-hour after alkylation-insult within the day-time cohort. This seen as the level
of Herpud1 gene expression remains unaffected upon alkylation exposure in both
wild-type and Aag-/- mice liver despite the observation of a significant treatment ef-
fect (p=0.024) within the day-time cohort. Within the night-time cohort, Herpud1
expression is upregulated in both genotypes upon alkylation exposure (p<0.0001).
It is induced by 2.5 fold in MMS treated wild-type liver compared to untreated ones
within the night-time cohort, whereas this induction is reduced to 1.5 fold within the
Aag-/- cohort. However, no basal differences (p=0.10) are observed in the expres-
sion of Herpud1 between the wild-type and Aag-/- mice despite the higher induction
observed in wild-type liver upon alkylation exposure compared to the Aag-/- liver.
Therefore, Alkylation induces Herpud1 expression, and this induction appears to
be in Aag and a circadian-time dependent-manner as well as a tissue-specific effect.
Overall,a tissue-specific induction of ER-stress/UPR upon alkylation exposure
is perceived in mice, and Aag apparently plays a role in this induction. In addition
to establishing the gene expression profile of the endoplasmic reticulum response to
alkylation exposure, analysis of the suppressor of cytokine signaling gene particu-
larly Socs3 upon alkylation exposure is performed in wild-type and Aag-/- animals,
including liver and eye tissues as shown next.
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4.5.2 Alkylation-Modulated the suppressor of cytokine signaling-3
(Socs3 ) expression
The gene expression profile of Socs3 6-hour after alkylation-treatment in wild-type
and Aag-/- mice liver and eye during either daytime or night-time is successfully
established using real-time RT-qPCR approach as shown in figure 4.2. As can be
appreciated from the figure below, an overall significant effect of alkylation treat-
ment (p≤0.0005) on Socs3 expression level is clearly evident as it is induced by at
least 5-fold if not higher in MMS-treated wild-type and Aag-/- mice liver and eye
in comparison with time-matched untreated wild-type and Aag-/- mice respectively
under either day-time or night-time treatment conditions. Therefore, alkylation
exposure upregulates the gene expression of Socs3 in both tissues liver and eye re-
gardless of treatment time and Aag.
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Figure 4.2: Alkylation-modulated gene expression ofSocs3 in WT and Aag-/- mice eye
and liver. Bar charts depicts (mean±SEM) mRNA expression of Socs3 6-hour post mock
treatment (filled bars) or MMS-treatment (hatched bars) in WT (green) and, Aag-/- (blue)
mice eye and liver during day-time as well as during night-time. mRNA expression of
targeted genes within day-time or night-time treatment cohort were normalised to specific
time-matched untreated WT mouse. Clear and grey backgrounds indicate treatment and
harvesting being carried out within the day-time or the night-time respectively. Horizontal
bars indicate time of lights-on (open) and lights-off. n=5/treatment condition; Mouse Actin
used as reference gene; normalised gene expressions were analysed by two-way ANOVA and
lSmeans pairwise comparison for MMS-treatment, and genotype effects;significant interac-
tion/effect other than treatment indicated in the top left corner of the chart; *, **, ***P
value 6 0.05, 0.01, and 0.001, respectively.
In terms of Aag effect, Aag apparently impacts the gene expression of Socs3 in
mice liver and eye upon alkylation exposure during the day-time in a tissue-specific
fashion (Figure 4.2). As can be appreciated from the figure, 10-fold induction of
Socs3 in MMS-treated wild-type eye tissue (p<0.000.1) compared to untreated wild-
type is shown, whereas the magnitude of the induction is reduced to 3.6-fold within
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the Aag-/- cohort (p=0.004) treated during the day-time. Hence, possessing Aag
induces Socs3 in the eye by no less than 6-fold if compared to Aag deficient eye
upon alkylation exposure during day-time (p=0.0003). Yet, this different magni-
tude of induction between both genotype is not perceived within the night-time
treatment cohort as Socs3 in both MMS-treated wild-type and Aag-/- eye increases
by the same magnitude (∼6-fold) compared to untreated wild-type and Aag-/- mice
respectively (Figure 4.2). Therefore, these finding indicates that Aag-mediated
alkylation induces Socs3 expression in eye tissue potentially in a circadian-time de-
pendent manner.
In the liver, Socs3 expression appears to be affected basally, and upon alkylation-
insult specifically. The gene expression level of Socs3 in wild-type and Aag-/- liver
is induced upon alkylation exposure during day-time to 9 and 12-fold respectively
as shown in figure 4.2 (p=0.0005). Yet, Socs3 in MMS-treated wild-type and Aag-/-
liver is induced by the same magnitude (8-fold) if compared to time-matched un-
treated wild-type and Aag-/- mice liver respectively within the day-time cohort, as
Socs3 is already basally elevated in livers from the Aag-/- untreated mice compared
to wild-type by 4-fold. This indicate a trend toward basal induction of Socs3 in
the untreated Aag-/- liver if compared to the wild-type ones within the day-time
cohort (p=0.18). This baseline induction of Socs3 expression level in untreated
Aag-/- livers is also apparent within the night-time treatment cohort but it is down
to ∼2-fold induction (p=0.93). In contrast to day-time cohort, Socs3 is induced
by 5 and 3 fold in MMS-treated wild-type and Aag-/- liver compared to untreated
wild-type and Aag-/- mice liver respectively within the night-time cohort (Figure
4.2). Therefore, Socs3 expression within mice liver appears to be influenced by
Aag basally and upon alkylation, and this influence could be in a circadian time
dependent manner.
Overall, baseline induction in the expression of one of the suppressor of cytokine
signaling namely Socs3 as well as the ER stress/UPR genes especially Chop and
Dnajc12 are observed particularly in the liver of Aag-/- cohort compared to the
wild-type cohort. Also, Aag knock-out leads to a differential response to alkylation
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insult at the level of mRNA expression in the mice liver and eye tissue compared
to the response seen within wild-type mice as shown by Socs3, Chop and Dnajc12
expression level. Hence, the induction in gene expression level in mice upon alky-
lation exposure are varied based on the presence and absence of Aag as well as the
time of administrating the test compound as discussed next.
4.6 Discussion
The gene expression profile of ER-stress/UPR related genes including ATF4, Chop,
Dnajc12, and Herpud1, as well as genes related to the suppressor of cytokine sig-
naling specifically Socs3 6-hour after alkylation-treatment in wild-type and Aag-/-
mice liver during either day-time or night-time was successfully established using
real-time RT-qPCR method. The mRNA expression of several players involved in
the ER stress/UPR and the suppression of cytokine signaling within mouse liver
showed a trend toward upregulation of these two pathways particularly in wild-type
cohort compared to the Aag-/- cohort. Therefore, confirming the transcriptomic re-
sults of wild-type and Aag-/- mice liver response to alkylation exposure done by
Meira and collaborators (unpublished) was accomplished.
Our result indicates that alkylation treatment induced-ER stress response is
partially Aag/time-dependent. The response of wild-type mouse to ER-stress and
accumulation of damaging proteins upon alkylation exposure was higher in the liver
compared to the Aag-/- cohort. This was observed by higher induction generally of
ATF4, Chop, Dnajc12 and Herpud1 in MMS-treated wild-type mice liver relative
to the untreated ones in comparison with dampened induction generally seen in the
Aag-/- cohort upon alkylation exposure. Also, knocking out Aag in mice appears to
differentiate the gene expression of Chop and Dnajc12 basally, and this effect seems
to be tissue-specific. This was seen by a basal induction of both genes within the
liver as depicted by the untreated Aag-/- mice compared to the untreated wild-type
animal.
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In addition, the impact of treatment-time on the ER response in mice liver
and eye tissue to alkylation exposure was tested. It showed that the induction of
ATF4, Chop, and Dnajc12 in MMS-treated wild-type mice appeared to be indepen-
dent of the time of treatment, whereas the induction of Herpud1 in both wild-type
and Aag-/- MMS-treated mice was time dependent as well as tissue specific (ma-
jor induction seen within the liver exposed to alkylation during the night-time).
Additionally, based on comparison to the time-matched untreated mice, ER stress
response seems to sometimes be time-of treatment (circadian time) and genotype
dependent as can be seen in the gene expression of both Chop and Dnajc12 within
the liver. Eventually, the response of the ER to the insults produced by alkyla-
tion exposure was much lower in the eye compared to the liver regardless of the
treatment-time (injection-time) condition.
We demonstrated an induction of the transcription of two transcriptional factors
associated with the ER-stress/UPR namely ATF4 and Chop upon alkylation expo-
sure, and this induction was even higher within the liver particularly the expression
level of Chop within the wild-type cohort compared to Aag-/- cohort. Translation
of ATF4 plays a role in cell survival and death. On one hand, the translated ATF4
enters the nucleus and activate the transcription of ER stress response genes re-
sponsible for the antioxidant response and amino acid biosynthesis and transport
to promote cell survival (Harding et al., 2000), while on the other hand, it acti-
vates tran-scription of Chop which plays a role in ER stress-mediated apoptosis
(Palam et al., 2011, Song et al., 2008, Marciniak et al., 2004). Therefore, exposure
to alkylation can trigger programmed cell death via insulting the ER homeostasis
leading to UPR activation, and hence cell cycle arrest and apoptosis via activat-
ing the transcription of Chop. This appeared to be Aag-dependent as the level of
Chop expression was induced less in Aag-/- mice, where resistance to alkylation-
induced cell degeneration is seen (Calvo et al., 2013, Meira et al., 2009), compared
to the wild-type cohort upon alkylation exposure particularly in liver within the
night-time cohort. Hence, ER stress/UPR appears to contribute to the resistance
of Aag-/- mice to alkylation-induced cell death.
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The effect of Aag proficiency and deficiency was also seen on the outcome of the
ER stress/UPR such as increasing the capacity of protein folding and transport. An
example of that is the induction of the co-chaperones Dnajc12 which forms com-
plexes with unfolded proteins to avoid aggregation, and hence assess the protein
folding process which in turn increases the capacity of the ER (Choi et al., 2014,
Fan et al., 2003). This induction of Dnajc12 expression level in the Aag-/- cohort
livers were observed basally, as well as upon the alkylation exposure particularly in
the night-time treatment cohort. This suggested that the capacity of ER to stress
in Aag-/- mice seems to be basally higher compared to the wild-type, which in turn
dampen the induction of ER stress genes upon alkylation exposure in the Aag-/-
cohort compared the wild-type cohort.
Another outcome of the ER stress/UPR potentially affected by Aag expres-
sion are genes involved in induction of protein degradative pathways namely ER-
associated degradation such as Herpud1. The induction level of Herpud1 expression
in mice liver upon alkylation exposure seemed to be modulated by treatment-time
(circadian-time) conditions as well as the presence of Aag. The effect of alkylation
insult on Herpud1 expression has been previously shown by van Laar et al. (2000)
as Herpud1 expression was induced 4-hour after MMS treatment in human diploid
skin fibroblasts and HeLa cells as well as after exposure to ultraviolet A irradiation.
This induction of Herpud1 upon MMS treatment was also seen in the wild-type
mice liver particularly within the night-time cohort, but the level of induction was
dampened in the Aag-/- mice liver (Figure 4.1b) where resistance to alkylation dam-
age induced by MMS previously found (Calvo et al., 2013, Meira et al., 2009).
Along with investigating the ER response to alkylation exposure, we also estab-
lished the gene expression profile of the suppressor of cytokine signalling-3 6-hour
after alkylation-insult during either day-time or night-time in mice liver and eye tis-
sue. Socs3 gene expression is significantly induced in both eye and liver tissues upon
alkylation exposure, but the expression level seemed to be modulated by both time
of exposure (day or night) and the base excision repair initiator Aag. In the eye,
where alkylation-induced retinal degeneration is Aag-dependent (Meira et al., 2009),
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the mRNA expression profile exhibited quite higher induction of Socs3 expression
level in wild-type mice compared to Aag-/- cohort (p<0.0001) upon alkylation ex-
posure during the day-time, whereas the induction level was identical between both
genotypes when the exposure applied during the night-time (Figure 4.2).
Exposure to Alkylating agent induces retinal degeneration in Aag-dependent
manner (Calvo et al., 2013, Meira et al., 2009), which in turn can trigger the in-
flammatory response via different signalling pathway. This will lead in turn to
activation and induction of Socs3 (highly induced in MMS-treated wild-type eye
particularly within the day-time cohort if compared to the Aag-/- mice eye; Figure
4.2). Socs3 negatively regulates some signalling pathways involved in the inflamma-
tory response such as JAK/STAT3 (reviewed in Rottenberg and Carow 2014), and
subsequently regulate visual function as well by reducing the ubiquitin-proteasome-
dependent degradation of rhodopsin during inflammation (Ozawa et al., 2008).
However, within the liver, basal induction of Socs3 was seen in the untreated
Aag-/- mice compared to the untreated wild-type animal regardless of the treatment-
time conditions. Also, the induction of Socs3 upon alkylation exposure was damp-
ened by 2 fold in the Aag-/- cohort in comparison with the induction level observed
in the wild-type cohort exposed during night-time. The basal induction of Socs3
expression in the Aag-/- mice might be due to cellular stress as basal induction of
ER stress/UPR genes was observed particularly in Chop where similar pattern of
gene expression induction was observed (Figure 4.1, and 4.2) as described above.
This is in line with what observed by Liu et al. (2008) and Amadi-Obi et al. (2007)
where cellular stress and chronic inflammation led to persistent induction of Socs3
expression. Eventually, treatment-time seems to play a role in the induction per-
ceived in Socs3 upon alkylation exposure along with the presence and absence of
Aag, and probably suggesting that alkylation induces Socs3 expression in mouse
liver and eye in Aag and a circadian-time dependent manner.
To summarise, the base excision repair initiator Aag facilitated the expression
of genes associated with the ER/UPR and the suppressor of cytokine signalling-
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3 upon alkylation exposure. Knocking out Aag modifies gene expression profile
of ER-stress/UPR and Socs3 6-hour after alkylation treatment, as well as modi-
fies them in the absence of treatment (basally). Also, the expression of the ER
stress/UPR, and Socs3 genes upon alkylation treatment differs sometimes based on
the treatment-time but this is not consistent. Upregulation of the ER-stress/UPR
genes upon alkylation exposure was more prominent in liver tissue compared to the
eye, while upregulation of Socs3 was observed in both tissues. Further investigation
into the role played by Aag, and treatment-time effect on the liver and eye tran-
scriptional response to alkylation insult is needed such as inspecting the effect on
genes closely associated with the circadian clock, as well as changes among other
signalling pathway involved in the UPR activation namely ATF6, and IRE1α.
Chapter 5
Alkylation Exposure and The Circadian Clock
5.1 Introduction
Sleep-wake and fasting-feeding cycles, and numerous metabolic parameters oscil-
late in day-time dependent manners. This rhythmicity in metabolic processes and
other cycles is driven partially by cell autonomous circadian clocks. In mammals,
circadian rhythms are guided by a timing system comprising a master pacemaker in
the supra-chiasmatic nuclei of the hypothalamus, and peripheral oscillators located
throughout the organism (Takahashi, 2016, Bailey et al., 2014, Takahashi et al.,
2008). Both the master and the peripheral oscillators possess a parallel molecular
base, explaining the many properties they are sharing.
In mammals, the circadian clock consists of transcription factors interacting
with each other to generate oscillations of gene expression. This oscillations of gene
expression leads to interconnected auto-regulatory feedback loops corresponding to
activation and repression cycles (Takahashi, 2016, Takahashi et al., 2008). The pri-
mary negative-feedback loop contains the genes Circadian Locomoter Output Cycles
Kaput (Clock), brain and muscle ARNT-Like 1 (Bmal1 ), period homologue 1 and 2
(Per1 and 2 ), and cryptochrome 1 and 2 (Cry1 and 2 ). During day-time, CLOCK
and BMAL1 (positive elements)interact through the PAS domain in CLOCK, and
the CLOCK-BMAL1 dimer activates transcription of both Per and Cry genes (neg-
ative elements of the loop) along with other circadian-controlled genes leading to
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high levels of these transcripts, and consequently of these proteins, to be produced.
Afterwards, PER and CRY proteins heterodimerize, and translocate to the nucleus
to interact with the CLOCK-BMAL1 complex and inhibit their own transcrip-
tion. While during the night-period, the PER-CRY repressor complex is degraded
through ubiquitin (Ub)-dependent pathways, and hence the CLOCK-BMAL1 com-
plex can activate a new cycle of transcription, and a whole transcription cycle takes
roughly 24 hours (Takahashi, 2016, Le´vi et al., 2010, Takahashi et al., 2008).
Additionally, the CLOCK-BMAL1 complex is a direct target for the secondary
negative-feedback loop by either repressing or inducing Bmal1 transcription. This
loop involves the nuclear receptor subfamily 1, group D, member 1, and 2 (Nr1d1,
and Nr1d2 ) known as Rev-erb α and β respectively which are strongly inhibitors
of Bmal1 transcription, and the retinoic-related orphan receptor α (ROR-α) that
activates the transcription of Bmal1 (Takahashi, 2016, Takahashi et al., 2008, Guil-
laumond et al., 2005). Other major components reported to influence clock func-
tion is D-element binding protein (Dbp). It is a liver-specific transcription factor
expressed within a circadian period, and its gene expression is regulated rhythmi-
cally by the clock proteins CLOCK-BMAL1 (Albrecht, 2002). Yet, Dbp in turn is
capable of binding to the promoter of the Per-1 gene, and hence positively influence
Per-1 transcription (Takahashi, 2016, Le´vi et al., 2010, Albrecht, 2002, Yamaguchi
et al., 2000). In fact, a large aspect of any given transcriptome is circadian/diurnal,
through transcriptional regulation.
Output from the clock is evident at the levels of transcription and post-translational
modifications as well. It has been shown that a number of genes encoding for pro-
teins affecting transcription, translation, signaling, cell cycle/survival, and metabolism
are clock-controlled genes (Bailey et al., 2014). Circadian timing was shown to mod-
ulates the extent of toxicity of some anticancer drugs in experimental animals. These
modifications in tolerability and efficacy involves the circadian control of phase I
and II metabolism (Le´vi et al., 2010, Gorbacheva et al., 2005, Porsin et al., 2003).
For example, 5-fluorouracil (5-FU) (antimetabolite anti-cancer drug) is most toxic
to healthy tissue during the dark (activity) span of rats and mice because of a peak
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in all enzymatic activities involved in the generation of the cytotoxic form of 5-FU
(Porsin et al., 2003).
The mechanism by which circadian timing modifies tolerability and efficacy of
anti-cancer drug, also includes the circadian control of cell cycle checkpoints, and
cell survival and apoptosis. The control of cell survival and apoptosis is achieved
via the rhythmic expressions of antiapoptotic and proapoptotic proteins, as well
as regulating the expression or activity levels of DNA repair proteins (Bee et al.,
2015, Le´vi et al., 2010, Kim et al., 2009, Marchenay et al., 2001). For instance, the
circadian clock rhythmically regulates activities or levels of the DNA repair pro-
tein O6-methylguanine DNA methyltransferase (Mgmt), which excises the lethal
DNA alkylated lesions (O6-methylguanine) generated by alkylating nitrosoureas
(Marchenay et al., 2001). In addition, cellular sensitivity to DNA damage and
efficiency of DNA repair have been observed to be regulated rhythmically by the
circadian clock. In human quiescent fibroblast cells, the efficiency of nucleotide
excision repair (NER) and sensitivity to UV damage peaks at BMAL1-peaks and
BMAL1-trough respectively (Bee et al., 2015).
Another DNA repair pathway modulated by the circadian clock is the base exci-
sion repair (BER) pathway initiated by alkyladenine DNA glycosylase (Aag). This
BER pathway is mainly responsible for repairing alkylated DNA base damage such
as 3-methyladenine, and 7-methylguanine. Analysis of the expression of DNA re-
pair proteins such as Aag and Mgmt in Clock-/- mice liver indicated that, among
several proteins examined, only the expression of Aag was significantly repressed in
Clock-/- mouse liver in comparison with wild-type mice liver. It is important to note,
however, that despite this decrease in expression there was no circadian pattern of
expression detected for Aag (i.e. there is no significant 24-h variation in the hepatic
expression of Aag) (Kim et al., 2009). The effect of knocking out the Clock gene
on Aag expression was evident as Clock-/- primary cultured hepatocytes exhibited
higher sensitivity to genotoxic stress induced by compounds such as the alkylating
agent methyl methanesulfonate (MMS) if compared to the wild-type primary hep-
atocytes, and this higher sensitivity was attributable by Kim and coworkers (2009)
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to the reduction of Aag expression associated with the knocking out Clock.
Hence, the circadian clock may modulate the response to alkylated DNA base
damage through positive regulation of Aag expression. As previously stated, Aag
excises alkylated/damaged bases and initiates the BER pathway in order to repair
damaged DNA bases. However, in certain cell or tissue types, Aag-mediated BER
initiation may not be beneficial since it has been shown to lead to the accumula-
tion of toxic BER intermediates and potentially cell death and tissue damage. This
scenario was observed in photoreceptor cells, bone marrow and other tissue types
where resistance to alkylation damage was observed in Aag-/- mice, while severe cell
death and tissue damage occurred after alkylation treatment in wild-type cells and
tissues Calvo et al. (2013), Meira et al. (2009). Thus, if Aag expression is modu-
lated in a clock-mediated fashion, then Aag-mediated alkylation genotoxicity could
be modulated by the circadian clock. For example, administration of the genotoxic
compound (MMS) in a specific circadian-phase (day-phase, or night phase) may in-
crease or decrease the extent of MMS toxicity especially where it is Aag-dependent
such as the photoreceptor cells within the eye. To address this possibility, I in-
vestigated the cellular stress response to alkylation treatment when performed at
different circadian time in Aag proficient and Aag deficient animals and did so, by
analysing the mRNA level of cellular-stress responsive genes. One of these cellular
stress responsive genes is the suppressor of cytokine signalling-3 (Socs3 ), which un-
derwent a dramatic induction upon alkylation insult as previously shown in Chapter
4.
The control of DNA-damage response pathways and cell-cycle progression by
the circadian clock has been reported in multiple studies; however, several studies
have also demonstrated that DNA damage can function as a resetting cue (syn-
chronising signal) for the circadian clock. Chemical or physical genotoxicants, such
as alkylating agents and ionizing-radiation respectively, are capable of phase shift-
ing (resting) the clock (Oklejewicz et al., 2008, Pregueiro et al., 2006). Ionizing
radiation was proven to reset the circadian rhythms of Per2 in vitro and in vivo
in a dose- and time-dependent manner. In vitro, the circadian rhythm of Per2 ex-
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pression was phase advanced in rat-1 fibroblasts reporter upon exposure to ionizing
radiation. This phase-shifting was mediated via ataxia-telangiectasia (ATM), as it
was repressed in fibroblasts extracted from cancer-predisposed ATM patients (i.e.
mutated in the ATM gene, deficient in the repair of DNA double strand breaks)
(Oklejewicz et al., 2008). In addition, ionizing-radiation induced-phase shifting was
perceived in vivo as the behavioural rhythm (indirect read-out of the circadian
clock) was phase-advanced in irradiated mice (Oklejewicz et al., 2008). DNA dam-
age’s role as a resetting cue for the circadian clock was also shown in Neurospora
crassa exposed to the alkylating agent MMS. MMS-induced DNA damage led to
phase-advances in the circadian rhythm of conidiation in Neurospora crassa by a
mechanism involving checkpoint kinase 2 mediated phosphorylation of the Neu-
rospora clock protein Frequency (Pregueiro et al., 2006).
Previous work done by Meira and collaborators (unpublished) indicated that
treatment with the alkylating agent MMS had a profound effect on the transcrip-
tional activity of the mouse liver in Aag-dependent manner. Treatment with a
sub-lethal dose of MMS led to a significantly changed transcriptional response in
wild-type mouse liver, but not in Aag mutant liver. In particular, it indicated
a link between the DNA repair process initiated by Aag, and the modulation of
transcripts associated with the endoplasmic reticulum stress, acute phase response,
the circadian clock and other cellular mechanism upon alkylation exposure. Thus,
upon MMS treatment, a significantly higher unique transcripts were modulated in
the wild-type mouse liver in comparison with the Aag-/- mouse liver, indicating
that the repair process initiated by Aag plays a role in the transcriptional response
to MMS. Among this set of modulated genes (meaning changed upon treatment
in the wild type but not in the Aag knock-out) were several circadian regulatory
genes such as Nr1d1, Nr1d2 and others. This result indicates that there could
be a potential effect of Aag-mediated alkylation-toxicity on the expression of clock
genes, and absence of Aag might somehow alter clock homeostasis particularly upon
MMS-exposure. We therefore decided to investigate this issue more closely, and to
verify whether, under strict circadian-controlled conditions, we could demonstrate
an effect of Aag on clock gene expression.
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5.2 Aims
Examining the role played by Aag in the clock homeostasis upon alkylation-insult.
5.3 Objectives
• Establishing the expression profile of the circadian genes Nr1d1, Nr1d2, and
Dbp in eye and liver tissue from wild-type and Aag-/- mice 6-hour after alky-
lation exposure during the day-time (light), and the night-time (dark).
• Analysing the potential effect of the circadian clock (time of administration)
on the transcriptional response to the alkylation exposure in eye and liver
tissue from wild-type and Aag-/- mice.
• Investigating the potential impact of Aag on circadian clock in vitro by estab-
lishing the circadian phase-response curve in wild-type and Aag-/- Bmal1 -dLuc
primary mouse embryonic fibroblast (pMEFs) upon alkylation exposure.
5.4 Method
The following method procedures detailed in chapter 3 were used in this study:
• Animal Breeding and Housing (2.5.1, page 50).
• Genotyping of Aag-/- Mice and Cells (2.5.2, page 50).
• In Vivo Studies:
– Evaluation of Genes Expression Levels Upon Alkylation Treatment in
Wild-type and Aag-/- Mice (2.5.3.2, page 55).
• mRNA Gene Expression by RT-qPCR (2.5.3.5, page 61).
• In Vitro Study (2.5.4, page 67).
• Statistical Analysis (2.6, page 75).
Briefly, light/dark cycle (12:12) entrained wild-type and Aag-/- mice were mock
treated (phosphate buffer saline) or (75 mg/kg) MMS treated at either ZT 02:00
(day-time) or ZT 14:00 (night-time), and harvested 6-hour later (at ZT 8:00, and
ZT 20:00 respectively) followed by collection and freezing of liver and eye tissues in
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liquid nitrogen (n=5/ treatment group). Then, total RNA was extracted from eyes
and liver tissues, followed by cDNA synthesis, and eventually running RT-qPCR for
several targeted genes including Nr1d1, Nr1d2, Dbp, and Socs3 along with mouse
Actin as a reference housekeeping gene. RT-qPCR results were then expressed as
(mean ±SEM) normalised mRNA expression of targeted genes in eye or liver relative
to the gene expression of one specific untreated wild-type eye or liver respectively
within the same treatment-time conditions unless highlighted.
Additionally, an in vitro approach was developed to study the impact of alkylation-
exposure on th circadina rhythm of Bmal1 in wild-type and Aag-/- pMEFs by
transfecting the cells with Bmal1 -dLuc luciferase reporter (reporter of Bmal1 tran-
scription). Cells were then synchronided by serum-shock for 2-hours, followed by
real-time bioluminescence monitoring and recording of Bmal1 transcription using
LumiCycle luminometer throughout the whole experiment. As Bmal1 is a distinct
phase marker of the clock, treatment time-points were set in a well defined phase
of the clock based on Bmal1 peak. Thus, cells were either left without applying
the treatment procedure (control), mock-treated (serum free medium), or treated
with 2.5 mM MMS-treated for 1-hour duration at 6, 12, 18 and 24 hours after
Bmal1-peak. Bioluminescence recordings were linearly detrended, and subsequently
a cosine curve was fitted. Therefore, phase-shifting in the rhythm in response to
mock-treatment (to inspect the effect of replacing the medium on the cells com-
pared to non-treated control) and MMS- treatment (to inspect the effect of MMS
on the cells compared to mock-treated cells) for both genotypes as well as for each
treatment time-point were calculated in order to plot the circadian phase response
curves.
5.5 Result
5.5.1 Associated Circadian Genes Respond Differently to
Alkylation-induced DNA Damage
Initially, the effect of alkylation exposure during either the day-time (light) or the
night-time (dark) as well as the role of Aag on genes closely associated with the
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circadian clock homeostasis is evaluated. This was accomplished by analysing the
mRNA expression of Nr1d1, Nr1d2, and Dbp in eye and liver tissue from wild-type
and Aag-/- mice 6-hour after exposure to sub-lethal dose of MMS at different time
as shown in figure 5.1.
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Figure 5.1: Profile of circadian genes expression in WT and Aag-/- mice eye and liver upon
alkylation exposure during either day or night time. Bar charts represents (mean±SEM)
mRNA expression of Nr1d1 (top panel), Nr1d2 (middle), and Dbp (bottom) 6-hour af-
ter mock treatment (filled bars) or MMS-treatment (hatched bars) in WT (green) and
Aag-/- (blue) mice eye (left sub column) and liver (right sub column). mRNA expression
of targeted genes within day (clear background) or night-time (grey background) cohort
were normalised to specific untreated WT mouse within the day or night cohort respec-
tively. Horizontal bars indicate time of lights-on (open) and lights-off. n=5/treatment
group; Mouse Actin as reference gene; normalised gene expressions were analysed by two-
way ANOVA and lSmeans pairwise comparison for MMS-treatment, and genotype effects;
significant interaction/effect other than treatment indicated in the top left corner of the
chart; *, **, ***P value 6 0.05, 0.01, and 0.001, respectively.
As can be appreciated from figure 5.1, no major changes in the gene expression
level of circadian relevant genes are observed in both eye and liver tissues after treat-
ment with MMS. Some small changes are, however, apparent and will be discussed.
For example, Nr1d1 expression is always lower in the alkylation-treated mice if com-
pared to control, particularly in the liver within the light cohort, but the magnitude
of the change (from ∼1.3 and 0.8 to 0.8 and 0.5 upon MMS-insult in wild type-and
Aag-/- mice liver) is small (p=0.052), raising question about its biological relevance.
Nr1d2 expression, however, is significantly changed upon alkylation-exposure in
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the liver for the night-time treatment cohort, this is shown by a 2-fold induction of
Nr1d2 expression in both wild-type and Aag-/- mouse liver upon MMS-insult dur-
ing the night (p=0.001; Figure 5.1). Finally, there is a trend for repression of Dbp
expression level upon alkylation exposure, but again the magnitude of the effect is
not substantial.
In terms of comparing Aag proficient and Aag deficient tissue, there is no sub-
stantial evidence that Aag alters the expression of the analysed circadian relevant
genes basally or upon alkylation-administration (Figure 5.1). As can be observed
from the figure, the expression of the Nr1d1, Nr1d2 and Dbp genes does not seem
to be mediated by Aag since no major change is seen, even though a significant
effect for Aag genotype is observed in some cases including Nr1d1 and Nr1d2 in
the liver within the light cohort (p=0.03). In addition, changes in the expression
of the analysed associated circadian genes appear to be evident more in the liver
(where alkylation toxicity is not strictly Aag dependent at the MMS dose used)
rather than the eye (where alkylation toxicity is clearly Aag dependent at the MMS
dose used) (Figure 5.1).
5.5.2 Alkylation Exposure Impacts The Clock in Day-time Dependent-
manner
The above-established profile of the analysed circadian relevant genes was obtained
from analysis of the expression of the genes of interest, and the potential effect of
alkylation exposure and the role played by Aag, within a similar circadian-phase
(parraled time-of adminstration). Next, we wanted to instead look into the possible
changes in the expression status of genes closely associated with the circadian clock
upon alkylation-insult under the influence of Aag across-different circadian-phases
(circadian time) rather than looking into the effect within each treatment-time
conditions seperately. To accomplish that, the gene expression profile of Nr1d1
was re-established, but with the normalisation of the target gene expression done
relative to its expression in a specific untreated wild-type mouse from the night-time
cohort for each of the investigated tissues (Figure 5.2).
As can be appreciated from the figure 5.2 (top panel) the influence of MMS ex-
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Figure 5.2: Gene expression of Nr1d1 and Socs3 genes modified in WT and Aag-/- mice
eye and liver after timed-alkylation-insult. Bar charts represents (mean±SEM) mRNA
expression of Nr1d1 (top panel), and Socs3 (bottom) 6-hour after mock treatment (filled
bars) or MMS-treatment (hatched bars) during either day (clear background) or night time
(grey background) in WT (green) and Aag-/- (blue) mice eye (left column) and liver (right).
mRNA expression of targeted genes were normalised to specific untreated WT mouse within
the night-time cohort. Horizontal bars indicate time of lights-on (open) and lights-off (filled).
n=5; mouse Actin as a reference gene; normalised gene expressions were analysed by three-
way ANOVA and lSmeans pairwise comparison for MMS-treatment, treatment-time, and
genotype effects; significant interaction/effect other than treatment or light indicated in the
top left corner of the chart; *, **, ***P value 6 0.05, 0.01, and 0.001, respectively.
posure, and Aag on the gene expression of Nr1d1 is clearly shown under the effect of
circaidan time in mouse liver. Comparing the day-time cohort with the night-time
cohort revealed that the circadian clock (time) significantly induced the expression
of Nr1d1 between 30 and 50-fold (depending on the genotype: 30-fold higher in
Aag-/- and 50-fold higher in the wild-type) (p<0.0001). Also, the trend observed
before of lower Nr1d1 expression level upon treatment in the liver within day-time
cohort (Figure 5.1) is clearly established when the gene expression is normalised to
a specific control sample from the night-phase (taking into account the influence of
circadian time), and so positive interactions effect of circadian time and alkylation
(p=0.03) as well as circadian time and genotype (p=0005) on Nr1d1 expression
level are evidently seen (Figure 5.2).
In terms of a potential Aag impact, the induction of Nr1d1 expression during
the day-time is basally reduced as stated above: we find that a 30-fold induction
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is seen in the Aag-/-, while a 50-fold induction is seen in the wild-type (p=0.005).
This means that the circadian clock-mediated induction of Nr1d1 in the Aag-/- is
reduced by approximately 20-fold in comparison to the wild-type (p=0.04) during
the day-time. The same response is seen after MMS-treatment. MMS-treatment in
combination with the clock/light-phase induced Nr1d1 expression in the wild-type
liver by 30-fold, while MMS-treatment in combination with the clock/light-phase
induced Nr1d1 expression level in the Aag-/- by 13-fold. So, again in the Aag-/- mice
liver the induction of Nr1d1 expression is reduced if compared to the wild-type re-
sponse by more or less 20-fold. Thus, Aag seems to play a role in maintaining the
clock homeostasis basally and upon alkylation-insult but probably because of the
basal response.
Another overall conclusion is that MMS-treatment reduces the clock-mediates
Nr1d1 expression within the liver (0.032) dring day-time. This reduction in Nr1d1
expression happens both in the wild-type and in the Aag-/-mice liver as it is re-
duced by 22-fold and 14-fold in the wild-type and Aag-/- cohorts respectively upon
alkylation-insult during day-time. Eventually, the magnitude of changes in Nr1d1
expression are high within the liver particularly under the influence of the clock,
whereas no major changes in the gene expression are observed within the eye even
under the influence of the clock.
5.5.3 Circadian Time Influence Aag-Modulated Responses to Alky-
lation Exposure
One of our objectives is to analyse the potential effect of the circadian clock (time
of administration) on the response to the alkylation exposure in eye and liver tis-
sue from both wild-type and Aag-/- mice. To accomplish that, the gene expression
level for one of the cellular stress responsive protein (Socs3 ), which was shown to
be highly induced upon alkylation exposure (see Figure 4.2, page 119), was re-
established taking into account the influence of the circadian phases. This was
achieved by a re-run of the qPCR analysis, but this time normalising the target
gene expression relative to that of a specific wild-type untreated mouse from the
night-time cohort, and so re-establishing the gene expression profile of Socs3 across
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different circadian-phases (Figure 5.2).
As can be appreciated from figure 5.2 (bottom panel), alkylation induces Socs3
expression levels in both eye and liver tissue regardless of the genotype and the cir-
cadian phases. In terms of liver, the expression of Socs3 is induced upon alkylation
exposure by at least 5-fold in the wild-type and ∼9-fold in the Aag-/- liver, when
treatment was performed during the day time, while a similar ∼5-fold induction was
seen when treatment was performed during the night time in both genotypes. This
indicates that the different circadian phases do not significantly affect the profile
of Socs3 induction upon alkylation. In addition, we find no clear evidence that
Aag modulates Socs3 expression in the liver (p=0.055). However, a trend toward
a changed basal induction of Socs3 expression in the Aag-/- mice liver by 2- and
3-fold during the day (p=0.97) and the night (p=0.99) phase, respectively, is ob-
served (Figure 5.2).
In the eye tissue, alkylation-induced Socs3 expression level is clearly demon-
strated and significant (p<.0001), as shown in figure 5.2. Considering treatment
durign day-time, Socs3 expression is induced by ∼8 fold upon alkylation exposure
in the wild type animals but this induction is reduced in the Aag-/- mice (induction
comparing untreated to treated is 3-fold in the Aag-/- mice) (p=0.038). However,
considering treatment during night-time, Socs3 is similarly induced upon alkylation
treatment in both genotypes (∼8-fold). Therefore, the effect of Aag on Socs3 ex-
pression level within the eye upon alkylation exposure (p=0.01) is not clear. This
result could indicate that alkylation-induced Socs3 expression level mediated via
Aag is a day-time dependent event (eyes, p=0.056; liver, p=0.13). What we find is
that in day-phase MMS-exposure, the Aag genotype seems to modify Socs3 expres-
sion, but the directionality of the change is tissue-specific with lower induction seen
in Aag-/- eye versus wild-type eye (p=0.038) and a trend toward higher induction
seen in Aag-/- liver versus wild-type liver (p=0.06). Overall, we propose that Aag
could play a role in modulating Socs3 expression in response to alkylation but more
experiments would be needed to establish whether this tissue specific response is
biologically meaningful.
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5.5.4 Paralleled Circadian Phase-response in Wild-type and Aag-/-
pMEFs Upon Alkylation Exposure
Our results above indicate that alkylation modifies the expression of genes closely
associated with the cellular circadian clock mechanisms, including Nr1d1 and Nr1d2
particularly in the liver in a circadian time dependent-manner (Figures 5.1 and 5.2).
Given the interaction between MMS-treatment and expression of these genes, we
developed an in vitro approach to study the effect of MMS treatment on the cel-
lular circadian clock in vitro. We did this both for cells that were Aag proficient
and deficient. To these ends, wild-type and Aag-/- pMEFs were transfected with
a lentiviral construct, that permanently transduces the cells with a Bmal1 :dLuc
luciferase reporter. After successful transduction, the circadian clocks in these cells
were synchronized using a serum-shock, followed by bioluminescence monitoring of
Bmal1 transcription over the complete duration of the experiment. Cells were sub-
sequently mock-treated, MMS-treated for 1-hour at 6, 12, 18 and 24-hours after the
Bmal1-peak or left without applying any treatment procedure. The complete time
series of bioluminescence recordings were linearly detrended (henceforth referred to
as baseline-subtracted), and subsequently fitted with a cosine curve before, and a
separate curve after treatment. An example of the baseline-subtracted data points,
along with the cosine curves fitted to these points are shown in figure 5.3.
We can use the phase of these fitted curved to determine the effect of alkylation
treatment and Aag expression on the phase of Bmal1 expression. Before treatment,
all bioluminescent reported circadian clocks exhibited a high amplitude rhythms,
and peak phases of expression were the same between treatment groups. As can be
seen in figure 5.4, these peak phases differed between the groups post treatment,
and we can examine the effect of any given treatments by comparing measuring the
delay or advance of the peak timing of a treatment group against the appropriate
control. Determining the phase diffference between mock-treatment relative to the
non-treatment control (Mock-treatment∆-phase) describes the phase shifting effect
of refreshing the medium on the clock, whereas the phase difference between MMS-
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Figure 5.3: Representative curves of Bmal1-bioluminescence data before and after MMS-
treatment (Indicated by black arrow), as well as the fitted cosine curve of Bmal1-dLuc
pMEFs. Detrended Bmal1-bioluminescence data of non-treated control (m), mock-treated
(∆), and 2.5 mM MMS-treated (o) Bmal1-dLuc pMEFs along with the fitted cosine curve
for each treatment condition (green, blue, and red continues line respectively). Coloured-
matched arrows indicated local peaks; Mock-treatment carried by serum-free medium; Time
of treatment -hour after Bmal1- peaks
treatment relative to mock-treatment (MMS∆-phase) describes the phase shift in
response to MMS treatment, controlled for the effects of the mock-treatment (indi-
cated as Mock-treatment∆-phase).
Mock‐treatment ∆‐phase
Mock‐treatment
∆‐phase
Phase Shift in 
response to mock‐
treatment relative to 
control
MMS ∆‐phase
Phase Shift in 
response to MMS‐
treatment relative to 
mock‐treatment
Representative Cosine Fitted Curve of Bmal1‐
Bioluminescence
MMS ∆‐phase
Figure 5.4: Diagram of the calcu-
lation of the phase-shift in Bmal1-
bioluminescence-peak in Bmal1-dLuc
pMEFs in response to mock-treatment
and MMS-treatment. Zoomed cosi-
nor fitted curve of Bmal1-dLuc pMEFs
were either control (n), mock-treated
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shows the calculation of phase-shift
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to control (Mock-treatment∆-phase),
and MMS-treatment relative to mock
treatment (MMS∆-phase).
These comparisons were made for both genotypes, as well as for each of the
4-treatment time-points, allowing the assessment of the responses of the circadian
clock to MMS treatment at these time points, known as a MMS-treatment phase-
response curve, in both genotypes. The phase-response curve for both wild-type
and Aag-/- in response to mock-treatment as well as to MMS-treatment are shown
in figure 5.5. Cosine fitted curve of Bmal1-bioluminescence counts of wild-type and
Aag-/- pMEFs that were control, mock-treated or MMS-treated at 6, 12 ,18, or 24
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Figure 5.5: Circadian phase-responses curves of WT and Aag-/- pMEFs in response to 1-
hour MMS-exposure. Panel (a) shows a representative Bmal1-bioluminescence cosine fitted
curves of individual WT (top) and Aag-/- (bottom) Bmal1-dLuc pMEFs of either control
(green filled), mock-treated (blue filled) or 2.5 mM MMS-treated (red filled) at 6,12,18 and
24-hours post Bmal1-peak. Panel (b) illustrates double plotted circadian phase-response
curve (mean±SD) in mock-treated WT (l)and Aag-/- (o) pMEFs relative control, while
panel (c) depicts it in MMS-treated WT (l) and Aag-/- (o) pMEFs relative to mock-
treatment.
after Bmal1-peak are shown in figure 5.5a. These curves were used to calculate and
plot the phase-response curves in both wild-type and Aag-/- pMEFs in response to
mock-treatment (Figure 5.5b) as well as MMS-treatment (Figure 5.5c).
I will first describe the genotype effects. The phase-response curves to both
mock treatment, and MMS treatment in wild-type and Aag-/- pMEFs mock-treated
or MMS-treated are apparently similar, and are shown in figure 5.5. The peak
phase of Bmal1 transcription is shifted by approximately the same magnitude in
both wild-type and Aag-/- pMEFs upon mock-treatment. It is phase-advanced in
both genotypes at 6, and 24 post Bmal1-peak; however, the peak of Bmal1 is phase-
advanced, and delayed in response to mock-treatment at 12, and 18 post Bmal1
respectively in the wild-type pMEFs, but not in the Aag-/- cells (slight delay in
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the phase by less than an hour, and no major change observed at 12 and 18-post
Bmal1-peak respectively). In terms of MMS-treatment the responses are even more
similar between both genotypes. Because this this data was acquired as a proof-of-
principle data set, the biological replicates per measure are insufficient to undertake
robust statistical analysis. However, the presence of the Aag gene seems to not
influence the altered expression of clock genes in response to MMS treatment, and
the absence of this genotype contrast in this data is not in line with what has been
shown by transcriptional (Meira et al., unpublished) and gene expression analysis
as shown above (Figure 5.1 and 5.2).
In terms of MMS treatment, irrespective of genotype, MMS-exposure signifi-
cantly shifts the circadian rhythm of Bmal1 transcriptions, and this effect is de-
pendent on time of treatment. As shown in figure 5.5, when cells are mock-treated
(with serum free medium only), the phase of the circadian rhythm of Bmal1 tran-
scription is shifted, as it is advanced in both wildtype and Aag-/- pMEFs at 6 and
24 post Bmal1-peak treatment time-points as well as at 12 post Bmal1-peak but
in the wild-type only (Figure 5.5b). Once the treatment procedure included 2.5
mM MMS, the phase shift compared to mock-treatment, is either phase-delayed
or advanced the rhythm in a circadian-phase dependent-manner. This is seen in
figure 5.5, as the phase in Bmal1 driven bioluminescence expression- in wild-type
and Aag-/- MMS-treated pMEFs is delayed when cells are treated with MMS 6 and
12 hours (following the last peak in Bmal1 expression) by approximately 2-4 hours,
whereas an advance is seen when treated with MMS at 18 and 24 hours after the
last peak in Bmal1 expression, by 5-6 hours relative to the wild-type and Aag-/-
mock-treated pMEFs (Figure 5.5c). Thus, MMS exposure shifts the rhythm of
Bmal1 transcription, and these phase shift have different directions and magnitude
depending on the time of treatment.
Due to the lower number of replicated per time point, the statistical power
of the curves is lower than we would want. Data shown in figures 5.5b and 5.5c
represent underpowered data with n of 1 biological replicates, except 12 and 18
hours treatment time-point for the wild-type pMEFs is showed with n of 2. Whilst
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these data are underpowered in terms biological replicates, they are indeed based
on several technical replicates, and similar responses are seen in both WT and
Aag-/- cells, which in effect are also biological replicates dues to a lack in genotype
differences. Encouraged by this finding, we propose a further experiment to inspect
the effect of MMS on the circadian clock, also including different cell types and
other circadian distinct genes such as hepatocyte and Per respectively.
5.6 Discussion
Our results indicated an effect of both alkylation-exposure and Aag deficiency on the
expression of genes closely associated with the circadian clock homeostasis. At the
beginning, the effect of Aag absence seemed to differ from one gene to another, and
to be seen more or less during the day-time. For instance, the expression of Nr1d1
and Nr1d2 genes in liver during the day-time was slightly repressed or induced to
some extent (p=0.03) respectively in the Aag-/- cohort compared to the wild-type
cohort (Figure 5.1 and 5.2). These differences in effect was also seen upon alkyla-
tion exposure as the gene expression of Nr1d2 was induced by 2-fold in the liver
within the night-time cohort, while Nr1d1 expression was inhibited but within the
day-time cohort (p=0.032). Nr1d1 and Nr1d2 target and down-regulate the Bmal1
transcription. Hence, changes perceived in the Nr1d1 and Nr1d2 gene expression
upon alkylation exposure indicates a repression of Bmal1 transcription during the
night when it is supposed to be induced, and stimulation of its transcription during
the day when it is supposed to be repressed (Filipski et al., 2005). This is due to
Nr1d2 induction upon alkylation-insult during the night, which in turn may reduce
Bmal1 transcription, and hence theoretically affect the peripheral clock homeosta-
sis within the liver. On the other hand, repression of Nr1d1 expression during the
day upon alkylation-treatment may in turn lead to less inhibition of Bmal1 tran-
scription during the day and hence affect the peripheral clock homeostasis within
the liver (Mang et al., 2016, Takahashi, 2016, Everett and Lazar, 2014, Takahashi
et al., 2008, Filipski et al., 2005).
The effect of alkylation exposure on the expression of genes closely associated
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with the circadian clock is apparently tissue-specific effect as the status of these
genes apparently affected less in the eye by alkylation-exposure as well as the defi-
ciency of Aag. None of the genes examined showed major fold-changes in expression
even though a significant effect of MMS-treatment and Aag was found statistically
in the eye. Also, Nr1d1 expression in the eye was not affected by the circadian time
(clock) as much as it was in the liver. In contrast, previous study showed that the
expression level of Nr1d1 within the eye was doubled at ZT 08:00 in adult mice
retina compared to fluctuation at one level throughout the whole day (Mollema
et al., 2011) , while another study observed a rhythmic pattern of Nr1d1 gene
expression within the eye along with an induction occurring in the day-period in
mice eye as well (Storch et al., 2007). This contrast in Nr1d1 expression in the
eye (Figure 5.2) with what in the literature might be due to some unseen differ-
ences in the method during the harvesting and collection of the eye process such
as eye exposed to light after complete culling of the animal and prior to removal
of the eye or unseen issues. However, this does not affect that alkylation exposure
apparently has a minor effect on the circadian relevant genes expression within the
eye (p≤0.03). Because normalising the circadian regulatory genes expression to the
gene expression of time-matched specific untreated wild-type mouse eye did not re-
veal major differences in gene expression between the treatment groups under the
same treatment time conditions even though significant statistical differences were
observed but the magnitude of the changes in the expression are minor within the
eye.
Modification observed in the expression of the Nr1d1 and Nr1d2 genes under the
influence of Aag absence and alkylation-insult within the liver suggested a poten-
tial effect on the peripheral clock homeostasis within the liver. This tissue-specific
effect on the cellular clock is presumed to be via Bmal1 transcription modulation
as a target of Nr1d1 and Nr1d2. In order to examine that possibility, we employed
an in vitro system based on real time monitoring and recording of the biolumines-
cence of Bmal1 using wild-type and Aag-/- Bmal1 -dLuc pMEFs along with applying
MMS-treatment at different circadian phases. This was followed by a mathematical
approach to determine the ability of alkylation to phase shift the rhythm of Bmal1
CHAPTER 5. ALKYLATION EXPOSURE AND THE CIRCADIAN CLOCK 144
transcription and if this effect is mediated by Aag.
The clear and strong circadian phase-shifts in response to MMS treatment are
similar in wild-type and Aag-/- pMEFs, indicating that the cellular clock is shifted
by MMS exposure without the involvement of Aag. It is interesting to observe that
the phase shifting ability of MMS changes in a circadian time dependent manner, as
a delay phase shift in the circadian rhythm of Bmal1 transcription was observed in
response to treatment with MMS at 6 and 12 hours post-Bmal1 peak, whereas an
advance phase shift in the clock was perceived in response to treatment with MMS
24 hours post-Bmal1-peak. Such an effect of MMS on the phase of the cellular
circadian clock was previously seen in Neurospora crassa, in which the rhythm in
conidiation was phase-advanced in a circadian time dependent manner, which was
mediated through altered the phosphorylation of the Neurospora clock protein Fre-
quency, by checkpoint kinase 2 (orthologues of Neurospora Period4) upon exposure
to MMS. (Pregueiro et al., 2006). Overall, exposure to alkylating agents such as
MMS appears to reset the rhythm of Bmal1 transcription, a core gene involved in
the generation of cellular circadian oscillations, and as such distinct circadian phase
marker, and hence influence the homeostasis of the cellular circadian oscillator in
a circadian time dependent manner. However, because we only present proof-of-
principle data here, no statistical analysis could be undertaken. Encouraged by
this finding, that is indeed based on several technical replicates, and 2 biological
replicates (albeit with a different genetic background), we propose to undertake
additional experiments to confirm, and clarify the effect of MMS treatment on the
phase of the circadian clock. We would also propose to use several different cell
types, including retinal cells and hepatocytes, as well as measure other key genes
that are part of the cellular circadian oscillator, such as Cry-1 and 2, and Per-1
and 2.
We also inspected the potential effect of circadian timing (time of treatment)
on the gene expression response in wild-type and Aag-/- mice liver and eye upon
alkylation exposure via establishing the gene expression profile of Socs3 with tak-
ing into account the circadian phases effect. The established profile of Socs3 gene
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expression shows a clear induction of Socs3 upon treatment in both genotypes and
tissues including liver and eye at all times. Also, the established profile does not
show a clear effect of Aag on Socs3 expression level within the eye and liver upon
alkylation exposure, yet it may indicate that alkylation-induced Socs3 expression
level mediated via Aag is a day-time dependent event. This is observed in day-
phase MMS-exposure as a lower induction seen in Aag-/- eye versus wild-type eye
(p=0.038), whereas a trend toward higher induction perceived in Aag-/- liver ver-
sus wild-type liver (p=0.06). Therefore, the Aag genotype appears to alter Socs3
expression in day-phase MMS-exposure, but the directionality of the change is ap-
parently tissue-specific. Additionally, this potent response in Socs3 expression level
seen in the wild-type mice eye compared to the Aag-/- mice eye appears to result
from the retinal-degeneration induced by the alkylating agents exposure (p=0.01),
as the Aag-/- mice retina has been proven to be resistant to it as previously shown
(Chapter 3) and published (Calvo et al., 2013, Meira et al., 2009). Overall, we
propose that Aag could play a role in modulating Socs3 expression in response to
alkylation but more experiments would be needed to establish whether this tissue
specific response is biologically meaningful, also including establishing the profile of
Socs3 in other tissues as well as the gene expression profile of other cellular stress
markers such as the transcription factor C/EBP homologous protein (Chop) with
taking into account the circadian time effect while establishing the profile.
To summarise, in vivo studies indicated an effect of alkylating agents as well
as knocking out Aag on the expression of the circadian associated genes such as
Nr1d1 and the effect was in a circadian time dependent-manner. The effect of
alkylation was also observed in one of the circadian core genes namely Bmal1 but
in vitro and the effect was in a circadian time dependent-manner but not an Aag-
dependent. Also, the cellular response to alkylation-exposure in vivo within the liver
and eye tissues seemed to be manipulated by time of treatment and Aag. Further
investigation is strongly recommended especially into the effect of alkylation on the
cellular clock homeostasis in vitro and in vivo.
Chapter 6
Discussion and Conclusion
6.1 Final Discussion
Photoreceptor cells have been shown to be susceptible to alkylation-induced cyto-
toxicity in an alkyladenine DNA glycosylase (Aag)-dependent manner (Calvo et al.,
2013, Meira et al., 2009). This Aag-dependent toxicity seems to be cell type-specific
as the retinal outer nuclear layer appeared to be the only affected cell layer among
other cell layers in the retina. The susceptibility of the retina outer nuclear cell
layer to the alkylation damage might be due to the photoreceptor cells function,
that involves exposure to light besides other photoreceptor-specific characteristics
such as high oxygen consumption, which increase their vulnerability to oxidative
stress, and hence cell death (Organisciak and Vaughan, 2010, Yang et al., 2003, Hao
et al., 2002, Organisciak et al., 1999). Therefore, we aimed to study the interaction
of light and alkylation in the phenotype of alkylation induced retinal degeneration
using mice expressing different levels of the glycosylase Aag; namely wild-type, and
Aag-/- mice.
Our results showed clear photoreceptor degeneration upon alkylation exposure
in an Aag dependent manner. This was shown by gross histology as well as quan-
tification method including the retinal width ratio of the outer nuclear layer to the
inner nuclear layer (ONL/INL), and analysis of photoreceptor-specific gene expres-
sion, and this is in line with what previously published (Calvo et al., 2013, Meira
et al., 2009). The retinal degeneration that was perceived in the wild-type retinas
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upon alkylation exposure seems to be exacerbated if accompanied by light exposure
(250-350 lux) when compared to dark-treated cohort. This seemed to indicate a
marginal better survival in photoreceptor cell upon alkylation exposure if alkyla-
tion treatment was carried out in the dark even though a significant interaction
between light and alkylation was not statistically observed in the retinal ratio of
ONL/INL width.
This marginally better survival in dark-treated photoreceptor cells was also ob-
served in the rod and cone photoreceptors specific-gene expression. For instance,
the expression of rod-specific gene including Rho (encoding the rod-specific opsin
rhodopsin) and Pde6b (encoding rods Pde6β subunit) (Larhammar et al., 2009)
was slightly higher in MMS-treated mice within dark cohort if compared to light
cohort, which could indicate a better survival of photoreceptor cells in the dark-
treated cohort. This marginal protection against retinal-degeneration induced by
alkylation exposure in dark-treated cohort seems to be rational considering that
retinal-degeneration can be induced by light with visible intensity (Hao et al., 2002,
Specht et al., 2000, 1999, Rapp et al., 1990).
Afterwards, we investigated if alkylation induced cell death in both types of
photoreceptor cell (rods and cones) in the outer nuclear layer, or it is a rod or cone-
specific toxicity. Quantification of photoreceptor-specific gene expression showed
that both type of the classical photoreceptors within the outer nuclear layer, namely
rods and cones, are sensitive to alkylation damage, and the sensitivity is Aag-
dependent. This is based on a striking reduction in the expression of rods-specific
gene expression including Rho and Pde6b and cone-specific gene expression includ-
ing Opn1sw (encoding cone opsin shortwave) and Pde6h (encoding cone phospho-
diesterase 6γ) in MMS-treated wild-type mice if compared to all other treatment
cohorts within wild-type and Aag-/- mice. Overall, within the retinal outer nuclear
layer alkylating agents induced cell degeneration in both types of photoreceptors
(rods and cones) in Aag-dependent manner, and this degeneration is enhanced in
the presence of light. As both type of light-sensing cells within the outer nuclear
layer were alkylation sensitive, the question then arose about the sensitivity of other
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retinal cells possessing the same ability (light sensing and processing) within the eye
but not in the outer nuclear layer particularly the intrinsically photosensitive retinal
ganglion cells (ipRGCs) within the retinal ganglion cell layer (Provencio et al., 2000).
We therefore assessed whether Aag status influence ipRGCs survival and func-
tion upon alkylation-insult. Immunofluorescence staining of ipRGCs and assessment
of ipRGCs-specific gene expression indicates a resistance of these cells to the alkyla-
tion damage. An equivalent number of melanopsin- expressing RGCs (∼2 cells per
eye section) were found in MMS-treated and untreated wild-type and Aag-/- mice
retina 72-hour after treatment regardless of light exposure conditions. Also, no re-
duction were observed in the mRNA gene expression of melanopsin (Opn4 ) in both
light and dark-treated cohort upon alkylation exposure, as well as the mRNA ex-
pression of the neurotransmitter pituitary adenylate cyclase-activating polypeptide
(PACAP, co-expressed with melanopsin; gene name is Adcyap1 ) (Hannibal et al.,
2002) but within the dark-cohort only. The ipRGCs survival upon MMS-exposure is
in line with the recent published report by Jain et al. (2016) where ipRGCs viability
and melanopsin mRNA expression remained stable in wild-type mice 10-days after
N -methyl-N -nitrosourea (MNU)-treatment. However, our results are partially in
contrast to Wan et al. (2006) observation where melanopsin mRNA expression was
reduced upon MNU-insult in rats, while ipRGCs survival as assessed by PACAP
mRNA gene expression levels was found unaffected (at ZT 14:00) at 0.5, 1, 5, 7,
13 and 28-days after MNU-treatment. Taken together, our findings along with the
studies just mentioned (Jain et al., 2016, Wan et al., 2006) indicates that the im-
pact of photoreceptor degeneration on melanopsin expression is controversial and
species-specific.
During the investigation of ipRGCs survival via quantification of the PACAP
mRNA expression (Adcyap1 ), different patterns of expression were observed among
treatment groups particularly in the wild-type mice eye within the light cohorts.
This seems to be expected for a light-inducible neurotransmitter (Wan et al., 2006,
Hannibal et al., 2002, 1997) as alkylation-induced retinal degeneration in the outer
nuclear cell layer (particularly in MMS-treated wild-type mice eye) led to less light
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being sensed, and so less induction of PACAP mRNA expression (Sakamoto et al.,
2005) This effect of alkylation on Adcyap1 gene expression in the wild-type animal
within the light cohort was minimized in the Aag-/- cohort, probably due to the per-
sistence of Aag-/- photoreceptor cells (Calvo et al. 2013, Meira et al. 2009, this work).
Additionally, a baseline difference in the expression of Adcyap1 within the light
cohort was found. Adcyap1 gene expression was induced more prominently in the
untreated wild-type mice (∼3.5-fold) if compared to untreated Aag-/- mice (∼2.5-
fold). PACAP is responsible for mediating the transmission of photic signal to the
suprachiasmatic nucleus (SCN) via the retinohypothalamic tract, and hence en-
train the SCN (Hannibal et al., 2001, 1997). Therefore, this basal lower induction
of PACAP mRNA expression in the Aag-/- animal indicates a potential reduction in
the establishment of the retinohypothalamic tract within the Aag-/-. This in turn
could affect various physiological processes regulated by the SCN such as inhibiting
the physiological suppression of mice behavioural activity (indirect output of the
circadian clock) in the presence of light. This was observed as the Aag-/- untreated
mice with a basal lower induction of Adcyap1 gene expression tend to be more active
over the time compared to the untreated-wild-type mice where a higher induction
level of Adcyap1 gene expression perceived within the light cohort.
The link between Adcyap1 gene expression and the suppression of mice be-
havioural activity during light exposure was also clearly observed in wild-type mice
exposed to MMS. Alkylation treatment induced photoreceptor cell degeneration in
wild-type mice, and that led to less light being sensed and therefore lower induc-
tion of PACAP expression. This in turn reduces the transmission of photic cue to
the SCN, and potentially repress the physiological suppression of mice behavioural
activity mediated by the light exposure. This was seen in MMS-treated wild-type
mice activity when compared to the untreated wild-type mice activity under con-
stant light exposure, but not in the Aag mutant animal where photoreceptor cell
persistence to alkylation damage is presumed (Calvo et al., 2013, Meira et al., 2009).
Therefore, Aag-mediated alkylation-induced retinal degeneration seems to impact
the photoreceptor function as well; however, further investigation is strongly rec-
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ommended in the future using different approach to evaluate the photoreceptor cell
function such as electroretinogram in both wild-type and Aag-/- mice basally and
upon alkylation exposure. We also observed a small significant basal reduction in
the mRNA expression of several key players in the photoreceptor function of Aag-/-
mice eye. The gene expression of Rho within rods and Opn1sw within cones was
slightly lower in the untreated Aag-/- eyes if compared to the untreated wild-mice
eye under the same light condition. This suggested that knocking out Aag impact
the transcription of some key player in the light sensing process within the eye as
shown by Rho and Opn1sw expression, as well as other key transcripts that seemed
to play an important role in cell response to alkylation-exposure.
By looking into previous work addressing the basal transcriptional differences
observed in the Aag-/- mice eye, we found that Meira and collaborators (unpub-
lished) had previously analysed the mammalian response to alkylation, and the role
played by DNA damage and repair in the process via global transcriptomics analysis
but in liver tissue instead. Clustering and gene ontology enrichment analysis done
by Meira et al. (2009) showed that the number of unique transcripts modulated
6-hour after MMS-treatment in the wild-type mouse liver was significantly higher if
compared to transcripts modulated in MMS-treated Aag-/- mouse liver. The set of
modulated key genes upon alkylation exposure (meaning changed upon treatment
in the wild type but not in the Aag-/-) included transcripts associated with endo-
plasmic reticulum (ER) stress/unfolded protein response (UPR), the suppressor of
cytokine signalling (Socs), and the circadian clock. Therefore, Aag activity seems to
be required for the activation of key transcripts that plays a role in the mammalian
liver response including cellular stress, and cell death process and survival upon
alkylation exposure (Meira et al., unpublished).
So, we aimed to validate the transcriptomic analysis data, by establishing the ex-
pression profile of several key genes associated with different cellular mechanisms,
upon alkylation exposure at different circadian time (day-time, and night-time)
within mouse liver and eye (where the toxicity is Aag-dependent) using RT-qPCR
approach. Hence, the expression profile of genes associated with ER-stress/UPR in-
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cluding the activating transcription factor-4 (ATF4 ), C/EBP homologous protein
(Chop), DNA J-domain superfamily C member 12 (Dnajc12 ), and the homocys-
teine responsive ER-resident ubiquitin-like domain member 1 protein (Herpud1 ),
as well as Socs particularly Socs3, 6-hour after alkylation-treatment in wild-type
and Aag-/- mice tissues during either day-time or night-time was established. The
established profile also included genes closely associated with the circadian clock
namely the nuclear receptor subfamily 1 group D members 1 and 2 (Nr1d1, and
Nr1d2 ), and D-element binding protein (Dbp).
The mRNA expression of several key players associated with the ER stress/UPR
and Socs3 within mouse liver apparently showed a trend toward upregulation of
these two pathways 6-hour after alkylation-exposure particularly in the wild-type
cohort compared to the Aag-/- cohort. Therefore, we successfully validated and
confirmed the transcriptomic results of wild-type and Aag-/- mice liver response to
alkylation exposure previously done by Meira and collaborators (unpublished), us-
ing RT-qPCR method. Also, the established gene expression profile indicated more
prominent upregulation of the ER stress/UPR genes upon alkylation exposure in
liver tissue compared to the eye suggesting a tissue-specific effect, while upregula-
tion of Socs3 was perceived in both tissues.
Our results indicated that the induction of ER-stress response within the liver
upon alkylation exposure seems to be partially Aag/time dependent, even though a
statistically significant interaction was not observed. The established gene expres-
sion profile indicated an induction of the transcription of two transcriptional factors
associated with the ER-stress/UPR namely ATF4 and Chop upon alkylation ex-
posure. This induction was even higher within the liver particularly the expression
level of Chop within the wild-type cohort compared to Aag-/- cohort. ATF4 plays
a role in cell survival and death process. In one hand, the translated ATF4 enters
the nucleus and activate the transcription of ER stress response genes that are re-
sponsible for the antioxidant response, and amino acid biosynthesis and transport
to promote cell survival (Wang and Kaufman, 2014, Hetz, 2012) , while on the other
hand, it activates transcription of Chop which plays a role in ER stress-mediated
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apoptosis (Palam et al., 2011, Song et al., 2008, Marciniak et al., 2004).
Therefore, exposure to alkylation can trigger programmed cell death via insult-
ing the ER homeostasis leading to UPR activation, and hence apoptosis via activa-
tion of the transcription factor Chop. This appeared to be Aag-dependent as the
level of Chop expression was lower in Aag-/- mice, where resistance to alkylation-
induced cell degeneration and less accumulation of BER toxic-intermediates are
expected (Calvo et al., 2013, Meira et al., 2009), compared to the wild-type cohort
upon alkylation exposure particularly in liver within the night-time cohort. Hence,
a lower ER stress and UPR activation seems to contribute to the resistance of Aag-/-
mice to alkylation-induced cell death. However, further investigation is required to
confirm this statement.
An additional potential output of the ER stress/UPR that promotes cell survival
is increasing the capacity of protein folding and transport as well as inducing pro-
tein degradation pathways namely ER-associated degradation (ERAD). One of the
proteins associated with increasing the ER-capacity of protein folding and transport
is the co-chaperone Dnajc12. Dnajc12 can form complexes with unfolded proteins
to avoid aggregation, and thereby assess the protein folding process that in turn
increases the ER-capacity of protein folding (Choi et al., 2014, Fan et al., 2003).
In our study, a trend toward inducing Dnajc12 expression in the Aag-/- cohort liv-
ers was observed basally, as well as upon the alkylation exposure particularly in
the night-time treatment cohort. This suggested that the capacity of ER stress in
Aag-/- mice liver seems to be basally higher compared to the wild-type liver, which
apparently dampen the induction of ER stress genes upon alkylation exposure in
the Aag-/- cohort compared the magnitude of induction within wild-type cohort.
We also established the gene expression profile of Herpud1, which is associated
with the ERAD pathway. The induction level of Herpud1 expression in mice liver
upon alkylation exposure seemed to be modulated by treatment-time (circadian
time) conditions as well as the presence of Aag. The effect of MMS insult on Her-
pud1 expression was previously reported as an induction of Herpud1 expression
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in human diploid skin fibroblasts and HeLa cells were observed 4-hour after MMS
treatment (van Laar et al., 2000). Our study also indicated an induction of Her-
pud1 6-hours post-alkylation treatment in mice liver particularly in night-treated
cohort. Although no statistically significant interaction between treatment and
genotype was observed, virtually Herpud1 induction appeared to be dampened in
the MMS-treated Aag-/- liver if compared to the magnitude of induction perceived
in MMS-treated wild-type mice liver within the night-treated cohort. This could
indicate that the induction of Herpud1, and potentially the ERAD pathway is up-
regulated upon alkylation exposure, but apparently, this upregulation is mediated
by Aag and the time of treatment (circadian time). Further investigation is strongly
recommended and involve analyzing the gene expression of other key players in the
ERAD pathway with taking into account the treatment-time effect.
In addition to ER-stress/UPR, the gene expression profile for one of the sup-
pressor of cytokine signalling genes, namely Socs3, was inspected as well. It was
significantly induced 6-hour after MMS-treatment in wild-type and Aag-/- mice liver
and eye, but the magnitude of induction seemed to be influenced by both the time
of exposure and Aag status. In the eye, a higher induction of Socs3 expression was
perceived in wild-type mice compared to Aag-/- mice upon alkylation exposure par-
ticularly during the day-time. We think this could be because the alkylation-induced
retinal damage, particularly within the wild-type mice, could trigger the inflamma-
tory response via different signalling pathway such as the Janus kinase pathway
(JAK) and the signal transducer and activators of transcription 3 (STAT3) path-
way. This will lead in turn to activation and induction of Socs3 (highly induced in
MMS-treated wild-type eye during the day-time), which correlate with the sever-
ity of inflammation (Li et al., 2014, Chaves de Souza et al., 2013), and negatively
regulates some signalling pathways associated with the inflammatory response es-
pecially JAK/STAT3 pathways (reviewed in Rottenberg and Carow 2014, Ozawa
et al. 2008).
Additionally, Aag appeared to mediate alkylation induced Socs3 expression
within the liver as well, especially within the day-time treatment cohort, but the
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directionality of the change is apparently tissue-specific if compared to the eye. A
trend toward higher induction was observed 6-hour after MMS treatment in the
Aag-/- liver versus the wild-type liver within the day-time treated cohort, while a
lower induction was observed in the Aag-/- eye versus the wild-type one. Although a
statistically significant genotype effect was not observed, knocking out Aag seemed
to induce the expression of Socs3 basally in the untreated Aag-/- liver when com-
pared to time-matched untreated wild-type mice liver regardless of the treatment
time conditions.
This basal induction of Socs3 within the Aag-/- liver might be associated with
cellular stress as basal induction of ER-stress/UPR was observed as well particularly
in Chop where nearly a similar pattern of gene expression induction was observed.
This association of cellular stress and chronic inflammation with the persistence
induction of Socs3 was previously noted by Liu et al. (2008) and Amadi-Obi et al.
(2007). Overall, we conclude that Aag could play a role in modulating Socs3 expres-
sion in response to alkylation but more experiments would be needed to establish
whether this tissue specific response is biologically meaningful, also including estab-
lishing the profile of Socs3 in other tissues as well as the gene expression profile of
other cellular stress markers.
We then investigated the potential link between Aag and the modulated tran-
scripts that closely associated with the circadian clock as previously indicated by
Meira et al. (unpublished), particularly upon alkylation exposure. We observed an
effect of both alkylation-exposure and knocking out Aag on the expression of genes
associated with the circadian clock. Within the eye, none of the genes examined in-
cluding Nr1d1, Nr1d2, and Dbp depicted a major fold- change in expression basally
and 6-hour after MMS-treatment in wild-type and Aag-/- despite the observation of
a statistical significant effect of MMS-treatment and Aag. However, within the liver,
knocking out Aag seemed to repress or induce expression of genes associated with
the circadian clock namely Nr1d1 and Nr1d2 respectively, and this appeared to be
a day-time dependent effect. The impact of Aag deficiency on Nr1d1 expression
within the liver was clearly seen when the effect of treatment-time (the circadian
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time) was accounted during the analysis, as the induction of Nr1d1 was generally
dampened in the Aag-/- liver during the day-time if compared to the induction per-
ceived in time-matched wild-type mice liver. Additionally, the induction in Nr1d1
perceived in both genotypes liver during the day-time was also dampened 6-hour
after alkylation exposure, indicating that the mammalian peripheral clock within
the liver is probably affected by alkylation exposure.
Nr1d1 and Nr1d2 target and negatively-regulate brain and muscle ARNT-Like
1 (Bmal1 ) transcription, a core gene involved in the generation of cellular circadian
oscillations. Thus, modifications observed in the expression of Nr1d1 basally and
upon alkylation exposure could indicate a stimulation of Bmal-1 transcription dur-
ing the day when it is supposed to be repressed (Filipski et al., 2005), and hence
affect the homeostasis of the cellular circadian oscillations within the liver (Mang
et al., 2016, Takahashi, 2016, Everett and Lazar, 2014, Bugge et al., 2012, Filipski
et al., 2005). To address this effect, the potential effect of Aag-deficiency and alky-
lation exposure on the cellular circadian oscillations more closely via a real time
monitoring of Bmal1 transcription (a distinct circadian phase marker) was accom-
plished, but in vitro.
In vitro system based on real time monitoring and recording of the biolumines-
cence of Bmal1 using wild-type and Aag-/- Bmal1 -dLuc pMEFs was developed to
determine the effect of administrating MMS at 6, 12, 18 and 24- hours post Bmal1-
peak on the circadian rhythm of Bmal1 -transcription. Our result indicate that the
cellular clock apparently shifted by MMS exposure without the involvement of Aag,
but in a circadian time dependent manner. This was indicated as clear and potent
circadian phase-shifts in response to MMS-treatment were observed to be paralleled
in wild-type and Aag-/- pMEFs.
Also, these circadian phase-shifts in Bmal1 transcription in response to MMS-
treatment were either a delay phase shift if MMS-administrated at 6 and 12 hours
post-Bmal1 peak, or an advance phase shift when MMS-administrated 24 hours
post-Bmal1 peak. This effect of MMS on the phase of the cellular circadian os-
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cillations was previously seen in Neurospora crassa, in which the circadian rhythm
of the Neurospora conidiation was phase-advanced (Pregueiro et al., 2006). This
phase-shift in the Neurospora circadian rhythm upon MMS exposure was mediated
via modified the phosphorylation of the Neurospora clock protein Frequency, by
checkpoint kinase 2 (orthologues of Neurospora Period4) upon exposure to MMS in
a circadian time dependent-manner, as this effect of MMS was not perceived when
the exposure associated with the peak of Frequency phosphorylation (Pregueiro
et al., 2006).
Thereby, administration of alkylating agents such as MMS seemed to reset the
rhythm of Bmal1 transcription, and so influence the homeostasis of the cellular
circadian clock in a circadian time dependent manner. Nevertheless, as we only
exhibited proof-of-principle in-vitro data here, no statistical analysis could be run.
Encouraged by this finding,that is indeed based on several technical replicates, and
2 biological replicates, we propose to undertake additional experiments to confirm,
and clarify the effect of MMS treatment on the phase of the circadian clock.
6.2 Conclusion
This study initially investigated the impact of Aag-mediated photoreceptor cell
death and function upon alkylation-insult as well as visible light exposure, and indi-
cated light exacerbation of Aag-mediated photoreceptor degeneration upon alkylation-
insult. The study also confirmed that Aag-mediated alkylation-induced retinal de-
generation had no effect on ipRGCs viability, and melanopsin expression, but it
seemed to partially impair the classical photoreceptor, and ipRGCs function based
on modification observed within the mice behavioural activity, and the gene ex-
pression of several cell-specific marker (Rho, and Adcyap1 ) basally and upon alky-
lation exposure. These modifications were also perceived among genes associated
with other cellular mechanisms such ER-stress/UPR, Socs, and the circadian clock
basally and upon alkylation exposure. Therefore, Aag deletion can rescue specific
cells upon alkylation exposure through reducing formation of BER toxic intermedi-
ates; yet, it is needed as it plays an important role in the transcriptional activation
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of several key genes associated with cell survival as well as cell death process upon
alkylation exposure.
6.3 Future Work
Knowledge derived from this study provided some important directions for future
studies and also some questions in need of further investigation. In order to validate
the role played by Aag in photoreceptor cell function basally and upon alkylation-
insult, a further evaluation of photoreceptor cell function including rods, cones, and
ipRGCs is recommended using different and more direct approach such as elec-
troretinogram. Also, as a lower mRNA expression of PACAP basally and upon
alkylation exposure were observed, analyzing the effect of changes perceived in
PACAP expression on the clock within the SCN using different approach including
immunostaining and mRNA expression of transcription factors/proteins associated
with the SCN function such as c-fos and period (Per 1 and 2 ) is strongly recom-
mended.
Regarding the effect of light and its ability to induce photoreceptor degeneration
probably via the generation of reactive oxygen species, it would be interesting to
investigate the effect of damaging light (light with high intensity) on photoreceptor
cell survival in the Aag-/- animal. This could suggest a therapeutic mechanism to
slow the progression of retinal degenerative disease such as the retinitis pigmentosa.
In addition, we stated that the expression of genes associated with ER-stress/UPR
and Socs upon alkylation exposure is mediated via the base excision repair initiator
Aag, and it is a tissue-specific effect. To justify this statement, establishing the gene
expression of other key players in these two mechanisms, ER-stress/UPR and Socs,
can be done such as the growth arrest and DNA damage-inducible protein- 34 and
Socs1, respectively. Also, establishing the splicing rate of X-box binding protein 1,
a key player in the UPR to ER-stress, in wild-type and Aag-/- mice liver will aid to
assess the link between Aag and the ER-stress/UPR upon alkylation exposure.
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Furthermore, the gene expression profile of ER-stress/UPR associated genes as
well as Socs3 are recommended to be established in other tissues where the alkyla-
tion toxicity is and not Aag-dependent such as thymus, and heart respectively, along
with accounting the circadian time impact. Eventually, inspection of the observed
changes in gene expression in the wild-type and Aag-/- mice liver and eye basally
and upon alkylation-exposure is recommended at the protein level.
Moreover, the relation between Aag and the circadian clock particularly upon
alkylation exposure is in need for further investigation. For example, establishing
the gene expression of the core genes of the circadian clock such as cryptochrome
(Cry 1 and 2 ), and Per 1 and 2, and Bmal1 in both wild-type and Aag-/- mice
liver after alkylation exposure during different circadian time (phase) will aid to
clarify the relation between Aag and the circadian clock. Also, evaluating the ex-
pression of these genes within the SCN itself in both genotypes basally and upon
alkylation exposure and linked to both PACAP expression within the eye as well
as the expression of the circadian associated genes within the liver. This may help
in identifying whether the basal differences seen in the expression of the circadian
associated genes particularly Nr1d1 within the liver are locally mediated by Aag,
or due to unseen changes in the rhythm within the SCN that manipulated by mod-
ifications perceived in PACAP basally and upon alkylation-insult.
Finally, as our in vitro observation represented proof-of-principle data, and no
statistical analysis could be run, we thereby propose to undertake additional ex-
periments to confirm, and clarify the effect of MMS treatment on the phase of the
circadian clock. We would also propose to use several different cell types, including
retinal cells and hepatocytes, as well as measure the transcription of other key genes
that are part of the cellular circadian oscillator, such as Cry 1 and 2, and Per 1
and 2.
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Figure A.1: Effect of sub-lethal dose of MMS on bone marrow of WT mice subjected differ-
ent light regiments. (A) and (C) mock treated mice subjected to different light conditions;
namely light or dark respectively after treatment, shows normal morphology of bone mar-
row, (B) and (D) 75 mg/kg MMS (sub-lethal dose) treated mice subjected to different light
conditions as well after treatment exhibiting similar pattern of morphology compared to
mock treated bone marrow. Absence of bone marrow ablation after MMS treatment prov-
ing of administration of non-toxic dose of alkylating agent. Mock treated by PBS within
the treatment volume rang (5l/.g bw; Magnifications 20X bar; H&E stained.
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Table A.1: Statistical analysis of photoreceptor cells specific=gene expression
Rho Pde6b Op1sw Pde6h Opn4 Adcyap1
<.0001 <.0001 <.0001 <.0001 0.0855 0.0216
0.0424 <.0001 0.0178 0.2198 0.3737 <.0001
<.0001 <.0001 <.0001 <.0001 0.051 <.0001
Phenotype X Light <.0001 0.0163 0.0002 0.0046 0.5801 0.0783
Phenotype X MMS <.0001 <.0001 <.0001 <.0001 0.0021 0.0152
Light X MMS 0.9619 0.0001 0.7024 0.6776 0.2197 <.0001
Phenotype X Light X MMS0.0085 0.0068 0.0955 0.1298 0.4807 0.0027
Aag-/- Aag-/-
Aag-/- Untreated DD Aag-/- MMS DD <.0001 0.0229 0.0051 0.0933 0.1112 0.9591
Aag-/- Untreated DD Aag-/- Untreated LL <.0001 0.0777 0.0003 0.0105 0.4233 <.0001
Aag-/- Untreated DD Aag-/- MMS LL <.0001 0.0458 <.0001 0.0023 0.6318 <.0001
Aag-/- MMS DD Aag-/- Untreated LL 0.2397 0.0002 0.3124 0.3305 0.4143 <.0001
Aag-/- MMS DD Aag-/- MMS LL 0.0455 0.7578 0.011 0.1234 0.257 <.0001
Aag-/- Untreated LL Aag-/- MMS LL 0.0025 0.0005 0.104 0.5565 0.7457 0.0348
WT WT
WT Untreated DD WT MMS DD <.0001 <.0001 <.0001 <.0001 0.0217 0.5313
WT Untreated DD WT Untreated LL 0.0093 <.0001 0.0639 0.0684 0.6476 <.0001
WT Untreated DD WT MMS LL <.0001 <.0001 <.0001 <.0001 0.0018 0.0001
WT MMS DD WT Untreated LL <.0001 <.0001 <.0001 <.0001 0.0597 <.0001
WT MMS DD WT MMS LL 0.9359 0.9658 0.8551 0.9299 0.3249 0.0007
WT Untreated LL WT MMS LL <.0001 <.0001 <.0001 <.0001 0.0059 <.0001
WT Aag-/-
WT Untreated DD Aag-/- Untreated DD 0.0029 0.0279 0.0025 0.2325 0.1658 0.9653
WT Untreated DD Aag-/- MMS DD 0.0084 0.9317 0.7789 0.6117 0.8274 0.9938
WT Untreated DD Aag-/- Untreated LL 0.117 0.0002 0.4627 0.1432 0.548 <.0001
WT Untreated DD Aag-/- MMS LL <.0001 0.8237 0.0215 0.0441 0.3571 <.0001
WT MMS DD Aag-/- Untreated DD <.0001 <.0001 <.0001 <.0001 0.327 0.56
WT MMS DD Aag-/- MMS DD <.0001 <.0001 <.0001 <.0001 0.0129 0.5263
WT MMS DD Aag-/- Untreated LL <.0001 <.0001 <.0001 <.0001 0.0803 <.0001
WT MMS DD Aag-/- MMS LL <.0001 <.0001 <.0001 <.0001 0.1488 <.0001
WT Untreated LL Aag-/- Untreated DD 0.6524 <.0001 0.1804 0.5084 0.3458 <.0001
WT Untreated LL Aag-/- MMS DD <.0001 <.0001 0.1116 0.0225 0.5006 <.0001
WT Untreated LL Aag-/- Untreated LL 0.0001 0.0038 0.012 0.0019 0.885 <.0001
WT Untreated LL Aag-/- MMS LL <.0001 <.0001 0.0001 0.0004 0.6395 <.0001
WT MMS LL Aag-/- Untreated DD <.0001 <.0001 <.0001 <.0001 0.055 0.0001
WT MMS LL Aag-/- MMS DD <.0001 <.0001 <.0001 <.0001 0.001 0.0001
WT MMS LL Aag-/- Untreated LL <.0001 <.0001 <.0001 <.0001 0.0085 0.0052
WT MMS LL Aag-/- MMS LL <.0001 <.0001 <.0001 <.0001 0.0186 0.4343
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Phenotype (Aag gene)
Light Exposure
MMS Treatment
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Table A.2: Statistical analysis of behavioural activities
Light Cohort Dark Cohort
0.002 0.0003
<.0001 0.0597
<.0001 <.0001
Genotype * MMS 0.0657 0.0952
Genotype * Time <.0001 <.0001
MMS*Time 0.0439 0.1108
MMS*Genotype*Time 0.6587 0.2662
Fixed Effect on Mice Activity
P Value
Genotype
MMS-Treatment
Time
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ra
ct
io
n
Bibliography
Albrecht, U. (2002), ‘Invited review: regulation of mammalian circadian clock
genes’, Journal of Applied Physiology 92(3), 1348–1355.
Amadi-Obi, A., Yu, C.-R., Liu, X., Mahdi, R. M., Clarke, G. L., Nussenblatt,
R. B., Gery, I., Lee, Y. S. and Egwuagu, C. E. (2007), ‘Th17 cells contribute to
uveitis and scleritis and are expanded by il-2 and inhibited by il-27/stat1’, Nature
medicine 13(6), 711–718.
Andrabi, S. A., Dawson, T. M. and Dawson, V. L. (2008), ‘Mitochondrial and
nuclear cross talk in cell death’, Annals of the New York Academy of Sciences
1147(1), 233–241.
Andrzejewski, P., Kasprzyk-Hordern, B. and Nawrocki, J. (2005), ‘The hazard of
n-nitrosodimethylamine (ndma) formation during water disinfection with strong
oxidants’, Desalination 176(1-3), 37–45.
Aschoff, J. (1965), ‘Circadian rhythms in man’, Science 148(3676), 1427–1432.
Atalla, L. R., Sevanian, A. and Rao, N. A. (1988), ‘Immunohistochemical localiza-
tion of glutathione peroxidase in ocular tissue’, Current Eye Research 7(10), 1023–
1027.
Bailey, S. M., Udoh, U. S. and Young, M. E. (2014), ‘Circadian regulation of
metabolism’, Journal of Endocrinology 222(2), R75–R96.
Barbin, A., Wang, R., O’Connor, P. J. and Elder, R. H. (2003), ‘Increased forma-
tion and persistence of 1,n(6)-ethenoadenine in dna is not associated with higher
susceptibility to carcinogenesis in alkylpurine-dna-n-glycosylase knockout mice
treated with vinyl carbamate’, Cancer Research 63(22), 7699–7703.
163
BIBLIOGRAPHY 164
Barrows, L. R. and Magee, P. N. (1982), ‘Nonenzymatic methylation of dna by
s-adenosylmethionine in vitro’, Carcinogenesis 3(3), 349–351.
URL: http://carcin.oxfordjournals.org/content/3/3/349.abstract
Bartsch, H. and Nair, J. (2002), ‘Potential role of lipid peroxidation derived dna
damage in human colon carcinogenesis: studies on exocyclic base adducts as stable
oxidative stress markers’, Cancer Detection And Prevention 26(4), 308–312.
Bartsch, H., Nair, J. and Owen, R. W. (2002), ‘Exocyclic dna adducts as oxidative
stress markers in colon carcinogenesis: potential role of lipid peroxidation, dietary
fat and antioxidants’, Biological Chemistry 383(6), 915–921.
Basu, A. K., Wood, M. L., Niedernhofer, L. J., Ramos, L. A. and Essigmann,
J. M. (1993), ‘Mutagenic and genotoxic effects of three vinyl chloride-induced
dna lesions: 1,n6-ethenoadenine, 3,n4-ethenocytosine, and 4-amino-5-(imidazol-
2-yl)imidazole’, Biochemistry 32(47), 12793–12801.
URL: http://dx.doi.org/10.1021/bi00210a031
Beard, W. A., Osheroff, W. P., Prasad, R., Sawaya, M. R., Jaju, M., Wood, T. G.,
Kraut, J., Kunkel, T. A. and Wilson, S. H. (1996), ‘Enzyme-dna interactions
required for efficient nucleotide incorporation and discrimination in human dna
polymerase beta’, The Journal Of Biological Chemistry 271(21), 12141–12144.
Bee, L., Marini, S., Pontarin, G., Ferraro, P., Costa, R., Albrecht, U. and Celotti,
L. (2015), ‘Nucleotide excision repair efficiency in quiescent human fibroblasts is
modulated by circadian clock’, Nucleic acids research p. gkv081.
Berson, D. M., Dunn, F. A. and Takao, M. (2002), ‘Phototransduction by retinal
ganglion cells that set the circadian clock’, Science 295(5557), 1070–1073.
URL: http://www.sciencemag.org/content/295/5557/1070.abstract
Biernbaum, M. S. and Bownds, M. D. (1985), ‘Light-induced changes in gtp and atp
in frog rod photoreceptors. comparison with recovery of dark current and light
sensitivity during dark adaptation’, The Journal of general physiology 85(1), 107–
121.
BIBLIOGRAPHY 165
Birch, D. G., Anderson, J. L. and Fish, G. E. (1999), ‘Yearly rates of rod and cone
functional loss in retinitis pigmentosa and cone-rod dystrophy’, Ophthalmology
106(2), 258–268.
Bolt, H. M. and Gansewendt, B. (1993), ‘Mechanisms of carcinogenicity of methyl
halides’, Critical Reviews in Toxicology 23(3), 237–253.
URL: http://informahealthcare.com/doi/abs/10.3109/10408449309105011
Breedlove, S. M., Rosenzweig, M. R. and Watson, N. V. (2007), Biological psychol-
ogy: an introduction to behavioral, cognitive, and clinical neuroscience, 5th edn,
Mass. : Sinauer Associates, Sunderland.
Bugge, A., Feng, D., Everett, L. J., Briggs, E. R., Mullican, S. E., Wang, F., Jager,
J. and Lazar, M. A. (2012), ‘Rev-erbα and rev-erbβ coordinately protect the
circadian clock and normal metabolic function’, Genes & development 26(7), 657–
667.
Burch, J. B., Augustine, A. D., Frieden, L. A., Hadley, E., Howcroft, T. K., John-
son, R., Khalsa, P. S., Kohanski, R. A., Li, X. L., Macchiarini, F. et al. (2014),
‘Advances in geroscience: impact on healthspan and chronic disease’, The Jour-
nals of Gerontology Series A: Biological Sciences and Medical Sciences 69(Suppl
1), S1–S3.
Calvo, J. A., Meira, L. B., Lee, C.-Y. I., Moroski-Erkul, C. A., Abolhassani, N.,
Taghizadeh, K., Eichinger, L. W., Muthupalani, S., Nordstrand, L. M., Klung-
land, A. et al. (2012), ‘Dna repair is indispensable for survival after acute inflam-
mation’, The Journal of clinical investigation 122(7), 2680–2689.
Calvo, J. A., Moroski-Erkul, C. A., Lake, A., Eichinger, L. W., Shah, D., Jhun, I.,
Limsirichai, P., Bronson, R. T., Christiani, D. C., Meira, L. B. et al. (2013), ‘Aag
dna glycosylase promotes alkylation-induced tissue damage mediated by parp1’,
PLoS Genet 9(4), e1003413.
Chaves de Souza, J. A., Nogueira, A. V. B., Chaves de Souza, P. P., Kim, Y. J.,
Silva Lobo, C., Pimentel Lopes de Oliveira, G. J., Cirelli, J. A., Garlet, G. P.
and Rossa, C. (2013), ‘Socs3 expression correlates with severity of inflammation,
BIBLIOGRAPHY 166
expression of proinflammatory cytokines, and activation of stat3 and p38 mapk
in lps-induced inflammation in vivo’, Mediators of inflammation 2013.
Choi, J., Djebbar, S., Fournier, A. and Labrie, C. (2014), ‘The co-chaperone dnajc12
binds to hsc70 and is upregulated by endoplasmic reticulum stress’, Cell Stress
and Chaperones 19(3), 439–446.
Coulondre, C., Miller, J. H., Farabaugh, P. J. and Gilbert, W. (1978), ‘Molecular
basis of base substitution hotspots in escherichia coli’, Nature 274(5673), 775–780.
Coussens, L. M. and Werb, Z. (2002), ‘Inflammation and cancer’, Nature
420(6917), 860–867.
Daan, S. and Aschoff, J. (1982), Circadian contributions to survival, in J. Aschoff,
S. Daan and G. Groos, eds, ‘Vertebrate Circadian Systems’, Proceedings in Life
Sciences, Springer Berlin Heidelberg, book section 34, pp. 305–321.
Daiger, S. (2017), ‘Retnet: Summaries of genes and loci causing retinal diseases.
university of texas health science center web site’.
URL: https://sph.uth.edu/Retnet/sum-dis.htm
Daiger, S., Sullivan, L. and Bowne, S. (2013), ‘Genes and mutations causing retinitis
pigmentosa’, Clinical genetics 84(2), 132–141.
David, S. S., O’Shea, V. L. and Kundu, S. (2007), ‘Base-excision repair of oxidative
dna damage’, Nature 447(7147), 941–950.
De Bessa, S. A., Salaorni, S., Patra˜o, D. F., Neto, M. M., Brentani, M. M. and Nagai,
M. A. (2006), ‘Jdp1 (dnajc12/hsp40) expression in breast cancer and its associ-
ation with estrogen receptor status’, International journal of molecular medicine
17(2), 363–368.
de la Monte, S. M. and Tong, M. (2009), ‘Mechanisms of nitrosamine-mediated
neurodegeneration: potential relevance to sporadic alzheimer’s disease’, Journal
of Alzheimer’s Disease 17(4), 817–825.
BIBLIOGRAPHY 167
Demontis, G. C., Longoni, B. and Marchiafava, P. L. (2002), ‘Molecular steps in-
volved in light-induced oxidative damage to retinal rods’, Investigative ophthal-
mology & visual science 43(7), 2421–2427.
Dizdaroglu, M. (2005), ‘Base-excision repair of oxidative dna damage by dna glyco-
sylases’, Mutation Research/Fundamental and Molecular Mechanisms of Mutage-
nesis 591(1), 45–59.
Donovan, M., Carmody, R. J. and Cotter, T. G. (2001), ‘Light-induced photore-
ceptor apoptosis in vivo requires neuronal nitric-oxide synthase and guanylate
cyclase activity and is caspase-3-independent’, The Journal Of Biological Chem-
istry 276(25), 23000–23008.
Doonan, F., Donovan, M. and Cotter, T. G. (2003), ‘Caspase-independent pho-
toreceptor apoptosis in mouse models of retinal degeneration’, The Journal of
Neuroscience 23(13), 5723–5731.
Dorner, A. J., Bole, D. G. and Kaufman, R. J. (1987), ‘The relationship of n-linked
glycosylation and heavy chain-binding protein association with the secretion of
glycoproteins.’, The Journal of cell biology 105(6), 2665–2674.
Dosanjh, M. K., Roy, R., Mitra, S. and Singer, B. (1994), ‘1,n6-ethenoadenine is
preferred over 3-methyladenine as substrate by a cloned human n-methylpurine-
dna glycosylase (3-methyladenine-dna glycosylase)’, Biochemistry 33(7), 1624–
1628.
Doublie, S., Tabor, S., Long, A. M., Richardson, C. C. and Ellenberger, T. (1998),
‘Crystal structure of a bacteriophage t7 dna replication complex at 2.2 a resolu-
tion’, Nature 391(6664), 251–258.
Drabls, F., Feyzi, E., Aas, P. A., Vaagb, C. B., Kavli, B., Bratlie, M. S., Pea-Diaz, J.,
Otterlei, M., Slupphaug, G. and Krokan, H. E. (2004), ‘Alkylation damage in dna
and rna–repair mechanisms and medical significance’, DNA Repair 3(11), 1389–
1407.
BIBLIOGRAPHY 168
Duncan, B. K. and Miller, J. H. (1980), ‘Mutagenic deamination of cytosine residues
in dna’, Nature 287(5782), 560–561.
URL: http://dx.doi.org/10.1038/287560a0
Ebrahimkhani, M. R., Daneshmand, A., Mazumder, A., Allocca, M., Calvo, J. A.,
Abolhassani, N., Jhun, I., Muthupalani, S., Ayata, C. and Samson, L. D.
(2014), ‘Aag-initiated base excision repair promotes ischemia reperfusion injury
in liver, brain, and kidney’, Proceedings of the National Academy of Sciences
111(45), E4878–E4886.
El Ghissassi, F., Barbin, A., Nair, J. and Bartsch, H. (1995), ‘Formation of 1,n6-
ethenoadenine and 3,n4-ethenocytosine by lipid peroxidation products and nucleic
acid bases’, Chemical Research in Toxicology 8(2), 278–283.
URL: http://dx.doi.org/10.1021/tx00044a013
Eliasson, M. J., Sampei, K., Mandir, A. S., Hurn, P. D., Traystman, R. J., Bao, J.,
Pieper, A., Wang, Z.-Q., Dawson, T. M., Snyder, S. H. et al. (1997), ‘Poly (adp-
ribose) polymerase gene disruption renders mice resistant to cerebral ischemia’,
Nature medicine 3(10), 1089–1095.
ElKhamisy, S. F., Masutani, M., Suzuki, H. and Caldecott, K. W. (2003), ‘A re-
quirement for parp1 for the assembly or stability of xrcc1 nuclear foci at sites of
oxidative dna damage’, Nucleic Acids Research 31(19), 5526–5533.
Engelward, B. P., Weeda, G., Wyatt, M. D., Broekhof, J. L. M., de Wit, J., Donker,
I., Allan, J. M., Gold, B., Hoeijmakers, J. H. J. and Samson, L. D. (1997),
‘Base excision repair deficient mice lacking the aag alkyladenine dna glycosylase’,
Proceedings of the National Academy of Sciences 94(24), 13087–13092.
URL: http://www.pnas.org/content/94/24/13087.abstract
Everett, L. J. and Lazar, M. A. (2014), ‘Nuclear receptor rev-erbα: up, down, and
all around’, Trends in Endocrinology & Metabolism 25(11), 586–592.
Fan, C.-Y., Lee, S. and Cyr, D. M. (2003), ‘Mechanisms for regulation of hsp70
function by hsp40’, Cell stress & chaperones 8(4), 309–316.
BIBLIOGRAPHY 169
Filipski, E., Innominato, P. F., Wu, M., Li, X.-M., Iacobelli, S., Xian, L.-J. and
Le´vi, F. (2005), ‘Effects of light and food schedules on liver and tumor molecular
clocks in mice’, Journal of the National Cancer Institute 97(7), 507–517.
Friedberg, E. C., Walker, G. C. and Siede, W. (2006), DNA repair and mutagenesis,
2 edn, ASM Press, Washington, D.C.
Fu, D., Calvo, J. A. and Samson, L. D. (2012), ‘Balancing repair and tolerance of
dna damage caused by alkylating agents’, Nature Reviews Cancer 12(2), 104–120.
Ganong, W. F. (2005), Review of medical physiology, 22 edn, Lange Medical Books.,
London.
Garc´ıa-Ayuso, D., Di Pierdomenico, J., Esquiva, G., Nadal-Nicola´s, F. M., Pinilla,
I., Cuenca, N., Vidal-Sanz, M., Agudo-Barriuso, M. and Villegas-Pe´rez, M. P.
(2015), ‘Inherited photoreceptor degeneration causes the death of melanopsin-
positive retinal ganglion cells and increases their coexpression of brn3aiprgcs
changes in p23h-1 rats’, Investigative ophthalmology & visual science 56(8), 4592–
4604.
Gorbacheva, V. Y., Kondratov, R. V., Zhang, R., Cherukuri, S., Gudkov, A. V.,
Takahashi, J. S. and Antoch, M. P. (2005), ‘Circadian sensitivity to the
chemotherapeutic agent cyclophosphamide depends on the functional status of
the clock/bmal1 transactivation complex’, Proceedings of the National Academy
of Sciences of the United States of America 102(9), 3407–3412.
Grimm, C., Wenzel, A., Hafezi, F., Yu, S., Redmond, T. M. and Rem, C. E. (2000),
‘Protection of rpe65-deficient mice identifies rhodopsin as a mediator of light-
induced retinal degeneration’, Nature Genetics 25(1), 63–66.
Grover, S., Fishman, G. A., Anderson, R. J., Alexander, K. R. and Derlacki,
D. J. (1997), ‘Rate of visual field loss in retinitis pigmentosa’, Ophthalmology
104(3), 460–465.
Guillaumond, F., Dardente, H., Gigue`re, V. and Cermakian, N. (2005), ‘Differential
control of bmal1 circadian transcription by rev-erb and ror nuclear receptors’,
Journal of biological rhythms 20(5), 391–403.
BIBLIOGRAPHY 170
Hafezi, F., Steinbach, J., Marti, A., Munz, K., Wang, Z., Wagner, E., Aguzzi,
A. and Reme´, C. (1997), ‘The absence of c-fos prevents light-induced apoptotic
cell death of photoreceptors in retinal degeneration in vivo.’, Nature medicine
3(3), 346–349.
Ham, A.-J. L., Engelward, B. P., Koc, H., Sangaiah, R., Meira, L. B., Samson, L. D.
and Swenberg, J. A. (2004), ‘New immunoaffinity-lc-ms/ms methodology reveals
that aag null mice are deficient in their ability to clear 1,n6-etheno-deoxyadenosine
dna lesions from lung and liver in vivo’, DNA Repair 3(3), 257–265.
Hamilton, J. T. G., McRoberts, W. C., Keppler, F., Kalin, R. M. and Harper,
D. B. (2003), ‘Chloride methylation by plant pectin: An efficient environmentally
significant process’, Science 301(5630), 206–209.
URL: http://www.sciencemag.org/content/301/5630/206.abstract
Hankins, M. W., Peirson, S. N. and Foster, R. G. (2008), ‘Melanopsin: an exciting
photopigment’, Trends in neurosciences 31(1), 27–36.
Hannibal, J., Ding, J. M., Chen, D., Fahrenkrug, J., Larsen, P. J., Gillette,
M. U. and Mikkelsen, J. D. (1997), ‘Pituitary adenylate cyclase-activating pep-
tide (pacap) in the retinohypothalamic tract: a potential daytime regulator of
the biological clock’, The Journal of neuroscience 17(7), 2637–2644.
Hannibal, J., Hindersson, P., Knudsen, S. M., Georg, B. and Fahrenkrug, J.
(2002), ‘The photopigment melanopsin is exclusively present in pituitary adeny-
late cyclase-activating polypeptide-containing retinal ganglion cells of the retino-
hypothalamic tract’, J Neurosci 22(1), RC191.
Hannibal, J., Vrang, N., Card, J. P. and Fahrenkrug, J. (2001), ‘Light-dependent
induction of cfos during subjective day and night in pacap-containing ganglion
cells of the retinohypothalamic tract’, Journal of Biological Rhythms 16(5), 457–
470.
Hao, W., Wenzel, A., Obin, M. S., Chen, C.-K., Brill, E., Krasnoperova, N. V.,
Eversole-Cire, P., Kleyner, Y., Taylor, A., Simon, M. I. et al. (2002), ‘Evidence
BIBLIOGRAPHY 171
for two apoptotic pathways in light-induced retinal degeneration’, Nature genetics
32(2), 254–260.
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M. and Ron, D.
(2000), ‘Regulated translation initiation controls stress-induced gene expression
in mammalian cells’, Molecular cell 6(5), 1099–1108.
Hartong, D. T., Berson, E. L. and Dryja, T. P. (2006), ‘Retinitis pigmentosa’, Lancet
368(9549), 1795–1809.
Hastings, M., Reddy, A., Garabette, M., King, V., Chahad-Ehlers, S., O’Brien, J.
and Maywood, E. (2004), Expression of clock gene products in the suprachias-
matic nucleus in relation to circadian behaviour, in ‘Novartis Found. Symp’, Vol.
253, pp. 203–217.
Hattar, S., Liao, H.-W., Takao, M., Berson, D. M. and Yau, K.-W. (2002),
‘Melanopsin-containing retinal ganglion cells: architecture, projections, and in-
trinsic photosensitivity’, Science 295(5557), 1065–1070.
Hecht, S. S. (1999), ‘Dna adduct formation from tobacco-specific n-nitrosamines’,
Mutation Research 424(1-2), 127–142.
Hetz, C. (2012), ‘The unfolded protein response: controlling cell fate decisions under
er stress and beyond’, Nature reviews Molecular cell biology 13(2), 89–102.
Hill-Perkins, M., Jones, M. D. and Karran, P. (1986), ‘Site-specific mutage-
nesis in vivo by single methylated or deaminated purine bases’, Mutation
Research/Fundamental and Molecular Mechanisms of Mutagenesis 162(2), 153–
163.
URL: http://www.sciencedirect.com/science/article/B6T2C-47N6PYC-
4R/2/f3bdb058acb9ae46adfda9024a99c145
Hitchcock, T. M., Dong, L., Connor, E. E., Meira, L. B., Samson, L. D., Wyatt,
M. D. and Cao, W. (2004), ‘Oxanine dna glycosylase activity from mammalian
alkyladenine glycosylase’, The Journal Of Biological Chemistry 279(37), 38177–
38183.
BIBLIOGRAPHY 172
Ho, D. V. and Chan, J. Y. (2015), ‘Induction of herpud1 expression by er stress is
regulated by nrf1’, FEBS letters 589(5), 615–620.
Hughes, A. and Piggins, H. (2011), ‘Feedback actions of locomotor activity to the
circadian clock.’, Progress in brain research 199, 305–336.
Hughes, S., Hankins, M. W., Foster, R. G. and Peirson, S. N. (2012), ‘2 melanopsin
phototransduction: Slowly emerging from the dark’, Progress in brain research
199, 19.
Jain, V., Srivastava, I., Palchaudhuri, S., Goel, M., Sinha-Mahapatra, S. K. and
Dhingra, N. K. (2016), ‘Classical photoreceptors are primarily responsible for the
pupillary light reflex in mouse’, PloS one 11(6), e0157226.
Jelinsky, S. A., Estep, P., Church, G. M. and Samson, L. D. (2000), ‘Regulatory net-
works revealed by transcriptional profiling of damaged saccharomyces cerevisiae
cells: Rpn4 links base excision repair with proteasomes’, Molecular and cellular
biology 20(21), 8157–8167.
Jelinsky, S. A. and Samson, L. D. (1999), ‘Global response of saccharomyces cere-
visiae to an alkylating agent’, Proceedings of the National Academy of Sciences
96(4), 1486–1491.
Jeon, C.-J., Strettoi, E. and Masland, R. H. (1998), ‘The major cell populations of
the mouse retina’, The Journal of Neuroscience 18(21), 8936–8946.
Keller, C., Grimm, C., Wenzel, A., Hafezi, F. and Rem, C. (2001), ‘Protective effect
of halothane anesthesia on retinal light damage: inhibition of metabolic rhodopsin
regeneration’, Investigative Ophthalmology & Visual Science 42(2), 476–480.
Kim, J., Matsunaga, N., Koyanagi, S. and Ohdo, S. (2009), ‘Clock gene muta-
tion modulates the cellular sensitivity to genotoxic stress through altering the
expression of n-methylpurine dna glycosylase gene’, Biochemical pharmacology
78(8), 1075–1082.
Klungland, A., Hss, M., Gunz, D., Constantinou, A., Clarkson, S. G., Doetsch,
P. W., Bolton, P. H., Wood, R. D. and Lindahl, T. (1999), ‘Base excision repair
of oxidative dna damage activated by xpg protein’, Molecular Cell 3(1), 33–42.
BIBLIOGRAPHY 173
Kraus, W. L. and Lis, J. T. (2003), ‘Parp goes transcription’, Cell 113(6), 677–683.
Kroese, E. D., Zeilmaker, M. J., Mohn, G. R. and Meerman, J. H. (1990), ‘Preven-
tive action of thioethers towards in vitro dna binding and mutagenesis in¡ i¿ e.
coli¡/i¿ k12 by alkylating agents’, Mutation Research Letters 245(2), 67–74.
Kubota, Y., Nash, R. A., Klungland, A., Schr, P., Barnes, D. E. and Lindahl, T.
(1996), ‘Reconstitution of dna base excision-repair with purified human proteins:
interaction between dna polymerase beta and the xrcc1 protein’, The EMBO
Journal 15(23), 6662–6670.
URL: http://europepmc.org/abstract/MED/8978692
Kyrtopoulos, S. A. (1995), ‘Variability in dna repair and individual susceptibility
to genotoxins.’, Clinical chemistry 41(12), 1848–1853.
Lamb, T. D. (1996), ‘Transduction in human photoreceptors’, Australian and New
Zealand Journal of Ophthalmology 24(2), 105–110.
URL: http://dx.doi.org/10.1111/j.1442-9071.1996.tb01562.x
Lamb, T. D. and Pugh, E. N. (1992), ‘A quantitative account of the activation
steps involved in phototransduction in amphibian photoreceptors’, The Journal
of Physiology 449(1), 719–758.
URL: http://jp.physoc.org/content/449/1/719.abstract
Larhammar, D., Nordstrm, K. and Larsson, T. A. (2009), ‘Evolution of vertebrate
rod and cone phototransduction genes’, Philosophical Transactions of the Royal
Society B: Biological Sciences 364(1531), 2867–2880.
Larson, K., Sahm, J., Shenkar, R. and Strauss, B. (1985), ‘Methylation-induced
blocks to in vitro dna replication’, Mutation Research 150(1-2), 77–84.
Le´vi, F., Okyar, A., Dulong, S., Innominato, P. F. and Clairambault, J. (2010),
‘Circadian timing in cancer treatments’, Annual review of pharmacology and tox-
icology 50, 377–421.
Li, Y., Han, M.-F., Li, W.-N., Shi, A.-c., Zhang, Y.-y., Wang, H.-Y., Wang, F.-x.,
Li, L., Wu, T., Ding, L. et al. (2014), ‘Socs3 expression correlates with severity
BIBLIOGRAPHY 174
of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and
hbv-aclf’, Journal of Huazhong University of Science and Technology [Medical
Sciences] 34, 348–353.
Liu, C.-y., Hsu, Y.-H., Wu, M.-T., Pan, P.-C., Ho, C.-K., Su, L., Xu, X., Li, Y.
and Christiani, D. C. (2009), ‘Cured meat, vegetables, and bean-curd foods in
relation to childhood acute leukemia risk: a population based case-control study’,
BMC cancer 9(1), 1.
Liu, X., Mameza, M. G., Lee, Y. S., Eseonu, C. I., Yu, C.-R., Derwent, J. J. K.
and Egwuagu, C. E. (2008), ‘Suppressors of cytokine-signaling proteins induce
insulin resistance in the retina and promote survival of retinal cells’, Diabetes
57(6), 1651–1658.
Luby-Phelps, K., Fogerty, J., Baker, S. A., Pazour, G. J. and Besharse, J. C. (2008),
‘Spatial distribution of intraflagellar transport proteins in vertebrate photorecep-
tors’, Vision Research 48(3), 413–423.
URL: http://www.sciencedirect.com/science/article/pii/S0042698907003689
Luo, D.-G., Xue, T. and Yau, K.-W. (2008), ‘How vision begins: An odyssey’,
Proceedings of the National Academy of Sciences 105(29), 9855–9862.
URL: http://www.pnas.org/content/105/29/9855.abstract
Mang, G. M., La Spada, F., Emmenegger, Y., Chappuis, S., Ripperger, J. A., Al-
brecht, U. and Franken, P. (2016), ‘Altered sleep homeostasis in rev-erbα knock-
out mice’, Sleep 39(3), 589–601.
Marchenay, C., Cellarier, E., Levi, F., Rolhion, C., Kwiatkowski, F., Claustrat, B.,
Madelmont, J.-C. and Chollet, P. (2001), ‘Circadian variation in o6-alkylguanine-
dna alkyltransferase activity in circulating blood mononuclear cells of healthy
human subjects’, International journal of cancer 91(1), 60–66.
Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R.,
Nagata, K., Harding, H. P. and Ron, D. (2004), ‘Chop induces death by promoting
protein synthesis and oxidation in the stressed endoplasmic reticulum’, Genes &
development 18(24), 3066–3077.
BIBLIOGRAPHY 175
Marnett, L. J. (2000), ‘Oxyradicals and dna damage’, Carcinogenesis 21(3), 361–
370.
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D.,
Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., Schauer,
D. B., Dedon, P. C., Fox, J. G. and Samson, L. D. (2008), ‘Dna damage induced
by chronic inflammation contributes to colon carcinogenesis in mice’, The Journal
Of Clinical Investigation 118(7), 2516–2525.
Meira, L. B., Burgis, N. E. and Samson, L. D. (2005), Base excision repair, in
‘Genome Instability in Cancer Development’, Springer, pp. 125–173.
Meira, L. B., Moroski-Erkul, C. A., Green, S. L., Calvo, J. A., Bronson, R. T., Shah,
D. and Samson, L. D. (2009), ‘Aag-initiated base excision repair drives alkylation-
induced retinal degeneration in mice’, Proceedings of the National Academy of
Sciences 106(3), 888–893.
URL: http://www.pnas.org/content/106/3/888.abstract
Meira, L. B., Moroski-Erkul, C. A., Green, S. L., Calvo, J. A. and Samson, L. D.
(unpublished), Aag-mediated modulation of transcriptional responses upon alky-
lation exposure. Data obtained in Massachusetts Institute of Technology, Cam-
bridge, MA, USA.
Mizumoto, K., Glascott Jr, P. A. and Farber, J. L. (1993), ‘Roles for oxidative stress
and poly (adp-ribosyl) ation in the killing of cultured hepatocytes by methyl
methanesulfonate’, Biochemical pharmacology 46(10), 1811–1818.
Mollema, N. J., Yuan, Y., Jelcick, A. S., Sachs, A. J., von Alpen, D., Schorderet,
D., Escher, P. and Haider, N. B. (2011), ‘Nuclear receptor rev-erb alpha (nr1d1)
functions in concert with nr2e3 to regulate transcriptional networks in the retina’,
PloS one 6(3), e17494.
Moriguchi, K., Yuri, T., Yoshizawa, K., Kiuchi, K., Takada, H., Inoue, Y., Hada,
T., Matsumura, M. and Tsubura, A. (2003), ‘Dietary docosahexaenoic acid pro-
tects against¡ i¿ n¡/i¿-methyl-¡ i¿ n¡/i¿-nitrosourea-induced retinal degeneration
in rats’, Experimental eye research 77(2), 167–173.
BIBLIOGRAPHY 176
Mullins, R. and Skeie, J. (2010), Essentials of retinal morphology, in I.-H. Pang and
A. F. Clark, eds, ‘Animal Models for Retinal Diseases’, Vol. 46 of Neuromethods,
Humana Press, book section 1, pp. 1–11.
Nagar, S., Krishnamoorthy, V., Cherukuri, P., Jain, V. and Dhingra, N. (2009),
‘Early remodeling in an inducible animal model of retinal degeneration’, Neuro-
science 160(2), 517–529.
Nakajima, M., Yuge, K., Senzaki, H., Shikata, N., Miki, H., Uyama, M. and
Tsubura, A. (1996), ‘Photoreceptor apoptosis induced by a single systemic ad-
ministration of n-methyl-n-nitrosourea in the rat retina’, The American journal
of pathology 148(2), 631.
Nambu, H., Nakajima, M., Shikata, N., Takahashi, K., Miki, H., Uyama, M. and
Tsubura, A. (1997), ‘Morphologic characteristics of nmethyinnitrosoureainduced
retinal degeneration in c57bl mice’, Pathology international 47(6), 377–383.
O’Connor, T. R. and Laval, F. (1990), ‘Isolation and structure of a cdna expressing a
mammalian 3-methyladenine-dna glycosylase’, The EMBO Journal 9(10), 3337–
3342.
Ogino, H., Ito, M., Matsumoto, K., Yagyu, S., Tsuda, H., Hirono, I., Wild, C. P. and
Montesano, R. (1993), ‘Retinal degeneration induced by n-methyl-n-nitrosourea
and detection of 7-methyldeoxyguanosine in the rat retina’, Toxicologic Pathology
21(1), 21–25.
Ohshima, H. and Bartsch, H. (1994), ‘Chronic infections and inflammatory
processes as cancer risk factors: possible role of nitric oxide in carcinogenesis’,
Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis
305(2), 253–264.
URL: http://www.sciencedirect.com/science/article/B6T2C-47P87CR-
69/2/d6fcb6aab91ba87b4ed9d28802b4f10e
Oklejewicz, M., Destici, E., Tamanini, F., Hut, R. A., Janssens, R. and van der
Horst, G. T. (2008), ‘Phase resetting of the mammalian circadian clock by dna
damage’, Current Biology 18(4), 286–291.
BIBLIOGRAPHY 177
Organisciak, D., Darrow, R., Darrow, R. and Lininger, L. (1998), Environmental
light and age-related changes in retinal proteins, in ‘Photostasis and Related
Phenomena’, Springer, pp. 79–92.
Organisciak, D. T., Darrow, R. A., Barsalou, L., Darrow, R. M. and Lininger, L. A.
(1999), ‘Light-induced damage in the retina: Differential effects of dimethylth-
iourea on photoreceptor survival, apoptosis and dna oxidation’, Photochemistry
and photobiology 70(2), 261–268.
Organisciak, D. T., Darrow, R. M., Barsalou, L., Kutty, R. K. and Wiggert, B.
(2000), ‘Circadian-dependent retinal light damage in rats’, Investigative Ophthal-
mology & Visual Science 41(12), 3694–3701.
URL: http://www.iovs.org/content/41/12/3694.abstract
Organisciak, D. T., Darrow, R. M., Barsalou, L., Kutty, R. K. and Wiggert, B.
(2003), ‘Susceptibility to retinal light damage in transgenic rats with rhodopsin
mutations’, Investigative Ophthalmology & Visual Science 44(2), 486–492.
URL: http://www.iovs.org/content/44/2/486.abstract
Organisciak, D. T. and Vaughan, D. K. (2010), ‘Retinal light damage: mechanisms
and protection’, Progress in Retinal and Eye Research 29(2), 113–134.
Ozawa, Y., Nakao, K., Kurihara, T., Shimazaki, T., Shimmura, S., Ishida, S.,
Yoshimura, A., Tsubota, K. and Okano, H. (2008), ‘Roles of stat3/socs3 pathway
in regulating the visual function and ubiquitin-proteasome-dependent degrada-
tion of rhodopsin during retinal inflammation’, Journal of Biological Chemistry
283(36), 24561–24570.
Paladino, N., Duhart, J. M., Fedele, M. L. M. and Golombek, D. A. (2013), ‘Charac-
terization of locomotor activity circadian rhythms in athymic nude mice’, Journal
of circadian rhythms 11(1), 2.
Palam, L. R., Baird, T. D. and Wek, R. C. (2011), ‘Phosphorylation of eif2 facilitates
ribosomal bypass of an inhibitory upstream orf to enhance chop translation’,
Journal of Biological Chemistry 286(13), 10939–10949.
BIBLIOGRAPHY 178
Pandya, G. A. and Moriya, M. (1996), ‘1,n6-ethenodeoxyadenosine, a dna adduct
highly mutagenic in mammalian cells’, Biochemistry 35(35), 11487–11492.
Pascucci, B., Maga, G., Hbscher, U., Bjoras, M., Seeberg, E., Hickson, I. D., Vil-
lani, G., Giordano, C., Cellai, L. and Dogliotti, E. (2002), ‘Reconstitution of the
base excision repair pathway for 7,8-dihydro-8-oxoguanine with purified human
proteins’, Nucleic Acids Research 30(10), 2124–2130.
Pittendrigh, C. S. (1993), ‘Temporal organization: reflections of a darwinian clock-
watcher’, Annual Review Of Physiology 55, 16–54.
Porsin, B., Formento, J.-L., Filipski, E., Etienne, M.-C., Francoual, M., Rene´e, N.,
Magne, N., Le´vi, F. and Milano, G. (2003), ‘Dihydropyrimidine dehydrogenase
circadian rhythm in mouse liver: comparison between enzyme activity and gene
expression’, European Journal of Cancer 39(6), 822–828.
Pregueiro, A. M., Liu, Q., Baker, C. L., Dunlap, J. C. and Loros, J. J. (2006), ‘The
neurospora checkpoint kinase 2: a regulatory link between the circadian and cell
cycles’, Science 313(5787), 644–649.
Provencio, I., Jiang, G., Willem, J., Hayes, W. P. and Rollag, M. D. (1998),
‘Melanopsin: An opsin in melanophores, brain, and eye’, Proceedings of the Na-
tional Academy of Sciences 95(1), 340–345.
Provencio, I., Rodriguez, I. R., Jiang, G., Hayes, W. P., Moreira, E. F. and Rol-
lag, M. D. (2000), ‘A novel human opsin in the inner retina’, The Journal of
Neuroscience 20(2), 600–605.
Ralph, M. R. and Menaker, M. (1988), ‘A mutation of the circadian system in
golden hamsters’, Science 241(4870), 1225.
Rapp, L., Tolman, B. and Dhindsa, H. (1990), ‘Separate mechanisms for retinal
damage by ultraviolet-a and mid-visible light’, Investigative Ophthalmology &
Visual Science 31(6), 1186–1190.
Rebeck, G. W. and Samson, L. (1991), ‘Increased spontaneous mutation and alky-
lation sensitivity of escherichia coli strains lacking the ogt o6-methylguanine dna
repair methyltransferase’, Journal Of Bacteriology 173(6), 2068–2076.
BIBLIOGRAPHY 179
Redmond, T. M., Yu, S., Lee, E., Bok, D., Hamasaki, D., Chen, N., Goletz, P., Ma,
J. X., Crouch, R. K. and Pfeifer, K. (1998), ‘Rpe65 is necessary for production
of 11-cis-vitamin a in the retinal visual cycle’, Nature Genetics 20(4), 344–351.
Richards, M. J., Nagel, B. A. and Fliesler, S. J. (2006), ‘Lipid hydroperoxide forma-
tion in the retina: correlation with retinal degeneration and light damage in a rat
model of smithlemliopitz syndrome’, Experimental eye research 82(3), 538–541.
Richardson, A. G. and Schadt, E. E. (2014), ‘The role of macromolecular damage in
aging and age-related disease’, The Journals of Gerontology Series A: Biological
Sciences and Medical Sciences 69(Suppl 1), S28–S32.
Ripperger, J. A. and Albrecht, U. (2012), ‘The circadian clock component period2:
from molecular to cerebral functions’, Prog Brain Res 199, 233–45.
Ron, I. G., Peleg, L., Rienstein, S., Dotan, A., Ticher, A., Wolfson, S. and
Ashkenazi, I. E. (1998), ‘Time dependency of hematopoietic growth factor cou-
pled to chronotoxicity of carboplatin’, Cancer chemotherapy and pharmacology
42(2), 135–141.
Roth, R. B. and Samson, L. D. (2002), ‘3-methyladenine dna glycosylase-deficient
aag null mice display unexpected bone marrow alkylation resistance’, Cancer
Research 62(3), 656–660.
URL: http://cancerres.aacrjournals.org/content/62/3/656.abstract
Rottenberg, M. E. and Carow, B. (2014), ‘Socs3, a major regulator of infection and
inflammation’, Frontiers in immunology 5, 58.
Rouet, P. and Essigmann, J. M. (1985), ‘Possible role for thymine glycol in the
selective inhibition of dna synthesis on oxidized dna templates’, Cancer Research
45(12 Pt 1), 6113–6118.
Rozanowska, M., Rosanowski, B. and Boulton, M. (2009), ‘Light induced damage to
the retina’, Photobiology of the Retina. Available at: http://www.photobiology.info
.
BIBLIOGRAPHY 180
Rydberg, B. and Lindahl, T. (1982), ‘Nonenzymatic methylation of dna by the in-
tracellular methyl group donor s-adenosyl-l-methionine is a potentially mutagenic
reaction’, The EMBO Journal 1(2), 211–216.
Saari, J. C., Garwin, G. G., Van Hooser, J. P. and Palczewski, K. (1998), ‘Reduction
of all-trans-retinal limits regeneration of visual pigment in mice’, Vision Research
38(10), 1325–1333.
Sakamoto, K., Liu, C., Kasamatsu, M., Pozdeyev, N. V., Iuvone, P. M. and Tosini,
G. (2005), ‘Dopamine regulates melanopsin mrna expression in intrinsically pho-
tosensitive retinal ganglion cells’, European Journal of Neuroscience 22(12), 3129–
3136.
Sakamoto, K., Liu, C. and Tosini, G. (2004), ‘Classical photoreceptors regu-
late melanopsin mrna levels in the rat retina’, The Journal of neuroscience
24(43), 9693–9697.
Schouten, K. A. and Weiss, B. (1999), ‘Endonuclease v protects escherichia coli
against specific mutations caused by nitrous acid’, Mutation Research/DNA
Repair 435(3), 245–254.
URL: http://www.sciencedirect.com/science/article/B6T2B-3Y8W992-
5/2/596c57f889117f7a7a459cb13951543a
Schreiber, V., Dantzer, F., Ame, J.-C. and De Murcia, G. (2006), ‘Poly (adp-
ribose): novel functions for an old molecule’, Nature Reviews Molecular Cell Bi-
ology 7(7), 517–528.
Schuck, S., Prinz, W. A., Thorn, K. S., Voss, C. and Walter, P. (2009), ‘Membrane
expansion alleviates endoplasmic reticulum stress independently of the unfolded
protein response’, The Journal of cell biology 187(4), 525–536.
Schwartz, W. J. and Zimmerman, P. (1990), ‘Circadian timekeeping in balb/c and
c57bl/6 inbred mouse strains’, Journal of Neuroscience 10(11), 3685–3694.
Sedgwick, B., Bates, P. A., Paik, J., Jacobs, S. C. and Lindahl, T. (2007), ‘Repair
of alkylated dna: Recent advances’, DNA Repair 6(4), 429–442.
BIBLIOGRAPHY 181
URL: http://www.sciencedirect.com/science/article/B6X17-4MC0TH4-
1/2/bf3ab47cbee848d6ad32d5f1e6d5a072
Semo, M., Peirson, S., Lupi, D., Lucas, R. J., Jeffery, G. and Foster, R. G. (2003),
‘Melanopsin retinal ganglion cells and the maintenance of circadian and pupillary
responses to light in aged rodless/coneless (rd/rd cl) mice’, European Journal of
Neuroscience 17(9), 1793–1801.
Senthong, P., Millington, C. L., Wilkinson, O. J., Marriott, A. S., Watson, A. J.,
Reamtong, O., Eyers, C. E., Williams, D. M., Margison, G. P. and Povey, A. C.
(2013), ‘The nitrosated bile acid dna lesion o6-carboxymethylguanine is a sub-
strate for the human dna repair protein o6-methylguanine-dna methyltransferase’,
Nucleic acids research p. gks1476.
Silverthorn, D. U. (2016), Human physiology : an integrated approach, 7th edn,
Pearson/Benjamin Cummings., Lonodon.
Sleeth, K. M., Robson, R. L. and Dianov, G. L. (2004), ‘Exchangeability of
mammalian dna ligases between base excision repair pathways’, Biochemistry
43(40), 12924–12930.
URL: http://dx.doi.org/10.1021/bi0492612
Slotten, H. A., Krekling, S. and Pe´vet, P. (2005), ‘Photic and nonphotic effects
on the circadian activity rhythm in the diurnal rodent arvicanthis ansorgei’, Be-
havioural brain research 165(1), 91–97.
Slupphaug, G., Mol, C. D., Kavli, B., Arvai, A. S., Krokan, H. E. and Tainer, J. A.
(1996), ‘A nucleotide-flipping mechanism from the structure of human uracil-dna
glycosylase bound to dna’, Nature 384(6604), 87–92.
URL: http://dx.doi.org/10.1038/384087a0
Sobol, R. W., Horton, J. K., Kuhn, R., Gu, H., Singhal, R. K., Prasad, R., Rajew-
sky, K. and Wilson, S. H. (1996), ‘Requirement of mammalian dna polymerase-
[beta] in base-excision repair’, Nature 379(6561), 183–186.
URL: http://dx.doi.org/10.1038/379183a0
BIBLIOGRAPHY 182
Sobol, R. W., Kartalou, M., Almeida, K. H., Joyce, D. F., Engelward, B. P., Horton,
J. K., Prasad, R., Samson, L. D. and Wilson, S. H. (2003), ‘Base excision repair
intermediates induce p53-independent cytotoxic and genotoxic responses’, The
Journal Of Biological Chemistry 278(41), 39951–39959.
Sobol, R. W., Prasad, R., Evenski, A., Baker, A., Yang, X.-P., Horton,
J. K. and Wilson, S. H. (2000), ‘The lyase activity of the dna repair pro-
tein [beta]-polymerase protects from dna-damage-induced cytotoxicity’, Nature
405(6788), 807–810.
URL: http://dx.doi.org/10.1038/35015598
Sobol, R. W. and Wilson, S. H. (2001), Mammalian dna -polymerase in base excision
repair of alkylation damage, in S. M. A. K. M. R. S. L. S. H. W. Kivie Moldave,
ed., ‘Progress in Nucleic Acid Research and Molecular Biology’, Vol. Volume 68,
Academic Press, pp. 57–74.
Song, B., Scheuner, D., Ron, D., Pennathur, S. and Kaufman, R. J. (2008), ‘Chop
deletion reduces oxidative stress, improves β cell function, and promotes cell sur-
vival in multiple mouse models of diabetes’, The Journal of clinical investigation
118(10), 3378–3389.
Specht, S., Leffak, M., Darrow, R. M. and Organisciak, D. T. (1999), ‘Damage to
rat retinal dna induced in vivo by visible light’, Photochemistry And Photobiology
69(1), 91–98.
Specht, S., Organisciak, D. T., Darrow, R. M. and Leffak, M. (2000), ‘Continuing
damage to rat retinal dna during darkness following light exposure’, Photochem-
istry And Photobiology 71(5), 559–566.
Storch, K.-F., Paz, C., Signorovitch, J., Raviola, E., Pawlyk, B., Li, T. and Weitz,
C. J. (2007), ‘Intrinsic circadian clock of the mammalian retina: importance for
retinal processing of visual information’, Cell 130(4), 730–741.
Takahashi, J. S. (2016), ‘Transcriptional architecture of the mammalian circadian
clock’, Nature Reviews Genetics .
BIBLIOGRAPHY 183
Takahashi, J. S., Hong, H.-K., Ko, C. H. and McDearmon, E. L. (2008), ‘The
genetics of mammalian circadian order and disorder: implications for physiology
and disease’, Nature Reviews Genetics 9(10), 764–775.
Taomoto, M., Nambu, H., Senzaki, H., Shikata, N., Oishi, Y., Fujii, T., Miki,
H., Uyama, M. and Tsubura, A. (1998), ‘Retinal degeneration induced by n-
methyl-n-nitrosourea in syrian golden hamsters’, Graefe’s Archive For Clinical
And Experimental Ophthalmology = Albrecht Von Graefes Archiv Fr Klinische
Und Experimentelle Ophthalmologie 236(9), 688–695.
Taverna, P. and Sedgwick, B. (1996), ‘Generation of an endogenous dna-methylating
agent by nitrosation in escherichia coli’, J. Bacteriol. 178(17), 5105–5111.
URL: http://jb.asm.org/cgi/content/abstract/178/17/5105
Terazono, H., Hamdan, A., Matsunaga, N., Hayasaka, N., Kaji, H., Egawa, T.,
Makino, K., Shigeyoshi, Y., Koyanagi, S. and Ohdo, S. (2008), ‘Modulatory effects
of 5-fluorouracil on the rhythmic expression of circadian clock genes: a possible
mechanism of chemotherapy-induced circadian rhythm disturbances’, Biochemi-
cal pharmacology 75(8), 1616–1622.
Tong, M., Neusner, A., Longato, L., Lawton, M., Wands, J. R. and de la Monte,
S. M. (2009), ‘Nitrosamine exposure causes insulin resistance diseases: relevance
to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and alzheimer’s disease’,
Journal of Alzheimer’s Disease 17(4), 827–844.
Trewick, S. C., Henshaw, T. F., Hausinger, R. P., Lindahl, T. and Sedgwick, B.
(2002), ‘Oxidative demethylation by escherichia coli alkb directly reverts dna
base damage’, Nature 419(6903), 174–178.
URL: http://dx.doi.org/10.1038/nature00908
Trivedi, R. N., Almeida, K. H., Fornsaglio, J. L., Schamus, S. and Sobol, R. W.
(2005), ‘The role of base excision repair in the sensitivity and resistance to
temozolomide-mediated cell death’, Cancer Research 65(14), 6394–6400.
BIBLIOGRAPHY 184
van Laar, T., Schouten, T., Hoogervorst, E., van Eck, M., van der Eb, A. J. and
Terleth, C. (2000), ‘The novel mms-inducible gene mif1/kiaa0025 is a target of
the unfolded protein response pathway’, FEBS letters 469(1), 123–131.
Vaughan, P., Lindahl, T. and Sedgwick, B. (1993), ‘Induction of the adaptive
response of escherichia coli to alkylation damage by the environmental mutagen,
methyl chloride’, Mutation Research/DNA Repair 293(3), 249–257.
URL: http://www.sciencedirect.com/science/article/B6T2B-47GGK8D-
29/2/924a9f78890227bfe16a7131fd6cc05b
Vidal, A. E., Boiteux, S., Hickson, I. D. and Radicella, J. P. (2001), ‘Xrcc1 coordi-
nates the initial and late stages of dna abasic site repair through proteinprotein
interactions’, The EMBO Journal 20(22), 6530–6539.
von Gall, C., Duffield, G. E., Hastings, M. H., Kopp, M. D., Dehghani, F., Korf,
H.-W. and Stehle, J. H. (1998), ‘Creb in the mouse scn: a molecular interface
coding the phase-adjusting stimuli light, glutamate, pacap, and melatonin for
clockwork access’, Journal of Neuroscience 18(24), 10389–10397.
Walker, M. W., Kinter, M. T., Roberts, R. J. and Spitz, D. R. (1995), ‘Nitric oxide-
induced cytotoxicity: involvement of cellular resistance to oxidative stress and
the role of glutathione in protection’, Pediatric research 37(1), 41–49.
Wan, J., Zheng, H., Hu, B.-Y., Xiao, H.-L., She, Z.-J., Chen, Z.-L. and Zhou, G.-M.
(2006), ‘Acute photoreceptor degeneration down-regulates melanopsin expression
in adult rat retina’, Neuroscience Letters 400(1), 48–52.
Wang, M. and Kaufman, R. J. (2014), ‘The impact of the endoplasmic reticu-
lum protein-folding environment on cancer development’, Nature Reviews Cancer
14(9), 581–597.
Wenzel, A., Grimm, C., Marti, A., Kueng-Hitz, N., Hafezi, F., Niemeyer, G. and
Reme´, C. E. (2000), ‘c-fos controls the private pathway of light-induced apoptosis
of retinal photoreceptors’, Journal of Neuroscience 20(1), 81–88.
Wenzel, A., Grimm, C., Samardzija, M. and Rem, C. E. (2005), ‘Molecular mech-
anisms of light-induced photoreceptor apoptosis and neuroprotection for retinal
BIBLIOGRAPHY 185
degeneration’, Progress in Retinal and Eye Research 24(2), 275–306.
URL: http://www.sciencedirect.com/science/article/pii/S1350946204000710
Wiegand, R., Giusto, N. M., Rapp, L. M. and Anderson, R. E. (1983), ‘Evidence
for rod outer segment lipid peroxidation following constant illumination of the
rat retina’, Investigative Ophthalmology & Visual Science 24(10), 1433–1435.
Wilhelm, D., Bender, K., Knebel, A. and Angel, P. (1997), ‘The level of intracel-
lular glutathione is a key regulator for the induction of stress-activated signal
transduction pathways including jun n-terminal protein kinases and p38 kinase
by alkylating agents’, Molecular And Cellular Biology 17(8), 4792–4800.
Wiseman, H. and Halliwell, B. (1996), ‘Damage to dna by reactive oxygen and
nitrogen species: role in inflammatory disease and progression to cancer’, The
Biochemical Journal 313 ( Pt 1), 17–29.
Yamaguchi, S., Mitsui, S., Yan, L., Yagita, K., Miyake, S. and Okamura, H. (2000),
‘Role of dbp in the circadian oscillatory mechanism’, Molecular and Cellular Bi-
ology 20(13), 4773–4781.
Yang, J.-H., Basinger, S. F., Gross, R. L. and Wu, S. M. (2003), ‘Blue lightin-
duced generation of reactive oxygen species in photoreceptor ellipsoids requires
mitochondrial electron transport’, Investigative Ophthalmology & Visual Science
44(3), 1312–1319.
URL: http://www.iovs.org/content/44/3/1312.abstract
Yoshizawa, K., Kuwata, M., Kawanaka, A., Uehara, N., Yuri, T. and Tsubura, A.
(2009), ‘N-methyl-n-nitrosourea-induced retinal degeneration in mice is indepen-
dent of the p53 gene’, Molecular Vision 15, 2919–2925.
Yoshizawa, K., Yang, J., Senzaki, H., Uemura, Y., Kiyozuka, Y., Shikata, N., Oishi,
Y., Miki, H. and Tsubura, A. (2000), ‘Caspase-3 inhibitor rescues n -methyl- n
-nitrosourea-induced retinal degeneration in spraguedawley rats’, Experimental
eye research 71(6), 629–635.
Yu, S.-W., Andrabi, S. A., Wang, H., Kim, N. S., Poirier, G. G., Dawson, T. M. and
Dawson, V. L. (2006), ‘Apoptosis-inducing factor mediates poly (adp-ribose)(par)
BIBLIOGRAPHY 186
polymer-induced cell death’, Proceedings of the National Academy of Sciences
103(48), 18314–18319.
